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ABSTRACT
BALB/c mice infected with P. chabaudi AS develop immunity to erythrocytic-
stage  infection  with  early  Th1  responses  followed  by  a  switch  towards  Th2
responses  later  to  mediate  protection  during  chronic  disease. In  order  to
determine  the  importance  of  the  Th2  cytokines,  IL-4/IL-13,  in  inducing
protective immunity, the course of P. chabaudi infection was monitored in
IL-4Rα-deficient mice. Interestingly,  an  early  delay  in  the  onset  of  peak
parasitaemia in IL-4Rα
-/- compared with WT control BALB/c mice was evident.
Consequently,  we  demonstrated  that  IL-4Rα  deficiency  resulted  in  mice
becoming  more  susceptible  to  chronic P.  chabaudi  infection  with  increased
recrudescence, mortality and an impaired Th2 immune response compared with
WT  control  mice.  Similar  results  in  the  overall  disease  and  immunological
profiles between IL-4R
-/- and wild-type mice were obtained whether male or
female mice or the AJ or AS strains of P. chabaudi were used to infect mice.
Thus,  the  protective  role  of  IL-4R  signalling  during  chronic  disease  was  not
parasite  strain-specific  or  host  gender  dependent.  However,  males  were
significantly  more  susceptible  than  female  mice  and  consequently  further
studies  involving  cell-type  IL-4R
-/-  mice,  utilized  female  mice to  identify
functional  targets  of  IL-4/IL-13  protection.  Abrogated  IL-4Rα  expression  on
macrophages/neutrophils  (LysM
creIL-4Rα
-/lox)  mice  had  minimal  effect  on  the
outcome of P. chabaudi AS chronic infection and was comparable to WT mice
implicating no major role for alternatively activated macrophages during chronic
infection.  In  contrast,  CD4
+  T-cell-specific  IL-4Rα
-/-  (Lck
creIL-4Rα
-/lox)  mice
infected  with P.  chabaudi AS  developed  increased  recrudescence,  increased
mortality and impairment of Th2 immunity during the chronic infection similar to
that of the global IL-4Rα
-/- mice. This highlights the importance of signalling via
CD4
+  T-cells  signalling  via  IL-4Rα  for  protective  immunity  during  chronic
infection.  Paradoxically,  CD4
+CD8
+  T-cell-specific  IL-4Rα
-/- (iLck
cre  IL-4Rα
-/lox)
mice displayed a similar disease profile to WT control mice but manifested a
delayed  Th2  phenotype  during  the  latter  stage  of  the  disease  with  enhanced
splenomegaly in comparison to the WT and IL-4Rα
-/- mice. Thus while  protection
during chronic infection with P. chabaudi AS appears dependent on CD4
+ T-cells
responsive to IL-4, CD8
+ T cells responsive to IL-4 have a more complex and more
difficult role to interpret.iv
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Chapter One
Literature Review2
1. INTRODUCTION
1.1 Malaria Epidemiology
Compared with 30 years ago, malaria remains one of the greatest burdens for
the developing world with increased infections, morbidity and mortality rates.
Infection is endemic in most parts of sub-Saharan Africa and in other tropical
regions. Approximately half of the world’s population is at risk of malaria. An
estimated 250 million cases and 1 million deaths, mostly among African children
under five years of age and pregnant women, occur annually amongst the 3.3
billion people at risk (WHO World Malaria Report, 2008)
There are over 200 species of Plasmodium, in the phylum Apicomplexa, and they
collectively infect humans and other mammals, birds and lizards although with a
significant amount of specificity for host species. They represent a successful
group  of  parasites  due  to  their  invasion  and  host  immunity  avoidance
capabilities.  There  are  four  types  of  human  malaria.  The majority  of  severe
cases and deaths are caused by Plasmodium falciparum. Relatively infrequent
causes of morbidity are caused by P. malariae and P. ovale while P. vivax is a
common  cause  of  severe  acute  febrile  illness  especially  in  Asia  and South
America but is rarely fatal (Price et al., 2009, 2007, Stevenson and Riley, 2004).
In  recent  years,  some  human  cases  of  malaria  have  also  occurred  with
Plasmodium knowlesi, a primate malaria that occurs in certain forested areas of
South-East Asia (Sabbatani et al., 2010).
Malaria transmission occurs via the bite of female Anopheles mosquitoes, which
bite mainly between dusk and dawn. Intensity of transmission depends on factors
related to the parasite, the vector, the human host, and the environment. There
are  about  100  species  of Anopheles which  can  transmit  malaria  with  30-40
regularly transmitting the parasite. About 20 different Anopheles species occur
around the world and breed in shallow collections of freshwater puddles, rice
fields, and hoof prints. Transmission is more intense in areas where the mosquito
is  relatively  long-lived  which  enables  the  malaria  parasite  to  complete  its
development  inside  the  mosquito,  and  where  the  mosquito  prefers  to  bite
humans rather than other animals. For example, the long lifespan and strong
human-biting  habit  of  the  African  vector  species, Anopheles  gambiae,  is  the
underlying  reason  why  more than  85%  of the  world's  malaria  deaths  occur  in
Africa. In areas of intense transmission, human immunity is another important3
factor. Immunity to malaria infection is developed over years of exposure to the
parasite but still does not provide complete protection (Hafalla et al., 2011;
Crompton et al., 2010; Marsh and Kinyanjui, 2006). It does, however, reduce the
risk of severe disease. This explains why the majority of deaths occur in young
children. In areas where there is lower transmission and low immunity, all age
groups are at risk of infection and clinical disease. Climatic conditions such as
rainfall  patterns,  temperature  and  humidity  is  another  factor  affecting  the
transmission rate of malaria by the mosquito. Malaria epidemics can occur when
climate conditions suddenly favour transmission (Paaijmans et al., 2010, 2009;
Parham and Michael, 2010) in areas where people have little or no immunity to
malaria. Alternatively this can occur when people with low immunity move into
areas  with  intense  malaria  transmission,  for  instance  to  find  work,  or  as
refugees.
Malaria is an acute febrile illness. Only the malaria parasite multiplying in the
red blood cell (RBC) will cause disease. Clinical symptoms associated with the
blood-stage  infection usually  include  bouts  of  fever,  headaches,  chills  and
vomiting which may be mild and difficult to sometimes recognize as malaria. If
not treated within 24 hours of clinical symptoms first appearing, P. falciparum
infection can progress to severe malaria often leading to death. Young children
with  severe  disease  where  malaria  is  endemic  frequently  develop  severe
anaemia and respiratory distress in relation to metabolic acidosis, which appears
between seven and fifteen days after an infective bite. Malaria during pregnancy
may cause severe disease in the mother, and may lead to premature delivery or
delivery of a low-birth-weight baby. In P. vivax and P. ovale infections, clinical
relapses may occur weeks to months after the first infection. These relapses
arise  from  dormant  liver  forms  of  the  parasite  termed  hypnozoites  that
reactivate  and  which  are  absent  in P.  falciparum  and P.  malariae  infections
(WHO, 2010). Special treatment targeted at these liver stages is mandatory for a
complete  cure. In  addition, host  inflammatory  mediators  have  also  been
implicated  to  play  a  role  in immune-mediated  pathology  in  humans  and  a
number of well-characterized animal models (Couper et al., 2008, Riley et al.,
2006, Engwerda et al., 2005, Artavanis-Tsakonas et al., 2003, Hunt and Grau,
2003, Omer et al., 2000, Kwiatkowski et al., 1997).4
A number of factors have been proposed to be responsible for the failure to
develop lasting immunity to natural malaria infections and for the difficulty of
inducing  strong  protective  immunity  against  malaria  in  trials  of  prototype
vaccines.  These  factors  include  the  following:  the  complex Plasmodium  life
cycle, antigenic diversity in and variation by the malaria parasites (Hafalla et
al., 2011, Marsh and Kinyanjui, 2006), genetic polymorphism and malnutrition of
the  human  host,  an  immature  immune  system  in  young  children  (Marsh  and
Kinyanjui,  2006,  Good,  2001,  Shankar,  2000)  and  the  consequence  of  socio-
economic  deficits  and  warfare  in  human  populations  (Trape et  al.,  2002).
Furthermore,  concurrent helminth  infections,  highly  prevalent  in  malaria
endemic areas, have recently been recognized as a possible contributing factor
modulating immune responses to pathogens including the malaria parasite (Melo
et al., 2010, Achidi et al., 2008, Su et al., 2005, Nacher, 2000).
1.2 Life-cycle (Plasmodium falciparum)
Plasmodium  parasites’  genome  encode  for  at  least  5600  genes  and  have  a
complex life cycle. The malaria parasite has two stages of development, first, in
the  human  host  (asexual  stage)  and  secondly  in  the  mosquito  vector  (sexual
stage). The first stage is divided into two phases, namely, the liver phase (pre-
erythrocytic phase) and the blood phase (erythrocytic phase). The second stage
within  the  mosquito  vector  involves  fusion  of  gametes  and  further  parasite
propagation via sporogony (Cowman and Crabb, 2006, Bannister and Mitchell,
2003, Phillips, 2001). An excellent animation of the life-cycle of P. falciparum
can be viewed on the following website:
http://www.wehi.edu.au/education/wehitv/malaria_lifecycle_part_1_human_h
ost/ (Drew Berry, Biomedical Animator, The Walter and Elisa Hall Institute of
Medical Research, WEHI-Tv, 2008).
ASEXUAL STAGE
Pre-erythrocytic Phase
Investigation  of  pre-erythrocytic  stages  remains  restrictive  because P.
falciparum only infects humans and a few primate species (Herrera et al., 2002,
Mazier et  al.,  1985). P.  berghei and P.  yoelii,  which  are  rodent  malaria
parasites,  provide  good  models for  pre-erythrocytic  stage  biology  studies  and
described below.5
Plasmodium sporozoites are injected into the skin by the bite of an infected
mosquito, which then move through dermal cells, enter a blood capillary and are
rapidly distributed to the liver in the blood circulation. Some sporozoites are
immobilized  in  the  skin  before reaching  the  blood  circulation and  eventually
undergo  incomplete  transformation  in  the  skin  before  being  eliminated  by
phagocytes. However, in a P. berghei model, it was shown that after 24 hours
about 10% of sporozoites develop in the epidermis and dermis where they can
survive for weeks, differentiate into merozoites and possibly persist (Gueirard et
al.,  2010). Some  sporozoites  are  removed  by  the  lymphatic  system to  the
draining lymph node where they provide a source of antigens for activation of T-
cell responses (Hafalla et al., 2011).
Sporozoites cross  the  liver  sinusoidal  barrier  possibly  through  Kupffer  cells.
Kupffer cells are specialized macrophages lining the liver sinusoids. In the liver
parenchyma, sporozoites do not immediately switch to productive invasion but
rather actively  traverse/glide  through  numerous  hepatocytes  (Amino et  al.,
2008) before invading a target cell by forming a parasitophorous vacuole, where
the  parasite  differentiates  into an  exo-erythrocytic  form  (EEF).  The  parasites
actinomyosin motor, a family of transmembrane proteins called thrombosponsin-
related adhesive protein (TRAP), powers this gliding motility (Baum et al., 2006,
Menard,  2001).  After  multiple  rounds  of  replication,  mature  EEFs  release
membrane-shielded  merosomes  that  contain  infectious  merozoites.  These
merosomes  are  transported  away  and  eventually  rupture  in the  lung
microvasculature, releasing thousands of modified merozoites directly into the
bloodstream for a brief extracellular period of about 20-40 seconds (Hafalla et
al., 2011).
Erythrocytic Phase
The  life-cycle  for  the  human  malarial  parasites  is  relatively  similar  and  is
described  here  for P.  falciparum  (Cowman  and  Crabb,  2006,  Bannister  and
Mitchell, 2003, Phillips, 2001).
Merozoites  (2-3μm  long)  are  well  suited  to  invade  and  establish  themselves
within  erythrocytes and  initiate  the  pathogenic  blood-stage  of  a  malaria
infection. Merozoites contain the organelles, micronemes, rhoptries and dense6
granules,  which  contain  many  of  the  key  proteins  needed  for its  apical
reorientation, then formation of an irreversible "tight" junction and finally entry
into the red blood cell (RBC) in a parasitophorous vacuole. Invasion in the RBC
appears  to  be  via  a  receptor  ligand-interaction  mechanism.  Within  the
erythrocyte, the parasite undergoes a number of maturation steps from mature
trophozoites to mature schizonts, ultimately containing 16-24 merozoites each.
Some of the changes to the erythrocytic surface in P. falciparum in the last third
of each asexual cycle are linked with the infected erythrocytes sticking, via a
cytoadherant molecule called P. falciparium erythrocyte membrane protein 1
(PfEMP1),  to  endothelial  cells  lining  capillary  venules  and  as  a  result  stop
circulating in the peripheral blood. This process is known as sequestration. 48
hours after merozoite invasion, the RBC ruptures releasing the merozoites into
the blood-stream where they either invade further RBC’s, repeating the cycle or
differentiate into gametocytes. Rupturing of numerous infected RBC’s occurs at
the  same  time  and  results  in  the  release  of  pyrogens  and  the  characteristic
periodic fever associated with malaria infection. Combined with the destruction
of RBC’s and haemoglobin, the malaria parasite produces haemozoin, a molecule
formed via haeme-catalyzed lipoperoxidation as a detoxification product and is
released together with other cell debris (Hänscheid et al., 2007).
SEXUAL STAGE
When a new mosquito takes a blood meal from an infected human host, the
male and female gametocytes would be taken up by this mosquito and develop
into  male  and  female  gametes.    The  gametes  fertilize,  form  a  zygote  which
differentiates into a motile ookinete.  The ookinete develops into an oocyst on
the midgut wall of the mosquito within which the sporozoites develop. Rupturing
of the oocyst releases numerous sporozoites into the haemocoel in the mosquito
and these migrate to the salivary glands of the mosquito ready to begin the cycle
again (Figure 1.1).7
Figure 1.1: The lifecycle of Plasmodium falciparum. The figure depicts the asexual stage in
the human host and the sexual stage in the mosquito vector. The asexual stage consists of two
phases  namely  the  pre-erythrocytic  phase  in  the  liver  and  the  erythrocytic  phase  in  blood-
stream.  Picture  taken  from  the  National  Institute  of  Allergy  and  Infectious  Diseases  (NIAID)
website at www.niaid.nih.gov/.../pages/lifecycle.aspx.
1.3 Parasite-specific proteins
Sporozoites  must  invade  and  develop  within  hepatocytes  in  order  to  produce
merozoites. The hepatic infection is a clinically silent phase of the parasite’s
life-cycle. These unique characteristics make the pre-erythrocytic phase an ideal
target for vaccine interventions and prophylactic drug discovery as this would
prevent both disease and transmission. In the early 1980’s it was discovered that
the  most abundant  protein  on  the  sporozoite  surface  is  the  circumsporozoite
protein (CSP) (Nussenzweig and Nussenzweig, 1985). The CSP is a multifunctional
protein required for sporozoite development and likely mediates several steps of
this  journey. It  was  the  first  pre-erythrocytic  antigen  to  be  cloned  and
sequenced, appears to be present in all malaria species and displays a similar8
structure across the species with a central region of repeats and two conserved
regions.  The  CSP  is  essential  for  parasite  development  and  participates  in
binding the sporozoite to hepatocytes. CSP’s are thus targets of anti-sporozoite
neutralizing  antibodies  (Phillips,  2001, Plebanski  and  Hill,  2000).    Most  pre-
erythrocytic vaccine candidates are based on the CSP, expressed in various cell
lines, microorganisms, or as the corresponding DNA.  Studies in which radiation
attenuated sporozoites, of P. falciparum and P. vivax in humans, and P. berghei
and P.  yoelii  in mice,  were  injected,  the  recipients  showed  resistance  to
infection  for  variable  periods  of  time  thereafter  (Marsh  and  Kinyanjui,  2006,
Nardin et  al.,  1999,).  Thus,  development  of  vaccines  against  the  pre-
erythrocytic stages has been attempted although it is not clear why vaccination
with attenuated sporozoites induces strong immunity compared to that induced
by natural infections. Irradiated sporozoites undergo partial development which
seems  to  be  essential. However,  since  infected  irradiated  mosquitoes  are
unavailable  for  large  scale  vaccination,  the  alternative  is  to  develop  subunit
vaccines. Naturally infected humans have a wide range of specificities for P.
falciparum CSP (Calle et al., 1992) and other pre-erythrocytic antigens including
liver-stage antigen 1 (LSA1) and thrombosponsin-related adhesive protein (TRAP)
(John et al., 2003) as well as to antigens recently known to also occur in the
sexual  stage,  namely,  STARP  (Pasquetto et  al.,  1997)  and  apical  membrane
antigen 1 (AMA-1) (Silvie et al., 2004). Antibodies, affinity purified on most of
these  proteins,  were  shown  to  block P.  falciparum  sporozoite  invasion  into
hepatocytes  in in  vitro  studies  (Silvie et  al.,  2004,  Pasquetto et  al.,  1997).
Currently, however, there is no clear evidence that the presence or level of
antibodies recognizing sporozoites is related to protection against infection or
disease.
Initial  erythrocyte  contact  by  the  merozoite  is  thought  to  be  partly  via  the
merozoite surface protein 1 (MSP-1), an immuno-dominant antigen and the most
abundant protein on the surface of the merozoite. MSP-1 was suggested to be
essential for parasite survival and is a major vaccine candidate (O’Donnell et al.,
2000). Although there is some evidence for the role of P. falciparum MSP-1 in
initial contact of the host erythrocyte in in vitro studies (Goel et al., 2003),
definitive proof is lacking. It, however, remains possible that MSP-1 is involved
in the early invasive recognition and attachment events but these events still9
remain to be defined (Cowman and Crabb, 2006, Bannister and Mitchell, 2003).
Furthermore, P.  falciparum  invasion  is  facilitated  by  the  erythrocyte  binding
antigen (EBA 175), an erythrocyte glycophorin A binding protein (Cowman and
Crabb, 2006, Sim et al., 1994); AMA-1, a micronemal protein thought to engage
in  apical  junction  formation  by secretion  into  the  merozoite  apex  before
invasion  (Mitchell et  al.,  2004,  Narum et  al.,  1994);  the  serine-rich  antigen
(SERA), secreted in the parasitophorous vacuole and the dense granules are also
associated  with  the  invasive  mechanism  of  the  merozoite  into  its  host
erythrocyte (Bannister and Mitchell, 2003). In P. falciparum the VAR genes are
responsible  for  antigenic  variation  and  code  for  PfEMP-1,  expressed  on  the
surface  of infected erythrocytes.  This  cytoadherent  protein  is  the  major
antigenically  variant  protein  and  due  to  its  variability  creates  difficulties  for
recognition  by  the  immune  system  and  for  vaccine  development  (Arnot  and
Jensen, 2011, Bannister and Mitchell, 2003, Phillips, 2001).
CSP  and  MSP  parasite-specific  proteins  in  recent  years have  been  vaccine
candidates  which  could  induce  immune  responses  to  prevent  invasion  of  the
parasite within the host cell.  However, several problems are associated with
vaccine development, namely (1) parasitic antigens are specific for each stage of
its life-cycle, (2) host genetic susceptibility and immune status and (3) antigenic
diversity  in  immunologically  dominant  polymorphic  antigens  (Stevenson  and
Zavala, 2006, Phillips, 2001).
After many years of research and testing, a partially efficacious first generation
vaccine, the RTS,S⁄AS01E vaccine against P. falciparum, is currently undergoing
pivotal phase III trials in Africa (Cohen et al., 2010). One of the obstacles facing
the development of a licensed malaria vaccine is the extensive heterogeneity of
many  of  the  current  malaria  vaccine candidate antigens.  To  counteract  this
antigenic diversity, an effective malaria vaccine may need to elicit an immune
response against multiple malaria antigens, thereby limiting the negative impact
of variability in any one antigen. Since most of the malaria vaccine antigens that
have been evaluated in people have not elicited a protective immune response,
there is a need to identify additional protective antigens. In a study by Limbach
and  colleagues,  the  efficacy  of  three  pre-erythrocytic  stage  malaria  antigens
(PY0311,  PY03424  and  PY03661)  was  evaluated  in  a P.  yoelii model  of10
protection. Their results suggested that vaccine combinations with vectors that
express PY03011 and PY03424, or PY03011, PY03424 and PY03661 protected mice
at significantly higher levels than vaccines that express the individual antigens
(Limbach et al., 2011). Other studies have also shown that combination vaccines
can  enhance  protection,  as  well  as  circumvent  the  HLA restricted  protection
observed with some single antigen vaccines in rodent (Doolan et al., 1996) and
primate models (Weiss et al., 2007). Combination vaccines, however, can have
several disadvantages. A multi-component vaccine may be more expensive to
manufacture than a single component vaccine. In addition, there is a risk that
one  vaccine  component  can  have  an immunosuppressive  effect  on  the  other
components. For example, a vaccine containing nine different DNA-P.falciparum
vectors  elicited  significantly  lower  immune  responses against  each  individual
antigen than a vaccine containing the individual vectors (Sedegah et al., 2004).
Therefore, combining vaccine antigens would need to be evaluated thoroughly to
see if synergistic, additive or antagonistic responses are observed.
A detailed understanding of the host immune response to malaria parasites in
terms of identifying mechanisms, which will either suppress or induce protection
within the host, will in addition to vaccine studies aid the development of an
effective and safe vaccine.
2. IMMUNITY TO MALARIA
In  humans,  natural  acquired  immunity, takes  several  years  to develop and is
followed by repeated exposure to the parasite in endemic regions (Stevenson
and Riley, 2004, Baird, 1995). Naturally acquired immunity is targeted against
the  erythrocytic  stage  of  the  parasite  and  only  protects  against  the  clinical
manifestations of the disease and does not provide complete/sterile protection.
The  malaria  parasites  have  evolved  intricate  mechanisms  to  avoid  the
development  of effective  anti-parasitic  immune responses  that would  protect
the human host against future re-infections. Other factors influencing immunity
to  malaria infection include  the  parasite  infective  dose, age,  genetic
background, pregnancy, nutritional and immune status of the human host.11
It has been widely established that immunity in humans and mice to blood-stage
malaria  infection  is  characterized  as  a  parasite-specific  innate  and  acquired
immune  response  involving  both  cell-mediated  and  antibody-dependent
mechanisms (Burns et al., 2004), essential for the control of parasitaemia levels
and  hence  parasite-induced  pathology  (Good,  2005,  Good et  al.,  2004,
Langhorne et al., 2004, Taylor-Robinson and Phillips, 1994, Taylor-Robinson et
al., 1993, Stevenson et al., 1992). Although host immunity may be protective, it
has also been implicated as a significant contributor to the pathology of malaria
(Artavanis-Tsakonas et al.,  2003,  Heddini,  2002).    Upon  malaria  infection,
activation  of  specific  cells  and  their  effector  mechanisms  during  innate
immunity  is  vital  as  it  greatly  influences  the  nature  and  magnitude  of  the
adaptive  response  (Stevenson  and  Zavala,  2006).  The  nature  of  the  immune
response  induced  depends  on  the  following  factors:  the  parasite  and  the
pathogen recognition receptor (PRR) and toll-like receptors (TLR) involved; the
cytokines  and  chemokines;  the  strength  of  the  activation  signal  between  the
antigen presenting cell (APC) and the pathogen receptors; the antigen dose and
the influence of cell memory (Langhorne et al., 2004).  The innate and adaptive
immune effector mechanisms in malaria infection can limit peak parasitaemia,
prevent  severe  pathology  and  reduce  the  levels  of  circulating  infected
erythrocytes  but  ultimately,  they  usually  fail  to  eliminate  the  infection
completely leading to a long-lasting or even persistent low-grade parasitaemia
which might persist for months to years (Stevenson and Riley, 2004, Franks et
al., 2001).
2.1 Rodent Plasmodium species causing malaria
P. chabaudi, P. berghei, P. yoelii and P. vinckei, isolated from small rodents in
central  and  West  Africa,  have  been used as  mouse  models to  mimic  human
malaria  infections (Table  1.1). At  present,  there  is  no  single  mouse  model
available to replicate all the features of human infection in terms of pathology
and immune responses (Hunt and Grau, 2003, Langhorne et al., 2002).  However,
mouse models have proved useful in the investigation of immune mechanisms
and pathology, identification of genes regulating susceptibility to infection and
for vaccine development studies (Dechamps et al., 2010, Langhorne et al., 2002,
de Souza et al., 2002, Fortin et al., 2002, Shear et al., 1998).  Genetic variations
among  inbred  strains  of  mice  have  been  shown  to  influence  susceptibility  to12
Plasmodium chabaudi
Plasmodium berghei
Plasmodium yoelii
Plasmodium vinckei
• P. chabaudi chaudi AS, P. chabaudi adami
• Study immune mechanisms, immunoregulation by cytokines, identify
susceptibility loci & immune basis of pathology
• P. chabaudi chabaudi AS: non-lethal in resistant mice & lethal in susceptible
mice.
• P. chabaudi adami: mild, non-lethal infection
• P. berghei ANKA, P. berghei K173
• Widely used to study pathogenesis. P. berghei ANKA: serves as an
experimental model of cerebral malaria (ECM)
• There is genetic variation in the development of ECM between inbred mouse
strains which correlates with the production of pro-inflammatory cytokines
• P. yoelii 17XL, P. yoelii 17XNL, P. yoelii YM
• Study immune mechanisms and pathogenesis & ECM, as recombinant
MSP-1 is available
• P. yoelii 17 XL widely used to identify vaccine-induced immunity
• Study pathogenesis and for chemotherapy studies
• Causes lethal infection
• P. vinkei petteri causes a non-lethal infection & used to study immune
mechanisms
infection  with  the  mouse Plasmodium species  (Fortin et  al.,  2002).  In  a P.
chabaudi  AS model,  non-lethal  infections  occur  in  BALB/c,  C57BL/6  and
C57BL/10 mice while lethal infections occur in A/J and DBA/2 mice (Langhorne
et al., 2004, Langhorne et al., 2002, Cross and Langhorne, 1998, Stevenson et
al., 1992).
Table 1.1: Plasmodium parasites that cause malaria in mice (Stevenson and
Riley, 2004)
2.2 Plasmodium chabaudi AS model of blood-stage infection
In  a  review  by  Phillips  and  colleagues,  the  immune  response  to  blood-stage
malaria parasites was characterized using NIH mice infected with P. chabaudi AS
(Figure 1.2) (Phillips et al., 1997). NIH mice are immunologically impaired and
can  survive  an  acute  infection  that  is  followed  by  one  or  two  patent
recrudescences. The course of infection resembles that in the natural host and
therefore used as an accessible model for further studies.13
An  unusual  feature  of  immunity  in  the P.  chabaudi  AS  model  compared  with
other parasitic infections is that CD4
+ Th1 and CD4
+ Th2 cells play an important
role in protection. It is worth remembering that the Plasmodium parasite has the
ability to undergo antigenic variation, a factor that has affected vaccine studies.
In P. chabaudi infection, antigenic variation occurs at high rates and because
different variable antigen types (VATS) switched at different rates provides for
their expression in a hierarchical sequence and consequent immune evasion by
the parasite. Consequently, the increasing parasitaemia is largely composed of
the parental VAT with minor VATS emerging at different rates as the infection
progresses. During the rising primary parasitaemia, immune effector mechanisms
that are effective against all VATS, are initially dominated by NK cells and CD4
+
Th1 cells which release IFN-γ. IFN-γ in turn activates macrophages and Kupffer
cells in the liver, which is a major site of parasite sequestration. Macrophage
functions  include  anti-parasitic  mechanisms  (including  TNF-α  and  IL-12
production) (Namazi and Phillips, 2010) and phagocytosis. IFN-γ production then
tails off, one or two days before peak parasitaemia, implying that non-specific
mechanisms are  declining.  Consequently,  initial  protection  against  rising
parasitaemia  is  mediated  through  cytotoxic  and  cytostatic  (NO)  non-specific
effector  mechanisms  largely  driven  by  Th1  cells.  All  VATS  present  might  be
expected to be vulnerable to the early immune clearance. Thus, the antigenic
stimulus for this Th1 acquired immune response would mainly occur from the
parent VAT. At peak parasitaemia, there are more specific effector mechanisms
that come into play and are mediated through IgG2a and IgM with possibly some
early IgG1 antibody production which in turn remove the parental VAT and leave
behind the minor VATS. Thereafter, there is a switch from being predominantly
CD4
+  Th1  to  predominantly  CD4
+  Th2  cells  with  IL-4  driving  the  major  anti-
parasitic  effector  mechanisms  mediated  by  IgG1  antibodies  to  the  individual
VATS and the recrudescence is controlled (Namazi and Phillips, 2010, Phillips et
al., 1997) as shown in Figure 1.2. Consequently, the erythrocytic stage of P.
chabaudi  AS  infection  depends  on  a  complex  and  dynamic  interaction  of
immunological events and parasite immune evasion strategies. Thus, both the
parasite and host contribute to this balance (Phillips et al., 1997).14
Figure 1.2: The immune response to the erythrocytic stage of P. chabaudi AS infection. The
initial control is mediated by CD4
+ Th1 cells and after the primary parasitaemia there is a switch
to CD4
+ Th2 regulated responses. This diagram suggests how the cytokine network drives the
immune  effector  mechanisms.  Immunopathology  can  also  be  a  consequence (Phillips et  al.,
1997).
Other studies using P. berghei and P.yoelii infection models, demonstrated that
humoral  immunity  was responsible  for  parasite  clearance  and  protection
(Stevenson and Riley, 2004, Phillips, 2001, Roberts et al., 1977). In contrast, P.
chabaudi  adami  required  antibody-independent  immunity  as  B-cell  deficient
mice  were  able  to  control  the  infection  (Stevenson and  Riley, 2004,  Phillips,
2001,  Grun  and  Weidanz,  1981).    On  the  other  hand, again, clearance  of P.
chabaudi infection has been shown to be associated with a switch from a B-cell
independent to B-cell dependent immune response (Stevenson and Riley, 2004,
Taylor-Robinson et al., 1993).  Supporting studies have demonstrated that both
T-cell  (McDonald  and  Phillips,  1978)  and  B-cell  responses  are  crucial  for
protective immunity and both antibody dependent and independent mechanisms
are  involved (Stevenson  and  Riley,  2004,  Taylor-Robinson  and  Phillips,  1994).
Depletion or deficiency in cell-mediated responses alters the course of infection
during both the acute and chronic phases whereas depletion or deficiency of B-
cells alters the course of infection during the chronic phase only (Figure 1.3).15
Evidence from the P. chabaudi AS model of blood-stage malaria highlights the
importance  of  adaptive,  CD4
+  T-cell  dependent  mechanisms  for  control.
However,  although  initial  studies  have  indicated  that  control  of  parasitaemia
levels, after the primary peak parasitaemia, is dependent on a Th2 response,
other  investigations  have  indicated  that  Th1  responses  are  required  not  only
during acute infection to promote cell-mediated immunity but also during the
chronic stage of infection to promote antibody responses (Stevenson and Riley,
2004, Su and Stevenson, 2002).
Figure 1.3: Course of infection with P. chabaudi chabaudi AS in C57BL/6 mice. Shown for (a)
C57BL/6 wild-type, (b)  CD4
+  T-cell  depleted  mice, (c)  IFN-γ  deficient  mice, (d)  γδ  T-cell
deficient mice, (e) B-cell depleted or deficient mice and (f) NK cell depleted mice. The infection
consists of an acute and chronic phase. In intact C57BL/6 wild-type mice, peak parasitaemia was
controlled during the acute phase by a CD4
+ T-cell (Th1), IFN-γ dependent mechanism that is
antibody independent. The parasite was eliminated during the chronic phase by a mechanism
that requires both CD4
+ T-cells and malaria-specific antibody. Depletion or deficiency of CD4
+ T-
cells  or  NK  cells  alters  the  course  of  infection  during  acute  and  chronic  infection,  whereas
depletion or deficiency of B-cells alters the course of infection during the chronic phase only. γδ
T-cells are not essential for resolution of infection. (Stevenson and Riley, 2004).16
2.3 CELL-MEDIATED IMMUNITY
2.3.1 Antigen presenting cells (APC’s)
Many  parasitic  infections  are  controlled  by  cell-mediated  immunity. A  key
question that needs to be resolved is the identity of the antigen-presenting cells
(APCs) that activate T-cells to produce IFN-γ and mediate class switching to the
protective IgG2a and IgG2b (in mice) and IgG1 and IgG3 (in humans) antibodies
during an acute Plasmodium infection (Su and Stevenson, 2002). Bone-marrow
derived macrophages, DC’s and B-cells isolated from immune mice have showed
that they have the ability to present malarial antigen to T-cells (Quin et al.,
2001).
Macrophages
In the early stages of inflammation/infection, neutrophils and macrophages kill
most  microbes  and  macrophages  remove  the  apoptotic  bodies  and  present
antigen  to  T-lymphocytes,  thereby  initiating  the  mechanisms  of  acquired
immunity, which ends in the production of antibodies and cytokines and memory
cells. Macrophage activity then switches from being pro-inflammatory to anti-
inflammatory, whereby they remove all the tissue debris, thus achieving healing
(Celada, 2009) (Figure 1.4).
The signals encountered by developing macrophages during migration determine
their functional properties at sites of inflammation or infection (Claasen et al.,
2009,  Celada,  2009).  Among  these  signals, cytokines,  which  can  act
synergistically or have opposing effects, are responsible for the development of
highly  divergent  macrophage phenotypes.  The  classification  of  macrophage
activation is described for in figure 1.5.17
Figure 1.4:  Dual  activity  of  macrophages  at  the  inflammatory  loci. In  the  initial  stages  of
inflammation, macrophages eliminate the remaining microbes that escape neutrophils, remove
the  apoptotic  bodies  of  dead  neutrophils  and  present  antigen  to  T-lymphocytes,  thereby
initiating the mechanisms of acquired immunity, which ends in the production of antibodies and
cytokines and memory cells. Macrophage activity then switches from being pro-inflammatory to
anti-inflammatory, whereby they remove all the tissue debris, thus achieving healing (Taken and
adapted from Celada, 2009).18
Figure  1.5:  Classification  of  macrophage  activation.  Type-1  cytokine-dependent
proinflammatory  responses  induce  classically  activated  macrophages  (caMac)  which  leads  to
nitric oxide (NO) production and the synthesis of several products of NO reaction. CaMac are
crucial  for  parasite  control  during  protozoan  infections  but  can  also  contribute  to  the
development of immunopathological disease symptoms. Type-2 cytokines such as IL-4 and IL-13
antagonize caMac  inducing  alternatively  activated  macrophages  (aaMac)  that  upregulate
arginase-1 expression. Arginase-1 can also be induced during the infection by apoptotic cells or
even directly by parasites or parasite components. Arginase-1 limits caMac-dependent parasite
clearance promoting parasite proliferation. Additionally, arginase-1 suppresses T cell response.
Therefore,  generation  of  alternative  activation  states  of  macrophages  could  limit  collateral
tissue damage because of excessive type-1 inflammation. However, they affect disease outcome
by promoting parasite survival and proliferation (Taken and adapted from Stempin et al., 2010).
During  an  early,  acute-phase  microbial  infection,  for  example  with  bacteria
(McCaffrey et al., 2004, Nau et al., 2002) or protozoa (Walther et al., 2006,
Plebanski and Hill, 2000, Kropf et al., 2004, Peluffo et al., 2004), macrophages
are activated by pathogen-associated molecular patterns (PAMPs) which allow
them  to  recognize,  engulf  and  kill  invading  pathogens  (Zhang et  al,  2010).
Interaction  with  different  PAMPs  and  cytokines  leads  to  different  states  of
macrophage  activation  (Zhang et  al,  2010).  Microbial  products  such  as
lipopolysaccharide (LPS) through engagement of pattern recognition receptors
(PRRs) and/or the presence of Th1-type proinflammatory cytokines particularly
IFN-γ but also TNF-α and IL-12 (Stempin et al., 2010, Mosser, 2003), induces
classically activated macrophages (caMac), also known as M1 cells (Zhang et al,
2010). The  prime  function of caMac is  initial  microbial  destruction,  which  is19
controlled  by  the  production  of  reactive  oxygen,  and  nitrogen intermediates
such as nitric oxide (NO) from inducible NO synthase (iNOS/NOSII) (Claasen et
al.,  2009,  Gordon,  2003,  Yu et  al.,  1999).  During  infections  with  protozoan
parasites such as Plasmodium (Walther et al., 2006, Plebanski and Hill, 2000),
Leishmania (Kropf et al., 2004) or Trypanosoma (Peluffo et al., 2004), an IFNγ-
dependent  proinflammatory  response  triggering  the  development  of  caMac  is
required  for  controlling  parasitaemia  particularly  during  the  acute  stage  of
infection (Stempin et al 2010). Consequently, caMac are essential components of
host defense but their activation must be securely regulated since the cytokines
and mediators that they produce can lead to host-tissue damage and pathology
(Stempin et al., 2010, Celada, 2009).
Alternatively,  depending  on  the  parasite  species  or  parasite  virulence,  host
genotype and stage of infection, type-2 cytokines such as IL-4 and IL-13, are
produced by the host and antagonize caMac and induce arginase-1 expression in
macrophages. These macrophages, termed alternatively activated macrophages
(aaMac), are commonly found during parasitic infections (Noël et al., 2004) and
have  been  associated  with  the  downregulation  of  type-1  immunity  and  the
survival of both protozoa (Raes et al., 2007) and helminths (Reyes and Terrazas,
2007). IL-4 and IL-13 upregulate the expression of the mannose receptor and
major histocompatibility complex (MHC) II molecules on macrophages and as a
result stimulate endocytosis and antigen presentation and induce the expression
of selective chemokines. The concept of alternative activation has been less well
studied  than  macrophage  activation  by  IFN-γ  or innate activation  by
lipopolysaccharide (LPS) or microbes. Studies with the latter led to the discovery
of toll-like receptors (TLR’s) and signalling pathways that are distinct from those
used by the IL-4/IL-13 receptor (IL-4Rα) (Menzies et al., 2010). Apart from IL-4
and IL-13 activation (Martinez et al., 2009) factors such as IL-10, TGF-β (Gordon,
2003)  and  phagocytosis  of  apoptotic  cells  (Freire-De-Lima et  al.,  2000)  also
antagonize  caMac  and  induce  alternative  non-M1  activation  states  in
macrophages.20
During P.  falciparum  infection, as  red  blood  cells  and  haemoglobin are
destroyed,  the  malaria  parasite  produces  hemozoin,  a  molecule  formed  via
heme-catalyzed  lipoperoxidation  as  a  detoxification  product  and  released
together with other cell debris (Hänscheid et al., 2007). Hemozoin induces the
release of endogenous ligands lipoxin A4 (LXA4), 5,15-diHETE and 15-HETE, that
can  activate  a  peroxisome  proliferator-activated  receptor  (PPAR)  which
suppresses  production  of  type-1  proinflammatory  cytokines  and  favour  the
development of aaMac which control inflammation and pathology (Chan et al.,
2010).  Significantly,  IL-4  and  IL-13  also  activate  PPAR  (Chan et  al.,  2010).
Overall studies would indicate that aaMac not only inhibit T-cell proliferation via
an arginase induced hypo-responsiveness (Kropf et al., 2005), but also promote
resolution of inflammation and fibrogenesis. They actively express a set of genes
enabling them  to  regulate  anti-inflammatory  processes,  induce tolerance  and
wound  healing  (Chan et  al.,  2010,  Celada,  2009).  These anti-inflammatory
regulatory mechanisms can act as a counterbalance to limit disease severity and
protect the host from detrimental effects of an excessive type-1 response.
In particular and with reference to the present study, IL-4Rα deficient mice and
more recently macrophage/neutrophil specific IL-4Ra deficient mice have been
exploited  in  various  parasitic  and  infectious  disease  models to  examine  the
importance  of  alternative  activation  of  macrophages  (Bryson et  al.,  2011,
Hölscher et al., 2006, Herbert et al., 2004, Gordon, 2003).
Dendritic cells
Dendritic  cells  (DCs)  are  the  most  important  heterogeneous  potent  antigen-
presenting-cells (APC) with a key role in the initiation and regulation of innate
and adaptive immune responses (Gordon, 2003, Banchereau et al., 2000).  DCs
have the remarkable ability to sample sites of pathogen entry, integrate signals
coming  from  the  environment,  take  up  and  process  antigen  and  deliver  this
antigen to naïve T-cells. In turn, DCs activate these and memory T-cells through
antigen  presentation via  receptor  interaction  bound to  the  MHC  inducing  the
appropriate response for the initial stimuli (Terrazas et al., 2010, Langhorne et
al., 2004, Sher et al., 2003, Guermonprez et al., 2002). DCs can be broadly
divided into plasmacytoid DCs (pDC) and conventional DCs (cDC) based on the21
expression  of  a  variety  of  cell  surface  markers  and  their  response  to  the
pathogen molecules (Colonna et al., 2006, Banchereau et al., 2000).
Toll-like  receptors  (TLRs),  expressed  by  cell-types  including  DCs  and
macrophages, have a vital role in triggering innate immunity and orchestrating
the acquired immune response during infection. In order to initiate an immune
response,  TLRs  recognize  certain  pathogen  associated  molecular  patterns
(PAMPs) (Gazzinelli and Denkers, 2006). The role of TLRs in immunity to malaria
has not been firmly established, although this area is under investigation. In a
model of cerebral malaria, Adachi and colleagues has analyzed the involvement
of TLRs in cerebral malaria by using a mouse infection P. berghei model whereby
myeloid differentiation primary response gene 88 (MyD88), an essential adaptor
molecule  for  most  TLRs,  was  critical for  IL-12  induction  by P.  berghei NK65
parasites and caused liver injury (Adachi et al., 2001). Furthermore, glycosyl-
phosphatidylinositol (GPI) and hemozoin (a parasite heme metabolite) derived
from P. falciparum has been identified as the ligands for TLR2, TLR4 and TLR9
and  induce  TNF-α  synthesis  (Coban et  al.,  2006,  Coban et  al.,  2005,
Krishnegowda et  al.,  2005).  Other  heat-labile  molecules derived  from  the
malaria parasite are still to be clarified for TLR9-mediated recognition (Coban et
al., 2006, Pichyangkul et al., 2004).
DCs  are  widely  accepted  as  having  a  crucial  role  in  Th1-cell  versus  Th2-cell
differentiation but DC plasticity in vivo and in vitro makes it inappropriate to
equate different types of DCs (pre-DC, DC1, DC2 and plasmacytoid DC) with Th-
cell subsets or with corresponding macrophage phenotypes. Depending on their
maturity  and  modulation,  DCs  can  activate  or  suppress  Th-cell  responses
(Gordon, 2003, Pulendran et al., 1999) or induce Th-cell anergy (Gordon, 2003).
In addition, modulation of TLRs by parasites to evade effects of the host immune
system  has  also  been  shown  in P.  falciparum and  P.  yoelii  infection  studies
(Gazzinelli  and  Denkers,  2006). DCs  and  phagocytes  infected  with  the
Plasmodium spp.  became  unresponsive  to  LPS-induced  activation  resulting  in
defects in T-cell activation. Furthermore, in P. chabaudi infection, phagocytosis
of malaria haemozoin, a TLR9 agonist, resulted in non-responsive of DCs to LPS
and  thus  their  inability  to  activate  T-cells  (Millington et  al.,  2006). A  more22
recent review by Terrazas and colleagues discusses in detail how Plasmodium
species through varied mechanisms (human and murine) modulate DC function in
order  to  survive  (Terrazas et  al.,  2010).  For  example,  modification  of  DC
function results in a decrease in the total number of DCs and an altered ratio of
myeloid versus plasmacytoid cell subsets, the latter involved in the induction of
Tregs and IL-10. Furthermore, the reduced capacity of Plasmodium-exposed DCs
to prime T-cells results in the inability to establish prolonged interactions with
naïve CD4
+ T-cells. Together, this suggests that Plasmodium species have the
ability to switch an aggressive immune response into a more permissive one in
order to survive within its host.
2.3.2 Natural Killer (NK) cells and Gamma-Delta T-cells (γδ T-cells)
The early source of IFN-γ remains controversial with both NK cells and γδ T-cells
being indicated as a potential source of this critical cytokine that is necessary
not only during the innate immune response to pathogens but also in activation
of  the  adaptive  immune  response and  development  of  protective  immunity
(Urban et al., 2005, Stevenson and Riley, 2004, Choudhury et al., 2000, Troye-
Blomberg et al., 1999). The mechanism by which they accomplish this appeared
to be mediated via their secretion of IFN-γ induced by cytokines such as IL-12,
TNF-α, and IL-6 produced by other components of the innate immune system,
including macrophages and DCs (Ing and Stevenson, 2009, Robinson et al., 2009,
van der Heyde et al., 2006, Stevenson et al., 2001, Mohan et al., 1997). NK cells
are  rapid  IFN-γ responders  to Plasmodium  falciparum-infected  erythrocytes
(PfRBC) in  vitro  and are  involved  in controlling  early  parasitaemia  in  murine
models,  yet  little  is  known  about  their  contribution  to  immune  responses
following malaria infection in humans. Therefore, McCall and colleagues have
studied the dynamics of and requirements for in vitro NK cell responses to P.
falciparum infected RBC (PfRBC) in malaria-naïve volunteers undergoing a single
experimental  malaria  infection  under  highly  controlled  circumstances,  and  in
naturally exposed individuals. They concluded that NK cells make a significant
contribution to total IFN-γ production in response to PfRBC but their innate role
was questioned because of their dependency on (memory) T-cell help (McCall et
al., 2010).23
P. chabaudi malaria is more severe in wild-type (WT) mice treated with IFN-γ
neutralizing antibody and in IFN-γ-deficient (IFN-γ
-/-) mice, as indicated by the
increased magnitude and duration of parasitaemia and mortality in the IFN-γ
-/-
mice compared to the intact controls (Su and Stevenson, 2000, van der Heyde et
al.,  1997,  Meding et  al.,  1990).  Earlier  genetic  studies  failed  to  correlate
susceptibility  to P.  chabaudi infection  with  NK  activity  (Urban et  al.,  2005,
Skamene et  al.,  1983).  Subsequently,  Mohan  and  colleagues  reported  that
depletion of NK cells during acute P. chabaudi AS infected C57BL/6 mice led to a
rapid increase in blood-stage parasitaemia levels and less efficient resolution of
the  infection  (Mohan et  al.,  1997).  The  mode  of  action  by  which  NK  cells
function  appeared  to  be  via  the  secretion  of  cytokines  rather  than  direct
cytotoxicity against blood-stage malaria parasites (Mohan et al., 1997).
Contrary to the findings of Mohan and colleagues, other studies indicate similar
P.  chabaudi parasitaemia  in  depleted  mice  and  intact  controls  after  NK1.1
monoclonal antibody (MAb) depletion of NK cells (Taniguchi et al., 2007, Yoneto
et al., 1999, Kitaguchi et al., 1996). Kim and colleagues showed that by using
microarray  analysis  of  blood  cells  from P.  chabaudi-infected  mice,  a  rapid
production  of  IFN-  γ and  activation  of  IFN-γ-mediated signalling  pathways  as
early as 8 hours existed after infection. However, NK cells did not express IFN-γ
or exhibit IFN-γ-mediated pathways in their analysis (Kim et al., 2008). At this
time, NK cells are replicating and migrating from the spleen to the blood. In
humans with P. falciparum infection, increased IFN-γ production by peripheral
blood mononuclear cells (PBMC) in response to parasitized RBCs correlated with
protection from acute parasitemia and clinical malaria (D’Ombrain et al., 2008,
2009). Early IFN-γ production by PBMC obtained from malaria naive donors was
primarily produced by γδ T cells and not by NK cells (Robinson et al., 2009).
Animal  models  do  not  exactly  mimic  the  human  condition  and  experimental
malaria in mice is species specific from those that infect humans. Nevertheless,
analysis  of  protective  immunity by  murine  models provides  important
information  on  how  a protective  immune  response  to Plasmodium may  be
elicited. Whether both NK cells and γδ T-cells have essential roles during the
early stages of immunity to blood-stage malaria remains to be determined and
whether these cells function early in cell-mediated immunity (CMI) to malaria
parasites is unknown. To address these issues, Weindanz and colleagues infected24
NK cell-or-γδ-T-cell-depleted JH
-/- mice with blood-stage P. chabaudi. Their data
indicated that the suppression of acute P. chabaudi infection by CMI was γδ T-
cell  dependent, was  independent  of  NK  cells,  and was  highlighted  by  the
deficient IFN-γ response seen early in γδ T-cell-depleted mice (Weindanz et al.,
2010).
2.3.3 CD8
+ T-cells
Research studies have shown that immune protection against pre-erythrocytic
stages  of Plasmodium infection  depends  on  CD8
+  T-cell  responses  (Good  and
Doolan,  1999).  However,  immunity  against  the  erythrocytic  stage  is  largely
antibody-mediated  although  CD4
+  T-cells  may  also  be  protective  (Good  and
Doolan, 1999). Mounting evidence in murine models has also shown that CD8
+ T-
cells  contribute  to  the  pathology  of  experimental  cerebral  malaria  (ECM)
although the precise mechanisms remain unclear (Renia et al., 2006, Belnoue et
al., 2002, Hermsen et al., 1997, Yanez et al., 1996).
Studies  implicating  CD8
+  T-cells  in  ECM  required  reinterpretation  in  light  of
recent evidence, which demonstrated that DCs expressing CD8α mediate priming
of T-cell responses to pathogens such as viruses (Belz et al., 2005, Smith et al.,
2003) and bacteria (Belz et al., 2005). For example, studies using depletion with
anti-CD8α antibody to implicate CD8
+ T-cells in pathology may be reinterpreted
as implicating CD8α DCs in CD4
+ T cell priming. Similarly, studies implicating
CD8
+ T-cells in ECM that used perforin-deficient mice might reflect a role for NK
cells rather than CD8
+ T cells in disease. Lundie and colleagues have recently
resolved the role of CD8
+ T cell responses to Plasmodium blood-stage infection.
In order to examine Plasmodium-induced CD8
+ T cell responses to blood-stage
malaria in the absence of known MHC class I (MHC I) restricted epitopes, they
generated transgenic P. berghei parasites expressing a variety of model T-cell
epitopes for which T-cell receptor (TCR) transgenic mice were available. Using
those parasites, they demonstrated that antigens expressed by blood-stage P.
berghei were captured and cross-presented by CD8α DC to stimulate naive CD8
+
T cell proliferation and lytic function (Lundie et al., 2008).25
2.3.4 CD4
+ T-cells
CD4
+ T-cells play a central role in the immune response to blood-stages of P.
chabaudi  AS  infection  (Langhorne et  al.,  2002).  They  produce  cytokines  that
amplify the phagocytic and parasitocidal response of the innate immune system,
as well as dampening this response later on to limit immunopathology (Stephens
and Langhorne, 2006, Stephens et al., 2005, Langhorne et al., 2002). CD4
+ T-
cells are also required to help B-cells produce the antibody that is essential for
parasite clearance (Stephens et al., 2005, Langhorne et al., 2002). Therefore,
understanding  the  mechanisms  by  which  T-helper  cells  undergo  priming,
expansion  and  development  of  specific  and  effective  T-cell  memory  and
immunity would aid the formulation of suitable treatment therapies (Stephens
and Langhorne, 2010).
Initial  priming  and  activation  of  T-cells  by  APCs  is  vital  for  effective  cell-
mediated and antibody-mediated responses. Thus, athymic mice, deficient in T-
cells, have been shown to be unable to control a primary infection, and die with
fulminating malaria following infection with P. berghei, P.yoelii (Weinbaum et
al.,  1976)  and P.  chabaudi  adami  (Cavacini et  al.,  1990)  indicating  the
importance of T-cells during early infection. In P. chabaudi AS infection, there is
debate  over  the  extent to  which  T-cells  protect  via  Th1  cytokine  mediated
mechanisms or by the Ab’s that they help to produce (Stephens et al., 2005).
Both mechanisms dominate the T-cell response to P. chabaudi in turn with an
early Th1  type  cytokine  response  that  has  been  shown  to provide  protection
during  the acute patent  parasitaemia  which  switches  later  to a  Th2  response
which provides effective help for malaria-specific Ab production as the infection
becomes  chronic  (Stephens et  al.,  2005,  Smith  and  Taylor-Robinson,  2003,
Langhorne, 1989, Langhorne et al., 1989). In support of these observations, CD4
+
T-cells isolated during acute P. chabaudi AS infection were shown to display a
typical Th1 phenotype while CD4
+ T-cells during the chronic phase displayed a
Th2 phenotype (Stevenson and Tam, 1993, Taylor-Robinson and Phillips, 1992).
During  chronic  infection,  CD4
+  T-cells  are  activated  to  produce  additional
cytokines such as IL-4 and IL-10 and it has been suggested that this change in Ag-
presenting splenic DC population is responsible for the switch away from the
predominantly IFN-γ-producing T-cells present in the acute infection (Sponaas et26
al., 2006). A similar T-cell profile seems to occur during human P. falciparum
infection (Riley et al., 1993, Brown et al., 1990).
Enhanced IFN-γ, TNF-α and IL-12 production are all associated with an acute
infection with P. chabaudi AS (Taylor-Robinson and Phillips, 1994). IL-12 is the
critically important cytokine in the establishment and differentiation of Th1 cells
(Manetti et  al., 1993)  and  is also required  for  NK  activity  (Kobayashi et  al.,
1989).  T-cells  and  NK  cells  are  important  for  IFN-γ  production,  which  is  an
essential mediator in immunity to P. chabaudi AS infection (Su and Stevenson,
2000,  van  der  Heyde et  al.,  1997,  Favre et  al.,  1997). IL-12  also  acts
synergistically, while participating in cellular immunity, it also contributes to
IgG2a  production  required  for  clearance  of  the  parasite  following  peak
parasitaemia (Su and Stevenson, 2002).
In-vivo  studies  have  shown  that  neutralization  of  IFN-γ  significantly  elevates
peak  parasitaemia  during P.  chabaudi  AS  infection  (Meding et  al.,  1990,
Stevenson et  al.,  1990).  In  addition,  IFN-γ has  been  shown  to  induce  IgG2a
antibody production during P. chabaudi AS infection (Stevenson and Tam, 1993).
P. chabaudi AS infection studies provided further evidence that in the absence of
IFN-γ the Th1 associated IgG2a antibody response was significantly reduced and
thought  to  account  for  the  failure  to  clear  parasitaemia  levels  (Su  and
Stevenson, 2000). Furthermore, IFN-γ deficient C57BL/6 mice infected with P.
chabaudi  AS  demonstrated  higher  morbidity  and  mortality  compared  to  the
controls (Yoneto et al., 2001, Balmer et al., 2000, Su and Stevenson, 2000).
TNF-α on the other hand exerts a dichotomy of functions during Plasmodium
infection,  providing  protection  but  also  contributing  much  to  the  pathology
associated with infection (Beutlar and Cerami, 1988). TNF-α is a potent activator
of  macrophages  and  nitric  oxide  production  (Liew et  al.,  1990)  but  not  a
necessity  for  the  development  of  immunity  whereby  other  cytokines  are
sufficient to replace its actions.27
While CD4
+ Th1 cells and their role in acute malaria infection have been widely
investigated, the mechanisms governing the Th1 to Th2 switch and the resulting
protective  mechanisms  that  occur  during  chronic malaria infection  await
elucidation.  IL-4  has  been  shown  to  be the  key  cytokine  driving  a  Th2  type
response  (Gordon,  2003,  Brombacher,  2000).    Studies  have  shown  that in
129SVxC57BL/6 mice deficient for IL-4 have elevated Th1 responses during P.
chabaudi AS infection as measured by increased IFN-γ production (Balmer et al.,
2000, Von der Weid et al., 1994).  These mice were able to control and clear the
infection similar to the wild-type mice although Balmer and colleagues noted
that  the  IL-4  deficient  mice  demonstrated a significantly  elevated  peak
parasitaemia (Balmer et al., 2000) whereas von der Weid and colleagues showed
increased recrudescent infection in these mice (von der Weid et al., 1994). The
Th2-type response initiated in the deficient mice was delayed but not absent.
Evidence  for  the  protective  Th2  response  in  the  IL-4  deficient  mice  was
attributed to IL-13 to substitute for the action of IL-4 (Balmer et al., 2000).
Taken together, the ability of the IL-4 deficient mice to control infection in the
absence of early Th2 responses indicated the importance of the Th1 response in
inducing  IFN-γ  and  IgG2a antibody production thereby  promoting  parasite
clearance. It is notable that in the same series of experiments, IFN-γ deficient
mice rapidly died at the primary patent parasitaemia (Balmer et al., 2000).
CD4
+ T-cell priming, expansion and memory in response to model antigens is also
an  important  factor  to  consider  since  it  has  been  suggested  that  continuous
exposure to the parasite may be required for the maintenance of immunological
protection  from  malaria  as  has  also  been  suggested  for Leishmania  major
(Uzonna et  al.,  2001)  and  other  (Hansen et  al.,  2009)  chronic  infections
(Stephens and Langhorne, 2010). Recent work with P. chabaudi demonstrated
that the diminishing protection is replicated in mouse models and that this may
be determinined by a decay in the memory T-cell function (Freitas do Rosário et
al., 2008).
Although  the  role  of  CD4
+T  cells  in  immunity  to  blood-stage  malaria  is  well
established (Yoneto et al., 2001) the complexity of the antigen repertoire of the
Plasmodium parasite, makes it difficult to identify which antigens are effective
in inducing protective CD4
+ T-cell–dependent immunity. Thus, the development28
and characterization of antimalarial immune responses in a CD4
+ T-cell antigen
receptor (TCR) transgenic mouse with a TCR specific for Plasmodium chabaudi-
derived  MSP-1,  a  major  vaccine  candidate  antigen  has  been  investigated
(Stephens  and  Langhorne,  2010,  Stephens et  al.,  2005)  and  could  provide
another tool to ascertain the role of CD4
+ T-cells in antimalarial immunity.
2.4 ANTIBODY-MEDIATED IMMUNITY
There  is  longstanding  evidence  that  naturally  acquired immunity  to  the
erythrocytic stages of malaria is strongly dependent on antibodies (Abs) (Osier et
al., 2008, Cavanagh et al., 2004, Metzger et al., 2003, Conway et al., 2000).
Malaria  infection  induces  both  polyclonal  and  specific  immunoglobulin  (Ig)
production and although the different Ig isotypes may have protective functions,
IgG is seen as the most important (Table 1.3). Passive antibody protection has
been  described  in P.  falciparum  infection  (Diggs et  al.,  1995)  as  well  as  in
animal studies. During P. falciparum infection, specific antibodies for a number
of the parasite antigens such as MSP-1 and MSP-2 (O’Donnell et al., 2001, Egan
et al., 1996, Al-Yaman et al., 1994) and PfEMP1 (Marsh et al., 1989, Celada et
al.,  1982)  have  been  correlated  with  resistance.    Similarly,  passive  transfer
experiments  in P.  chabaudi  infection  have  also  shown  the  protective  role  of
antibodies during P. chabaudi infection where treatment with anti-serum at the
time of infection in mice subsequently induced a delay in patent parasitaemia
levels (Falanga et al., 1984, McLean et al., 1982). Furthermore, P. chabaudi AS
infection  involving  the  switch  from  a  Th1  to  Th2 response  that  induced  the
characteristic  switch  from  IgG2a  to  IgG1  antibody  production  (Phillips et  al.,
1997,  Stavnezer,  1996, Taylor-Robinson  and  Phillips,  1994). Thus,  during  the
acute infection, IgG2a antibodies were shown to predominate while during the
chronic stage, IgG1 antibodies were associated with protection. Earlier mouse
studies with P. yoelii (White et al., 1991) and P. berghei (Waki et al., 1995)
infections  also  showed  that  antibody-dependent  protection  and  parasite
clearance was related to IgG2a production. In addition, a more recent study by
Couper and colleagues has demonstrated that IgM also has a significant role to
play in controlling both primary and recrudescent P. chabaudi AS parasitaemias
(Couper et  al.,  2005).  The  effector  mechanisms  of  IgE  antibody  (generated
during  a  Th2  response)  during Plasmodium  infection  in  humans  and  mouse
models are not as clear. However, in P. falciparum infection in humans, total29
and specific parasite IgE levels were shown to be increased (Perlmann et al.,
1994).  Furthermore,  parasite-specific  IgE  antibodies  were  shown  to  be
associated with pathogenesis of disease when total IgE and specific IgE Ab’s were
higher in Thai patients with severe P. falciparum infection. Specific IgE Ab’s
detected in apprpoximately 65% of the patients were also positively correlated
to parasitaemia (Perlmann et al., 2000).  In contrast, others have demonstrated
that high parasite-specific IgE antibody levels in asymptomatic individuals were
associated with the reduced risk of clinical episodes (Bereczky et al., 2004).
Thus,  the  significance  of  IgE,  which  is  present  in  increased  levels  in  severe
malaria, remains unknown.
Both experimental malaria models and human malaria, have shown evidence for
loss of memory or activated CD4
+ T-cells, B-cells and plasma cells and short-lived
malaria specific Abs after a primary acute infection (Langhorne et al., 2008,
Wykes et al., 2005, Struik and Riley, 2004, Xu et al., 2002). This suggested that
some of the components contributing to the humoral response might be short-
lived. Moreover, other  studies  have  suggested  that  maintenance  of malaria-
specific  Abs was  dependent  on  the  presence  of  chronic  parasitaemia
(Akpogheneta et al., 2008). However, there are conflicting reports on the life-
span of Ab reponses to Plasmodium. In some longitudinal studies short-lived Ab
responses with reduced half lives have been reported (Akpogheneta et al., 2008,
Kinyanjui et al., 2007, Kinyanjui et al., 2003, Cavanagh et al., 1998), whereas
other studies report that Ab responses persist and are protective (Osier et al,
2008, Drakeley et al., 2005, Taylor et al., 1996). Nonetheless, it still has to be
determined whether  there  are  any  deficiencies  in  the  generation and
maintenance  of Plasmodium-specific  memory  B  cells  and  Abs. Long  term
production of Abs was maintained by a combination of short-lived and long-lived
Ab secreting cells (ASC). Although short-lived ASC die within 3–5 days, Ab levels
can be maintained by continuous proliferation and differentiation of memory B
cells into  short-lived  ASC upon  continuous  re-activation  either  by  persistent
antigen  during  chronic  infection  (Gatto et  al.,  2007,  Zinkernagel  and
Hengartner,  2006)  or by polyclonal stimulation (Crompton et  al.,  2009,
Bernasconi et  al.,  2003,  Bernasconi et  al.,  2002).  Alternatively,  long-term
production  of  Ab is maintained  by  long-lived  ASC,  which  migrate  to  survival
niches within the bone marrow (Manz et al., 1997, Slifka et al., 1995) and spleen30
IgM Complement activation against merozoites
Opsonization
Neutralization of merozoites
Agglutination of merozoites and pRBC’s
Immune complex formation and clearance in the spleen
IgG2a Complement activation against merozoites
Opsonization
Neutralization of merozoites
Agglutination of merozoites and pRBC’s
Immune complex formation and clearance in the spleen
Cytophillic and may induce ADCC by macrophages and PMN’s
IgG1 Neutralization of merozoites
Agglutination of merozoites
Immune complex formation and clearance in the spleen
IgE Binds CD23 and may induce pathology by upregulating type 1 cytokine production
IgD Function largely unknown
(Slifka et  al.,  1998)  and  can  exist  for  the  life-time  of  the  mouse (Manz  and
Radbruch, 2002, Manz et al., 1997), and this is probably also the case in humans
(Cambridge et al., 2003). In a more recent study by Ndungu and colleagues, they
showed  that P.  chabaudi-MSP-1-specific  B-cells  and  plasma  cells  were  still
detectable  after  eight  months  following  infection  and  that  both  long-lived
memory  B cells  and plasma  cells  secreting  anti-MSP119  Abs  can  be  generated
after a single infection (Ndungu et al., 2009).
Table  1.2:  Associated  antibodies  and  their  functional  properties  during
Plasmodium infection (Taken from Couper, 2003)
2.5 PROTECTION VERSUS PATHOLOGY
Immunity to malaria infection clearly involves a complex network of cells and
cytokines, as well as both pro-inflammatory and regulatory mechanisms. Innate
immunity  involving  rapid  pro-inflammatory  responses  is  of  great  benefit in
controlling  primary  infection  but  rapid  and  potent  cytokine  development  can
lead  to  severe  malaria  either  directly  or  by  amplifying  the  effects  of  the
adaptive response (Riley, 1999). The ability of the immune response to control31
circulating levels of pro-inflammatory cytokines so that they facilitate parasite
clearance  but  do  not  trigger  pathology  is  one  of  the  hallmarks  of  acquired
immunity to malaria. However, the mechanisms by which this may be achieved
are still unknown. In mice (Omer and Riley, 1998, 2003, Li et al., 2003) and
humans  (Schmieg et  al.,  2003, Kurtzhals et  al.,  1998) the  key  regulatory
cytokines are IL-10 and TGF-β. The primary function of IL-10 and TGF-β is to
prevent  the  pathological  consequences  of  both  Th1  and  Th2  responses.  Both
cytokines  can  be  produced  by  cells  of  the  innate  (macrophages)  or  adaptive
immune systems (T-cells) and can regulate either system (O’Garra and Vieira,
2007). The source of IL-10 was thought to be via T-cell subsets (Th1, Th2, Tr1
cells, Treg cells) (Niikura et al., 2011) but today, it is known that the sources of
IL-10 is not only CD4
+ T-cells but also almost all leukocytes (Niikura et al., 2011).
IL-10  has  been  shown  to  inhibit  IL-12  production  by  DCs  and  macrophages
thereby downregulating IFN-γ production by NK cells and T-cells (Niikura et al.,
2011, D’Andrea et al., 1993). The depletion of IL-10, using neutralizing IL-10-
specific  or  IL-10  receptor  (IL-10R)-specific monoclonal  antibodies  or  IL-10
–/–
mice,  has  been  shown  to increase  the  resistance  of  mice  to  a number  of
intracellular  pathogens  namely, Listeria  monocytogenes,  Toxoplasma  gondii,
Mycobacterium avium, Mycobacterium bovis bacillus Calmette–Guérin (BCG), P.
chabaudi chabaudi, Candida albicans, Trypanasoma cruzi (O’Garra and Vieira,
2007). However, in a model of P. chabaudi chabaudi, inhibition of IL-10 also
resulted in immunopathology (Moore et al., 2001).TGF-β has also been shown to
inhibit pro-inflammatory cytokine responses resulting in unconstrained parasite
growth in P. yoelii (Omer et al., 2003) and P. chabaudi (Tsutsui and Kamiyama,
1999) mouse infection studies by antibody depletion.  Other studies have also
shown  that  TGF-β  can  inhibit  human  IFN-γ  production  from  NK  cells  directly
(Ortaldo et al., 1991).
Recently there has been considerable interest as to the mechanisms by which
parasites can modulate the immune response. For example, it has been shown
that  malaria parasites  could  directly  activate endogenous  latent  TGF-β  to its
bioactive  form  indicating  that  the  parasite  itself  can  manipulate  the  innate
response of the host (Omer et al., 2003).  In addition, the malaria parasite has
been  implicated  in  modulating  DC  function  as  mentioned  in  chapter  2.3.1
(Millington et al., 2006).32
2.6 ROLE OF IL-4-RECEPTOR-ALPHA (IL-4Rα) IN IMMUNITY/PATHOLOGY
The role of the Th2 response in immunity to malaria is particularly intriguing.
Classically Th2 responses and the associated cytokines IL-4 and IL-13 are thought
to  counter-regulate  Th1  responses  (Brombacher,  2000).  Consequently,  during
early P.  chabaudi  infection  when  it  has  been  recognised  that  protective
immunity is Th1 dependent it might be expected that a Th2 response would serve
primarily to limit pathology associated with a pro-inflammatory type-1 response.
Similarly, a Th2 response early in infection may limit the effectiveness of a Th1
response and promote parasite growth. Thus, in the absence of IL-4/IL-13 or IL-
4/IL-13  signalling  reduced  parasitaemias  and  increased  pathology  might  be
expected.  Conversely,  during  chronic  infection  with P.  chabaudi,  immunity  is
primarily dependent on a Th2 response and IgG1 production. Consequently, in
the absence of IL-4/IL-13 signalling it might be expected that enhanced parasite
growth would result. However, recent evidence would suggest that the roles of
Th2 cytokines might not be as clear-cut as early publications would suggest. In
certain disease and immune-modulatory models, Th2 responses can be induced in
the absence of IL-4 or IL-4/IL-13 signalling (Brewer et al, 1999). Furthermore,
infectious and inflammatory disease models have provided a substantial body of
evidence  indicating  that  the  typical  Th2  cytokines,  IL-4/IL-13, can  not  only
counter-regulate Th1 responses but also in particular examples actually drive,
facilitate or promote Th1 responses (Alexander and McFarlane, 2008). In various
disease  models  such  as Toxoplasma  gondii (Suzuki et  al.,  1996), Listeria
monocytogenes (Flesch et al., 1997), Cryptosporidium parvum (Menacacci et al.,
1998), Leishmania  major (McDonald et  al.,  2004)  and Leishmania  donovani
(Alexander et al., 2000, Biedermann et al., 2001, Stager et al., 2003, Murray et
al., 2006), IL-4/IL-13 has been shown to drive protective Th1 responses as well as
in an experimental autoimmune uveoretinitis and murine model of colitis (Fort
et al., 2001, Ramanathan et al., 1996), IL-4/IL-13 has been shown to aggravate
the Th1 responses (Alexander and McFarlane, 2008). Taken together (Alexander
and  McFarlane,  2008),  it  has  been  suggested  that  IL-4/IL-13  mediate  their
functions by inducing IL-12 production from macrophages and/or dendritic cells
(McDonald et al., 2004, Hochrein et al., 2000), enhance IFN-γ production (Noble
and Kemeny, 1995) or synergise with IFN-γ for enhanced antimicrobial activity
(Lean et al., 2003, Bogdan et al., 1993).33
Previous  work  utilising  IL-4
-/-  mice  on  the  B6  and/or  129  backgrounds  has
indicated no significant role for IL-4 in malaria pathology (Balmer et al., 2000,
van der Heyde, 1997, von der Weid et al., 1994) but potential roles for IL-4 in
controlling parasite growth in either the early acute phase (Balmer et al, 2000)
of infection or during chronic infection (von der Weid et al.,1994). The former
observation with regard to parasite numbers during primary infection in IL-4
-/-
mice would be contra-intuitive if IL-4 was indeed inhibiting a Th1 response, while
the latter observation might be expected if control of chronic infections was
indeed Th2 dependent. The moderate alteration in susceptibility observed in
IL-4
-/- mice as opposed to a more significant effect was attributed to the related
cytokine IL-13 compensating for a deficiency in IL-4 and promoting protective
immunity.
It has been documented that IL-4 and IL-13 share 30% homology (Brombacher,
2000, McKenzie et al., 1993) with functional overlaps. They have broadly similar
effects on macrophages and other cell types because they share a common IL-
4Rα chain (Figure 1.6) but there are also differences with regards to the range of
cell types that respond to each cytokine which correspond with the presence of
different  receptor  subunits.  The  signalling  pathway  involves  members  of  the
Janus-activated  kinase  (JAK)  and  signal  transducer  and  activator  of  the
transcription (STAT) families (Brombacher, 2000, Zurawski and de Vries., 1994,
Minty et al., 1993).34
Figure 1.6: IL-4 and IL-13 receptor complexes. IL-4 interacts with the IL-4Ra binding protein in
combination with either gc (IL-4 type 1 receptor), IL-13Ra1 or IL-13Ra2 (IL-4 type 2 receptor). IL-
13 interacts with IL-13Ra1 or IL-13Ra2 binding proteins in combination with the IL-4Ra chain. The
IL-4Ra chain is the signal transducing receptor for IL-4 and IL-13 and signal are transmitted via
STAT6 or IRS-2 pathways. Increasing thickness of the arrows indicate increasing binding affinities
(Kd) (Taken from Brombacher, 2000).
2.7 AIMS OF STUDY
In order to determine whether, in the absence of IL-4, IL-13 might drive a Th2
response  and  promote  parasite  clearance  during P.  chabaudi  infections
preliminary studies were carried out in our laboratory to compare the course of
P. chabaudi infection in IL-4
-/- and IL-4R
-/- BALB/c mice that are deficient in
both IL-4 and IL-13 signalling (Couper et al, 2003). In agreement with previous
studies  IL-4
-/-  mice  displayed  delayed  parasite  clearance  and  enhanced
recrudescent infection  compared  with  wild-type  mice  but  were  able  to  clear
infections to sub–patent levels. IL-13 contributed to parasite control as shown by
elevated recrudescent infections in IL-4R
-/- mice compared with IL-4
-/- animals.
However,  in  the  absence  of  IL-4,  but  not  IL-4  and  IL-13  signalling,  mortality
increased  significantly  suggesting an additional exacerbatory  role  for  IL-13
during P. chabaudi infection. Thus, our preliminary work indicated that both IL-4
and IL-13 played immunomodulatory roles during P. chabaudi infection.35
However, IL-4 and IL-13 are pleiotropic cytokines and numerous cell types of
both the innate and adaptive immune responses produce these cytokines as well
as express their receptors. In order to differentiate better the specific role of IL-
4/IL-13 responding cells from global effects in vivo, tissue specific IL-4R
-/- mice
have been produced in the laboratory of our co-principal investigator Professor
Frank Brombacher in the University of Cape Town. So far macrophage/neutrophil
specific (LysM
creIL-4R
-/lox) (Herbert et al., 2004), CD4
+ T cell specific (Lck
creIL-
4R
-/lox)  (Radwanska et  al.,  2007)  and  pan  T-cell  specific (iLck
creIL-4R
-/lox)
(Dewals et al., 2009) IL-4R
-/- mice have been generated.
Consequently, the aims of the present project were:
1. To re-establish an appropriate murine model of P. chabaudi infection in the
laboratory  that  was  compatible  with  current  ethical  guidelines  and  was
reproducible.
2. To  determine  whether  the  results  previously  obtained  in  the  laboratory
utilizing  IL-4R
-/-  mice  were  reproducible  and  whether  results  were  mouse
gender and/or parasite strain dependent.
3. To  identify  a  potential  role  for  alternative  macrophage  activation  by
comparing  disease  in  macrophage/neutrophil  specific  (LysM
creIL-4R
-/lox)  mice
and wild-type equivalent mice.
4. To  identify  potential  roles  for  IL-4  signaling  via  CD4
+ T-cells  in
pathology/immunity by utilizing CD4
+T-cell (Lck
creIL-4R
-/lox) IL-4R
-/- mice.
5. To  identify  a  potential  role  for  IL-4  signalling  via  T-cells  in
pathology/immunity by utilizing pan T-cell (iLck
creIL-4R
-/lox) IL-4R
-/- mice.
6. To characterize the immune mechanisms underlying any disease phenotypes
characterized.36
Chapter Two
Methodology37
2.  GENERATION  AND  BREEDING  STRATEGY  OF  TISSUE-SPECIFIC  IL-4-Rα-
DEFICIENT (IL-4Rα
-/-) BALB/c MICE
Tissue-specific IL-4Rα
-/- mice were created using homologous recombination in
embryonic stem (ES) cells in combination with the Cre/loxP recombinase system.
Gene  targeting  in  BALB/c  ES  cells  and  Cre/loxP-specific  site-specific
recombination was performed to generate floxed IL-4Rα
lox/lox BALB/c mice which
resulted in a silent mutation of the IL-4Rα gene (Mohrs et al., 1999). Mice that
specifically express the Cre recombinase in macrophages/neurtophils under the
control of the lysozyme M promoter (LysM
cre mice) were generated by a knock-in
approach (Clausen et al., 1999). This approach was similar for mice expressing
Cre recombinase in CD4
+ T-cells under the control of the Lck promoter (Lck
cre
mice) (Gu et al., 1994) and for mice expressing Cre recombinase in all T-cell
populations under the control of the iLck promoter (iLck
cre mice) (Garvin et al.,
1990). These mice (kindly provided by Prof. F. Brombacher, University of Cape
Town) were first backcrossed to BALB/c for nine generations and then inter-
crossed with global IL-4Rα
-/- BALB/c mice (Mohrs et al., 1999) to establish double
transgenic  LysM
creIL-4Rα
-/-  BALB/c, Lck
creIL-4Rα
-/-  BALB/c  and iLckM
creIL-4Rα
-/-
BALB/c  mice  respectively  in  specific  pathogen-free  conditions  in  individual
ventilated cages. These mice were further inter-crossed with IL-4Rα
lox/lox BALB/c
mice  to  generate  cell-type-specific LysM
CreIL-4Rα
-/lox (McFarlane et  al.,  2011,
Brombacher et al., 2009, Herbert et al., 2004), Lck
CreIL-4Rα
-/lox (Bryson et al.,
2011, Radwanska et al., 2007) and iLck
CreIL-4Rα
-/lox (Dewals et al., 2009) BALB/c
mice respectively. The Cre-negative IL-4Rα
lox/- littermates served as “wild-type”
controls  for cell-type specific  LysM
creIL-4Rα
-/lox, Lck
creIL-4Rα
-/-,  and iLckM
creIL-
4Rα
-/- BALB/c mice. An example of how the tissue-specific IL-4Rα gene-deficient
mice were generated, namely for LysM
creIL-4Rα
-/lox mice, is shown in Figure 2.138
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Challenge (i.g)
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Day 0 Day 7 Day 14
Challenge (i.g)
4mg/mouse
and sacrifice
G1: PBS/PBS
G2: PBS+Alum/PBS
G3: OVA+Alum/OVA
G4: CPE+Alum/CPE
(G= group)
Sensitization (i.p) 50µg/mouse
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Figure 2.1: Principle of  macrophage/neutrophil specific deletion of IL-4Rα. Conditional  IL-
4Rα
lox/- mice were generated by homologous recombination. In these mice exons of the IL-4Rα
are flanked by two loxP sites (triangles) that are recognized by the Cre recombinase. Mice that
specifically  express  the  Cre  recombinase  in  macrophages/neutrophils  under  control  of  the
lysozyme  M  promoter  (LysM
cre  mice)  were  first  intercrossed  with  global  IL-4Rα
-/-  mice.  To
facilitate  efficient  Cre-mediated  recombination,  LysM
creIL-4Rα
-/-  mice  were  crossed  with
conditional IL-4Rα
lox/lox mice. Because the Cre recombinase is only expressed in macrophages and
neutrophils of hemizygote LysM
creIL-4Rα
-/lox offspring, loxP-flanked exons of the IL-4Rα locus on
one  allele  was  deleted  only  in  these  cell  types.  Hemizygote  mice  were  used  to  reduce  the
substrate  for  the  enzyme  and  to  increase  efficiency  of  Cre-mediated  deletion  in
macrophages/neutrophils. In other cell types, the enzyme was not active and a functional IL-4Rα
was still expressed. In experiments, Cre-negative IL-4Rα
lox/- littermates served as controls for
macrophage/neutrophil-specific  LysM
creIL-4Rα
-/lox  mice.  Adapted  from  Brombacher  and
colleagues (Brombacher et al., 2009).39
2.1 Genotyping of the tissue-specfic IL-4Rα
-/lox mice
One capillary (Hawksley and Sons Ltd, West Sussex, UK) of blood was removed
from the tail of the mouse being genotyped and was placed into a RNA/DNA free
eppendorf  (Axygen  Scientific,  California,  USA).  To  lyse  erythrocytes,  1ml  of
Boyle’s solution (1:9 v/v 0.17M Tris: 0.16M ammonium chloride) was added to
the sample and was incubated at room temperature for 5 minutes. The blood
was centrifuged at 13, 000 rpm for 3 minutes and the supernatant removed. The
resulting pellet was resuspended in 100μl Tris-HCL and freeze-thawed at -80
oC.
The sample was then ready for use in a PCR reaction.
2.1.1 Cre determination by PCR
Two PCR reactions were carried out on the samples: a Cre PCR to determine
which  mice  were  positive  for  Cre-recombinase  and  a  second  PCR  reaction  to
determine if the mice were IL-4Rα-deficient or flox (presence of IL-4Rα gene on
Macrophages/Neutrophils,  CD4
+  T  cells  and pan-T-cells  flanked  by  lox-p
sequences). All reagents were kept on ice at all times and all plasticware was
RNA/DNA free. The primers and primer sequences used are summarised in Table
1.1. All PCR reactions used 13μl total volume: 6μl 2x Readymix (ABgene, Epsom,
UK), 0.5μl of the relevant primers (obtained from Invitrogen, Paisley, UK) and an
appropriate volume of molecular grade water (Sigma Aldrich, Poole, UK) to give
12μl. Lastly, 1μl of blood sample, prepared in 2.1, was added to give a final
volume of 13μl.
A relevant positive control was included in the PCR studies and molecular grade
water was used as a negative control for PCR reactions. The product sizes for the
relevant genes are shown in Table 1.2 and the PCR conditions are shown in Table
1.3. Samples were maintained at 4
oC until an electrophoresis of samples could
be completed. Electrophoresis of the PCR products for each tissue-specific group
is shown in Figure 2.2.40
Table 2.1: The primer sequences for each of the primers used in the genotyping
of the LysM
creIL-4Rα
-/flox, iLck
creIL-4Rα
-/flox and Lck
creIL-4Rα
-/flox BALB/c mice. All
primers were obtained from Invitrogen (Paisley, UK).
PRIMER PRIMER SEQUENCE
LysM Cre F 5’- CTT GGG CTG CCA GAA TTT CTC –3’
LysM Cre R 5’– CCC AGA AAT GCC AGA TTA CG -3’
iLck Cre F 5’- GAG GGT GGA ATG AAA CTC TCG GT –3’
iLck Cre R 5’– CAG GTA TGC TCA GAA AAC GCC TGG -3’
Lck Cre F 3’– TGC ATG ATC TCC GGT ATT GAA AC
Lck Cre R 5’– GGT GAA CGT GCA AAA CAG GCT CTA
IL-4R P2 5’- CCT TTG AGA ACT GCG GGC T -3’
Flox IL-4R Intron 6.2 F 5’- CCC TTC CTG GCC CTG AAT TT -3’
Flox IL-4R Intron 6 R 5’- GTT TCC TCC TAC CGC TGA TT -3’
Glyceraldehyde-3-phosphate
dehydrogenase (GADPH) F
AGA TTG TTG CCA TCA AAC GAC
GADPH R ATG ACA AGC TTC CAT TTC TTC
Table 2.2: The band sizes (base pairs) for the LysM Cre, iLck Cre, Lck Cre,
IL-4Rα deleted and flox PCR gene products.
GENE BAND SIZE (bp) REFERENCE
LysM Cre 450 Herbert et al., 2004
LysM IL-4Rα deleted 1300 Herbert et al., 2004
Lck Cre 450 Dewals et al., 2009
Radwanska et al., 2007
Lck IL-4Rα deleted 471 Dewals et al., 2009
Radwanska et al., 2007
Lox-p 188 (floxed)
94 (wild-type)
Dewals et al., 2009
Radwanska et al., 2007
Herbert et al., 200441
Table 2.3: The thermal profile for the PCR reactions carried out to determine
the  genotype  of  the LysM
creIL-4Rα
-/flox,  iLck
creIL-4Rα
-/flox and Lck
creIL-4Rα
-/flox
BALB/c mice.
2.1.2 Electrophoresis
An electrophoresis gel was prepared using 1.6% w/v agarose (Bioline, London,
UK)  in  TBE  buffer  (0.5  strength:  10.8g  Tris  base,  5.5g  boric  acid  and  7.54g
EDTA). The agarose was dissolved by microwaving the suspension for 1-2 minutes
then cooled to prevent the release of a vapour when adding ethidium bromide
(Sigma Aldrich, Poole, UK). 2μl ethidium bromide/100 ml of agarose/TBE was
added and the solution was poured into a gel tank containing a sealed gel bed.
Running buffer (0.5 strength TBE) was added to the gel tank and the samples
were  added  to  the  gel  along  with  a  DNA  ladder  Forever  Marker  (Seegene,
supplied from Insight Biotechnology, Wembley, UK). Samples were exposed to an
electrophoresis voltage of 150 V. Once the samples had run sufficiently far along
the gel, the gel bed was removed and the gel was viewed using an ultraviolet
transilluminator (Viber Lourmat) and photographed for a permanent record.
TEMPERATURE TIME STEP
94
oC 1 minute Enzyme activation
94
oC 30 seconds Denaturation
60
oC 30 seconds Annealing
72
oC 1 minute Extension (40 cycles)
72
oC 5 minutes Final extension42
A. B.
C.
Figure 2.2: Genotyping. Genotyping of the transgene bearing (A) LysM
cre, (B) iLck
cre and (C)
Lck
cre IL-4Rα
-/lox deletion PCR fragment of (A) 1300bp and (B+C) 471bp, the loxP-specific PCR
product of 188bp and the 94bp product is present in the wildtype configuration. The Cre-specific
PCR generates a 450bp PCR product (Dewals et al., 2009, Radwanska et al., 2007, Herbert et al.,
2004).43
2.2 MICE
2.2.1 Infection and Monitoring of the course of P. chabaudi AS infection
8-9 week old BALB/c wild-type mice, IL-4Rα
-/- and tissue specific gene deficient
BALB/c mice were housed in the Strathclyde University animal facility and were
kept in a reverse light/dark cycle from 19h00 to 07h00 and fed with the standard
diet. The capsule of cryopreserved infected blood was taken from liquid nitrogen
(N2) storage and thawed in a 37
oC waterbath. To the thawed blood, an equal
volume of 0.5ml 17.5% sorbitol was mixed and then inoculated intraperitoneally
(ip) into a passage BALB/c mouse. Parasites were then maintained if required by
subpassage through susceptible mice. Briefly, infected mice were sacrificed in a
carbon  dioxide  (CO2) chamber  and  bled  by  cardiac  puncture  into  a  syringe
containing sodium heparin at 10 i.u. heparin per ml of blood. The parasitemia of
the donor mouse was determined by examination of a Giemsa (10% R66 improved
Giemsa-staining Gurr (BDH Limited) v/v PBS pH 7.4 for 20 minutes) stained thin
blood smear. The infected blood was subsequently diluted to give the required
infective doses of the parasitized red blood cells (pRBCs). Here, infective doses
were 1 × 10
5 pRBCs for P. chabaudi AJ and Plasmodium AS. Subsequently, the
experimental  mice  were infected  intraperitoneally  with  1X10
5 Plasmodium
chabaudi AJ or AS parasitized red blood cells (pRBCs) obtained from 4-5 day
infected passage BALB/c mice. The stabilates were stored at -80
oC or in liquid N2
until required. P. chabaudi AJ stabilate was obtained from Dr. Owain Millington
from the University of Strathclyde and P. chabaudi AS stabilates were obtained
from Dr. Paul Hunt from the University of Edinburgh. Thin blood smears from 3-6
mice per group, depending on the group size, were performed daily initially and
then  every  second  to  third  day  during  the  course  of infection  (0-47  days)  to
monitor parasitaemia. Smears were evaluated via microscopy following fixation
for 1 minute in 100% methanol and Giemsa’s staining. Daily and then on selected
days weight loss was determined as a sign of morbidity and the mean red blood
cell count was followed during infection to monitor malaria induced anaemia. On
selected  days,  tail  bleeds  were  performed  to  follow  cytokine  and  antibody
profiles during the infection.44
2.2.2 Measurement of P. chabaudi AS induced anaemia
3 μl of non-infected and P. chabaudi infected mice venous blood obtained by tail
tip  bleeding  were  mixed  with  597μl  formaldehyde/saline  buffer  (10ml  40%
formalin  adjusted  to  1  litre  with  32g/l  trisodium  citrate).  Following  vortex
mixing, the red blood cell concentration was then determined by microscopy
using a haemocytometer
2.3 Antigen preparation
P. chabaudi antigen and control red blood cell antigen were prepared for use in
in vitro stimulation of splenocytes and ELISA. P. chabaudi antigen was prepared
from mature trophozoite or schizont-infected red blood cells as only these life
cycle stages induce expression of parasite specific antigens on the red blood cell
surface.
2.3.1 P. chabaudi antigen preparation
Late stage trophozoites or schizont-infected red blood cells were obtained at
high pRBC to RBC ratio from BALB/c mice. The parasites were washed in 5% RPMI
at 200G for 10 minutes, and then washed twice in sterile PBS at 200G for 10
minutes. Following washing the pellet was resuspended to the original volume
and  freeze-thawed  5  times  in  liquid  nitrogen.  The  pRBC  antigen  containing
supernatant was then collected by centrifugation at 1500G for 10 minutes and
the protein concentration was determined using the Bradford assay.
2.3.2 RBC (-ve) control antigen preparation
Red  blood  cell  control  antigen  was  prepared  by  bleeding  uninfected  BALB/c
mice. Following collection, the blood was subjected to snap-freeze thawing 5
times  in  liquid  nitrogen.  The  supernatant  was  then  collected  following
centrifugation  at 1500G  for  10  minutes.  The  protein  concentration  was
determined using the Bradford assay.
2.3.3 The Bradford protein concentration estimation assay
300  μl  Bradford  reagent  (100mg  Coomaise  brilliant  blue  dissolved  in  50ml
methanol  and  100ml  85%  orthophosphate  acid  and  adjusted  to  1  litre  with
deionised water) were mixed 1:4 with de-ionised water and added to 10 μl of
BSA standards ranging from 1mg/ml to 0.0625μg/ml or 10μl of sample in a 9645
well  microtitre  plate.  The  absorbance  was  read  at  570nm  using  a  Molecular
Devices Spectramax Pro spectrophotometer.
2.4 Splenocyte Stimulation Assay
Mice spleens were removed aseptically and placed in petri dishes containing 5ml
complete  media  (RPMI  1640  (Lonza,  Belgium),  10%  v/v  heat  inactivated  FCS
(Sigma Aldich, Poole, UK), 1% v/v of 2mM L-glutamine solution and 1% v/v of 100
IU/ml Penicillin-100 μg/ml Streptomycin (PAA Laboratories, GmbH, Austria). Half
a spleen per mouse was used. Cell suspensions were prepared by teasing the
spleens  apart  using  nitex  (monofilament  filter  nylon  cloth  100mm,  Cadisch
Precision  Meshes,  London,  UK)  and  a  2ml  syringe  (Becton  Dickinson,  Madrid,
Spain) and the resultant suspension was centrifuged at 1200rpm for 5 minutes.
The supernatant was poured off and 2ml Boyle’s solution (1:9 v/v 0.17M Tris:
0.16M ammonium chloride) was added to lyse erythrocytes. The reagents were
mixed before use and sterile filtered through a 0.22μm syringe driven filter unit
(Millipore, Cork, Ireland). The resultant cell suspension was centrifuged for 5
minutes at 1200rpm. The pellet was washed twice in 5ml complete media by
centrifuging at 1200rpm for 5 minutes. The pellet was then resuspended in 1ml
complete media and the number of viable cells was then estimated by trypan
blue  exclusion  using  a  haemocytometer  (Assistant,  Germany).  The  cell
suspension was adjusted to 5x10
6 cells/ml (equivalent to 5x10
5 cells/well) and
100μl was added to the wells of a 96-well sterile flat-bottomed tissue culture
plate  (Iwaki,  Japan)  to  which P.  chabaudi  antigen  (prepared  as  previously
described,  10;  50;  100μg/ml)  and  Concanavalin  A  (Sigma-Aldrich,  Poole,  UK,
10μg/ml) had previously been added. The plates were incubated at 37
oC and 5%
CO2/95%  air  for  60  hours  before  being  stored  at -20
oC  for  cytokine
quantification.
2.5 Enzyme Linked Immunosorbent Assay (ELISA)
Serum P.  chabaudi  specific  IgG2a  and  IgG1  isotype  titres  were  quantified  by
indirect  ELISA.  Spleen  cytokine  (IFN-γ,  IL-12  p40/70,  IL-10,  IL-4)  levels  were
measured using sandwich ELISA protocols.46
2.5.1 Anti P. chabaudi AS and RBC specific antibody ELISA
Blood was harvested at sacrifice, serum prepared and stored for up to 24 hours
at 4
oC. Clotted blood was centrifuged at 13 000 rpm for 10 minutes and the
resulting serum collected and stored at -20
oC until assayed. 96-well microtitre
plates  (Greiner  Bio-One,  Germany)  were  coated  overnight  with P.  chabaudi
antigen  or  RBC  antigen  at  2μg/ml.  The  plates  were  then  washed  3  times  in
phosphate buffered saline (PBS) pH 7.4, 0.05% Tween 20 (Sigma-Aldrich, Poole,
UK) and blocked using 200μl/well 10% Foetal calf serum (FCS) (Harlan Sera-Lab
Ltd) in PBS pH 7.4, at 37
oC for 1 hour. Thereafter, serum samples were serially
diluted. Dilutions were performed in PBS pH 7.4, 10% FCS buffer. Plates were
then incubated at 37
oC for 2-3 hours. Thereafter, plates were washed 4 times
and 100μl of horseradish peroxidise conjugated goat anti-mouse IgG1 or IgG2a
(Southern Biotechnology, supplied by Cambridge BioScience Ltd, Cambridge, UK)
diluted 1/20 000 or 1/10 000 v/v respectively in PBS pH 7.4, 10% FCS buffer were
added  to  the  plate.  The  plate  was  then  incubated  at  37
oC  for  1  hour  then
washed 4 times and 100μl of substrate tetramethylbenzidine (6mg/ml in DMSO)
diluted  1/100  in  0.1M  sodium  acetate  pH  5.5  containing  hydrogen  peroxide
(which  was  added  just  before  the  substrate  was  applied  to  the  plate)  were
added. The plate was covered in foil until an appropriate colour change was
observed. The reaction was stopped with 50μl of 10% sulphuric acid added to
each well. The absorbance was read at 450nm on a SOFTmax  Pro (Molecular
Devices,  California,  USA).  The  end  point  titres  of  parasite  specific  IgG1  and
IgG2a for each sample were regarded as the last dilution to give an absorbance
above background levels.
2.5.2   Cytokine ELISA
A  96  well  microtitre  plate  (Greiner  Bio-One,  Germany)  was  coated  with
50μl/well  of  1μg/ml  w/v  of  the  appropriate  purified  anti-mouse  capture
antibody  (IFN-γ  R4-6A2,  IL-12  p40/70,  IL-10 JES5-2AS  and  IL-4  11B11
(PharMingen, supplied by Insight Biotechnology, Wembley, UK) diluted in PBS pH
9 respectively and incubated overnight at 4
oC. The plates were then washed 3
times and the wells were blocked using 10% FCS in PBS pH 7.4, at 37
oC for 1
hour. After washing 3 times, samples were added neat. Standards were prepared
for  each  cytokine.  Murine  recombinant  IFN-γ,  IL-12  p40/70,  IL-10  and  IL-4
standards  (R&D  Systems  Europe  Ltd,  Abingdon,  UK)  were  diluted  in  10%  v/v47
FCS/PBS.  Standards  started  at  20ng/ml  for  IFN-γ,  10ng/ml  for  IL-12  p40/70,
10ng/ml for IL-10 and 1ng/ml for IL-4. The samples were incubated at 37
oC for 3
hours before being washed 4 times and 100μl of the appropriate biotinylated rat
anti-mouse monoclonal antibody at 2μg/ml (IFN-γ, IL-12 p40/70, IL-10 and IL-4)
(PharMingen, supplied by Insight Biotechnology, Wembley, UK) diluted in 10% v/v
FCS/PBS were added to the plate. The plate was then incubated for 1 hour at
37
oC  before  being  washed  4  times.  100μl  Streptavidin-alkaline  phosphatase
(PharMingen, supplied by Insight Biotechnology, Wembley, UK) diluted 1/2000 in
10% v/v FCS/PBS were used for the IFN-γ, IL-12 p40/70 and IL-10 assays whilst
100μl of a streptavidin horseradish peroxidise conjugate diluted 1/4000 in 10%
v/v FCS/PBS (PharMingen, supplied by Insight Biotechnology, Wembley, UK) were
used for the IL-4 ELISA. The plate was incubated for 45 minutes at 37
oC before
being washed 4 times. 100μl/well of substrate p-nitrophenylphosphate (pNPP)
(1mg/ml,  Sigma-Aldrich,  Poole,  UK)  dissolved  in  0.1M  glycine  buffer  pH  10.4
(7.51g  glycine,  0.203g  MgCl  and  0.136g  ZnCl)  were  used  for  the  IFN-γ,  IL-12
p40/70  and  IL-10  ELISA.  The  substrate  for  the  IL-4  ELISA  was
tetramethylbenzidine (6mg/ml in DMSO) diluted 1/100 in 0.1M sodium acetate
pH 5.5 containing hydrogen peroxide (which was added just before the substrate
was applied to the plate). The plates were covered in foil and incubated at 37
oC
until a colour change developed. For IL-4, the reaction was stopped by adding
50μl of 10% sulphuric acid to each well. The absorbance was read at 405nm for
IFN-γ,  IL-12  p40/70  and  IL-10  ELISA  and  at  450nm  for  the IL-4  ELISA  using  a
SOFTmax Pro (Molecular Devices, California, USA). The cytokine concentration
(ng/ml) was determined by linear regression using the standard value.
2.6 Statistics
Values are given as mean ±SEM and significant differences were determined by
the unpaired 2-tailed Student t-test using the computer software GraphpadPrism
4 (GraphPad Software Inc, San Diego, California). Values P<0.05 were considered
statistically significant.48
Chapter Three
The course of Plasmodium chabaudi AJ erythrocyte infection in wild-
type (WT) and global IL-4R-alpha-deficient (IL-4Rα
-/-) female mice.49
3.1 Abstract
Preliminary studies from our laboratory using male BALB/c mice infected with P.
chabaudi AS indicated that IL-4Rα
-/- mice were more susceptible than their wild-
type  counterparts  as  determined  by  greater  recrudescent  parasitaemia  and
severity  of  chronic  infection.  The  present  study  was  undertaken  in  the  first
instance  to determine  whether this  result  was  parasite  strain dependent and
secondly whether it was host gender specific. Consequently, wild-type and
IL-4Rα
-/- mice were infected with P. chabaudi AJ. As with the previous study
using  AS  strain  parasites,  IL-4Rα
-/- mice  were  also  more  susceptible  to P.
chabaudi  AJ  infection  than  wild-type  mice  as  measured  by  severity  of
recrudescent infection. Interestingly, there was an early delay in the onset of
peak  parasitaemia  in  IL-4Rα
-/- mice  compared  to  the wild-type  counterparts.
There was evidence of an enhanced Th1 response early in infected IL-4Rα
-/- mice
as measured by increased ConA stimulated splenic IFN-γ production and elevated
serum IgG2a antibody levels followed by a diminished Th2 response during the
chronic  infection  as  measured  by  reduced  splenic  IL-10  and  IL-4  cytokine
responses and serum IgG1 antibody titres. These results are extremely similar to
those previously  obtained  using  the P.  chabaudi  AS  strain indicating  that  the
observation (chronic infection) is not parasite strain dependent. In addition, the
present  study  used  female  mice  suggesting  that  the  observation  (enhanced
recrudescence in IL-4Rα
-/- mice) is independent of host gender.50
3.2 Introduction
The most characterized rodent model of malaria is P. chabaudi AS which can
result in lethal and non-lethal infections in various mouse strains. Comparative
studies  in  resistant  and  susceptible  mice  have  shown  that  pro-inflammatory
responses seem to be necessary for the subsequent development of protective
immunity  (Su  and  Stevenson,  2002,  Sam  and  Stevenson,  1999). The  current
understanding of protective immunity towards the blood-stage of P. chabaudi AS
infection is that initial protection is mediated through Th1 responses that control
the acute patent parasitaemia followed by a switch toward a Th2 response that
controls  and  eventually  eliminates  the  chronic-stage  of disease  (Namazi  and
Phillips, 2010, Phillips et al., 1997, Langhorne et al., 1989).
Preliminary  studies  from  our  laboratory  have  shown  that  in  comparison  to
BALB/c wild-type (WT) mice, IL-4-deficient (IL-4
-/-) mice survive P. chabaudi AS
infection with only a slight but consistent elevation in peak parasitaemia and
significantly higher recrudescent parasitaemias. Given that the role of antibody
as an effector mechanism was well established, it was surprising that the IL-4
-/-
mice survived the infection and produced a Th2 response (Couper, 2003, Balmer
et al, 2000, von der Weid et al., 1994).  An explanation for this finding was that
IL-13 can exert a functionally similar effect to IL-4 on macrophages and in the
absence of IL-4 takes over its activities. In addition, it is well established that
Th2 responses  can  be  induced  independently  of  IL-4  (Brewer et  al.,  1999).
Subsequent findings by our group also demonstrated a role for IL-4Rα signalling
in chronic P. chabaudi AS infection in male BALB/c mice (Couper, 2003). That is,
that  mice  deficient  in  IL-4/IL-13  (IL-4Rα
-/-)  were  more  susceptible  to  the
chronic-stage of P. chabaudi AS infection contrary to their WT counterparts. In
the present study, we aimed to further investigate whether the previous findings
were reproducible and whether observations were parasite-strain specific and/or
host gender dependent.51
The absence of a suitable P. chabaudi AS strain early in the course of the project
allowed us to study the outcome of P. chabaudi AJ strain infection in IL-4Rα
-/-
and wild-type BALB/c mice. Female BALB/c WT and IL-4Rα
-/- mice were infected
with P. chabaudi AJ and the infection was monitored over a 47-day period and
was  subsequently  terminated.  Overall,  results  of  the  present  study  were  in
agreement with previous findings and demonstrate a role for IL-4Rα signalling
during the chronic stage of P. chabaudi infection with AJ as well as AS strain
parasites.  Recrudescent  infections  were  significantly  greater  in  IL-4Rα
-/-  mice
than their wild-type counterparts.52
3.3 Results
3.3.1 Comparison of the survival rates and disease phenotypes of wild-type
(WT)  and  global  IL-4R-alpha-deficient  (IL-4Rα
-/-) female mice  following
Plasmodium chabaudi AJ infection.
The IL-4Rα
-/- mice displayed an enhanced mortality rate of 60% by day 13 post-
infection when compared to their WT counterpart, 40% mortality (Figure 3.1, A).
Parasite burdens at day 5 were significantly lower in the IL-4Rα
-/- mice compared
to the WT control while peak parasitaemia was comparable between the groups
(days 10-12). However, an elevated recrudescent episode was observed in the IL-
4Rα
-/- mice  who  were  unable  to  effectively  clear  and  control  the  infection
compared to the WT mice on days 32 and 36 (Figure 3.1, B) thus highlighting an
exacerbated infection in the absence of IL-4 and IL-13 function. Following day
36,  IL-4Rα
-/- mice  suppressed  the  infection  and  was  subsequently  able  to
mediate the chronic infection until termination of the experiment on day 47 in a
comparable  manner  to  the  WT  controls. In  addition,  these  findings  were  in
accordance  with  a  previous  study  conducted  in  our  research  group  (Couper,
2003). In the latter study, male BALB/c WT and IL-4Rα
-/- mice were infected with
P. chabaudi AS parasites. Peak parasitaemia was comparable in both the WT and
IL-4Rα
-/- mice. Furthermore, the IL-4Rα
-/- mice displayed elevated recrudescence
on days 14-17 compared to the WT mice. In the IL-4Rα
-/- mice, the infection was
then controlled following day 21 in a comparable manner to the WT controls
(Addendum One, Figure A).
WT  and  IL-4Rα
-/-  mice  displayed  similar  weight  loss  during  infection  with  no
significant differences between the groups at peak and post infection (Figure
3.2, A). Maximal weight loss occurred between days 10-12 post infection and
following parasite control a recovery in weight loss was observed in the WT and
IL-4Rα
-/- mice (Figure 3.2, A). Furthermore, Couper showed maximal weight loss
in both WT and IL-4Rα
-/- mice at day 9 and elevated weight loss in the IL-4Rα
-/-
mice  on  days  8-20  when  compared  to their  WT  counterparts (Couper, 2003)
(Addendum One, Figure B).53
Severe malarial induced anaemia was observed in both groups between days 10-
12 post infection (Figure 3.2, B) corresponding to peak parasitaemia (Figure 3.1,
B). Following parasite control, reduced RBC counts were only observed in the IL-
4Rα
-/- mice  compared  to  the  WT  control  at  day  32  of  the chronic  infection
(Figure 3.2, B). Results were similar to Couper who showed that peak anaemia
was observed around day 10 in the WT and IL-4Rα
-/- mice but the severity of
anaemia was greater in the IL-4Rα
-/- mice compared with the WT controls on day
14 post-infection (Couper, 2003) (Addendum One, Figure C).54
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Figure 3.1: (A) Comparison of the survival rates of P. chabaudi AJ infection in WT and IL-4Rα
-/-
female  mice  on  a  BALB/c  background. (B)  Comparison  of  the  disease parasitaemias of P.
chabaudi AJ infection in  WT and  IL-4Rα
-/- female  mice on a BALB/c background.  Results are
displayed as a log % of parasitaemia levels. Data are representative of two similar studies, n=3-4
and * denotes p<0.05.55
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Figure 3.2 Comparison of (A) weight loss and (B) malaria induced anaemia during the course of
P. chabaudi AJ infection in WT and IL-4Rα
-/- female mice on a BALB/c background. Data are
representative of two similar studies, n=3-4 and * denotes p<0.05.56
3.3.2 Comparison of the splenic cytokine production in wildtype (WT) and
global IL-4Rα-deficient (IL-4Rα
-/-) female mice following Plasmodium chabaudi
AJ infection.
IFN-γ production by IL-4Rα
-/- derived splenocytes were significantly greater than
WT derived splenocytes following ConA stimulation from day 12 infected mice
while IFN-γ production was comparable following stimulation with antigen (Ag)
(Figure  3.3,  A).  IL-12  production  by  IL-4Rα
-/-  derived  splenocytes  was
significantly increased following P. chabaudi AJ Ag stimulation (Figure 3.3, B)
compared to their WT counterparts (Figure 3.3, B). Furthermore, a significantly
elevated IL-10 response was observed following ConA and P. chabaudi AJ antigen
stimulation of  IL-4Rα
-/-  derived  splenocytes  compared  with  WT  derived
splenocytes  (Figure  3.3,  C).  IL-4  production  was not  significantly  different
between the groups in WT and IL-4Rα
-/- mice (Figure 3.3, D).
At day 47, IFN-γ production by IL-4Rα
-/- derived splenocytes were significantly
lower than the WT derived splenocytes following any of the stimulation methods
(Figure  3.4,  A).  IL-12  production  by  WT  and  IL-4Rα
-/-  derived  splenocytes
displayed  no  significant  comparable  differences upon  any  of  the  stimulation
methods (Figure 3.4, B). IL-10 production from the IL-4Rα
-/- derived stimulated
splenocytes were below the sensitivity of the ELISA compared to the increased
IL-10 production observed from WT derived splenocytes stimulated with ConA
(Figure 3.4, C). In addition, IL-4 production was significantly reduced in IL-4Rα
-/-
derived  splenocytes  following  ConA  stimulation  when  compared  to the WT
derived splenocytes (Figure 3.4, D).57
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Figure 3.3 Comparison of day 12 splenic (A) IFN-γ, (B) IL-12,(C) IL-10 and (D) IL-4 production in
P.  chabaudi  AJ  infected  WT  and  IL-4Rα
-/- female  mice  on  a  BALB/c  background.  Data  are
representative of two similar studies, n=3-4. ND indicates not detected within the standard curve
range of the ELISA. * denotes p<0.05.58
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Figure 3.4 Comparison of day 47 splenic (A) IFN-γ, (B) IL-12, (C) IL-10 and (D) IL-4 production in
P.  chabaudi  AJ  infected  WT  and  IL-4Rα
-/- female  mice  on  a  BALB/c  background.  Data  are
representative of two similar studies, n=3-4. ND indicates not detected within the standard curve
range of the ELISA. * denotes p<0.05.59
3.3.3 Comparison of the IgG2a and IgG1 antibody responses in wildtype (WT)
and  global  IL-4Rα-deficient  (IL-4Rα
-/-) female mice  following Plasmodium
chabaudi AJ infection.
Significantly increased IgG2a antibody responses were observed in both infected
groups between days 10-21 and again between days 30-45 when compared to the
non-infected control mice (Figure 3.5, A). Comparable IgG2a antibody responses
were observed between the infected WT and IL-4Rα
-/- mice during the course of
the infection except for day 21 when significantly elevated IgG2a Ab titres were
observed in the IL-4Rα
-/- mice compared to their WT counterparts (Figure 3.5,
A).
IgG1  antibody  responses  were comparable  in  both  the  infected  and  the  non-
infected  control  groups  during  the  course  of  the  infection  except  for  the
infected WT mice which displayed elevated IgG1 Ab titres between days 28-45
(Figure  3.5,  B).  Furthermore, significantly decreased  IgG1  Ab  titres  were
observed  in  the infected IL-4Rα
-/-  mice  on  days 25,  32  and  39  post-infection
when compared to their WT counterparts (Figure 3.5, B).60
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Figure 3.5 Comparison of the (A) IgG2a and (B) IgG1antibody responses of P. chabaudi AJ
infected WT and IL-4Rα
-/- female mice on a BALB/c background. Data are representative
of two similar studies, n=3-4. * denotes p<0.05.61
3.4 Discussion
The  data  presented  in  this  study  demonstrate  that  IL-4Rα
-/- female mice  are
more susceptible to P. chabaudi AJ during the chronic stage of infection than WT
mice.  These  observations  confirm  previous  results  from  our  group which
illustrated  a  role  for  IL-4 and  IL-13  in  the  protective  immune  response  to P.
chabaudi AS infected male mice (Couper, 2003). Although a different parasite
strain was used to the latter investigation due to strain availability at the time,
similar  observations  were  obtained.  Consequently,  our  findings  were  also
focussed on whether the two parasite strains reproduced similar disease profiles
in the gene deficient mice.
It  is  established  that  Th2  responses,  driven  by  IL-4,  are  thought  to  control
elimination  of  malarial  parasites  at  the  chronic  stage  of  infection.  However,
studies  have  shown  that  male  IL-4
-/-  (129SV  X  C57BL/6)F2  mice  were  able  to
control P.chabaudi AS primary erythrocytic infection in a comparable manner to
WT mice (Balmer et al., 2000, Von Der Weid et al., 1994) so IL-4 alone was not
responsible  for  protection.  It  is  known  that  IL-4  and  IL-13  have  similar
fundamental roles in protection as they both signal via their shared receptor
component, IL-4Rα.
In  this  study,  WT  and  IL-4Rα
-/-  mice  displayed  comparable  elevated  peak
parasitaemia but IL-4Rα
-/- mice were unable to clear and control the infection as
effectively  as  WT  mice  with  recrudescence  on  days 32  and  36.  This is
comparable with previous findings in our group in which the lack of IL-4 and IL-
13  does  affect  parasite  clearance  (Couper,  2003).  It  has  also  been  shown in
previous findings that IL-4Rα
-/- mice displayed greater recrudescence than IL-4
-/-
mice, which indicated that in the absence of IL-4, IL-13 played a part in parasite
control.  IL-13  thus may  replace  the  function  of  IL-4. Although  IL-13  may  be
protective  with  regard  to  controlling  parasite  growth,  greater  mortality  was
found in IL-4
-/- mice in comparison to IL-4Rα
-/- mice infected with P. chabaudi AS
during  primary  infection  which  suggested  that  IL-13  not  only  contributes  to
protection  but  also  to  the  pathology  of  malaria  disease.  IL-13  may  promote
pathology by synergistic activity with IL-2 to promote IFN-γ production by NK
cells or by directly affecting cellular function (Defrance et al., 1994, Punnonen62
et al., 1993) thereby over stimulating the pro-inflammatory response. Despite
the  potential  pathological  role  of  IL-13  in  contributing  to  mortality  in  the
absence of IL-4 during P. chabaudi AS infection, it was also required to limit
parasite burden since IL-4Rα
-/- mice displayed elevated recrudescence compared
with IL-4
-/- mice (Couper,2003).
In the present study at day 5 of the early stage infection, IL-4Rα
-/- mice showed
a significantly reduced  parastaemia  count  than  WT  mice.  It  may  be  of
significance  that  IL-4Rα
-/-  mice  have  an  enhanced  Th1  response  compared  to
wild-type mice as measured by increased IFN-γ production from ConA stimulated
splenocytes on day 12. Studies using IFN-γ or its receptor gene deficient mice
provide conclusive evidence for the pivotal role for this cytokine in the control
of acute parasitemia and survival of the host during primary infection (Sue and
Stevenson, 2000, van der Heyde et al., 1997, Favre et al., 1997, Meding et al.,
1990).  Studies  in  human  malaria  have  also  shown  that  IFN-γ  production  is
associated  with  protection  (Plebanski  and  Hill,  2000  Luty et  al.,  1999).
Furthermore,  nitric  oxide  (NO)  a  hallmark  of  macrophage  activation,  causes
direct parasite killing. In line with these findings, the present study showed that
IFN-γ production is more pronounced in mice deficient in IL-4 and IL-13 during
the very early stage of P. chabaudi AS infection. What we also found was that at
day 47, IFN-γ production from stimulated splenocytes was significantly reduced
in the IL-4Rα
-/- mice compared to the WT control. Our findings were similar to
that of Thawani and colleagues (Thawani et al., 2009). Their data from malaria-
infected STAT6-deficient mice had significantly lower IFN-γ levels than infected
WT mice. Consequently, they suggest that there may be a link between IFN-γ
levels  and  IL-4  dependent  STAT6  signalling  in  malarial  anaemia  during  acute
blood-stage infection (Thawani et al., 2009). Previous studies have also shown
that IL-4 can promote Th1 responses (Alexander and McFarlane, 2008, McDonald
et al., 2004,  Lean et al., 2003, Hochrein et al., 2000, Noble and Kemeny, 1995,
Bogdan et al., 1993). It is clear that the cellular sources of IFN-γ induced by
human and murine malarial infections have not been definitively identified but
NK cells, CD4
+ T-cells, NKT cells, γδ-T cells and dendritic cells have all been
proposed  as  potential  sources  (Couper et  al.,  2007,  D’Ombrain et  al.,  2007,
Soulard et al., 2007, Newman et al., 2006, Leisewitz et al., 2004, Perry et al.,
2004, Mohan et al., 1997, Pichyangkul et al., 1997). In addition, Charles and63
colleagues have shown that an early host response to P. chabaudi infection is
mediated  by  IFN-γ  by  an  expansion  of  NK  cells  (Charles et  al.,  2008).  The
relevance however of these responses to the generation of protective immunity
is  still  to  be  addressed  which  provides  another  reason  for  utilizing  the
availability of cell-specific gene deficient mice to address these questions.
Interestingly, at  day  12, antigen-specific  splenocyte  stimulation  resulted  in
elevated IL-10 and IL-4 production in IL-4Rα
-/- mice compared to WT mice. These
findings indicate the production of non-specific IL-4 production in the IL-4Rα
-/-
mice.  Studies  have  proved  the  existence  of  non-specific  IL-4  because  of the
presence of soluble IL-4Rα and soluble IL-13Rα2 chains by alternate splicing or
shredding and their ability to modulate IL-4 and IL-13 responses (Brombacher,
2000; Jung et al., 1999; Zhang et al., 1997).
The extent of the disease phenotype, characterized by reduced RBC counts, and
reduced weight loss was evident in the WT and IL-4Rα
-/- mice at peak infection
with no differences observed. This is in line with previous studies conducted in
our group (Couper, 2003). These phenotypic characteristics do not identify with
the recrudescence and mortality observed in the IL-4Rα
-/- mice during chronic P.
chabaudi AS infection.
At  peak  infection,  parasite  burdens  reach  similar levels  in  both  groups  but
recrudescence is only evident in the IL-4Rα
-/- mice. Indeed, IL-4 inhibits IFN-γ
production from T-cells and IL-12 production from macrophages thereby down-
regulating a Th1 response (Skeen et al., 1996, Powrie et al., 1993) and inducing
the Th2 switch (Phillips et al, 1994, 1997).  Wild-type mice displayed the typical
Th1/Th2 switch with elevated splenic IL-4, IL-10 and induction of IgG1 antibodies
and  promotion  of  Ab-mediated  immunity  against  chronic P.  chabaudi  AS
infection. It has been shown previously that IL-10 by itself and in co-operation
with  Th1  cytokines  such  as  IL-12  also  regulates  Th2  responses  (Wilson et  al.,
2007, Hoffmann et al., 2000, Joss et al., 2000, Grunig et al., 1997, Schandene et
al., 1994). Couper and colleagues reviewed the importance of IL-10 as a master
regulator of immunity to infections. They discuss IL-10 as a key immunoregulator
in various types of infections and ablation of IL-10 signalling results in the onset
of severe, often fatal, immunopathology in different types of infections namely64
Plasmodium spp, Toxoplasma gondii, Trypanosoma spp, Mycobacterium spp and
HSV and can be seen in the table summarized in Addendum two (Couper et al.,
2008).  The IL-4Rα
-/- mice on the other-hand displayed reduced splenic IL-4 and
IL-10 cytokine production and IgG1 antibody production at day 47 compared to
WT  mice.  Since  both  IL-4  and  IL-13  enhance  B-cell  function,  IL-4Rα
-/-  mice
showed an impaired B-cell antibody response with lower IgG1 antibody levels
during  the  chronic  stage  of  infection  compared  to  the  WT  control.  IL-10
production  was  only  impaired  in  the  IL-4Rα
-/-  mice  and  may  therefore  be
controlled by IL-4 and IL-13 stimulation.
Ab mediated immunity, involving both B cell and CD4
+ T cells is considered to
play a major role in the resolution of the chronic stage of infection. The acute
primary  parasitaemia  is  accompanied  by  IgG2a  antibody  production  which  is
preferentially  induced  by an  IL-12  driven  Th1  response  and  IFN-  production.
Studies with P. yoelii (White et al., 1991) and P. berghei (Waki et al., 1995)
models have also demonstrated that Ab-dependent protective immunity against
these species is mediated by the Th1-dependent IgG2a Ab. It is possible that IL-
12  and  associated  Th1  type  cytokines,  produced  early  during  blood-stage P.
chabaudi  AS  infection,  modulate  the  Ab  subclass  response  and  consequently
exert influence on Ab-mediated protective immunity for control of the chronic
infections. Su and Stevenson further support the role for IL-12 and the type-1
response during both acute and chronic phases of blood-stage malaria (Su and
Stevenson, 2002). They have demonstrated that IL-12 is required not only for
activation  of  innate  and  cell  mediated  immune  mechanisms  to  control  acute
primary  infection,  but  also  for  the  development  of  efficient  Ab-dependent
immunity  to  resolve  the  chronic  phase  of  primary  infection  and  to  control
challenge  infection  (Su  and  Stevenson,  2002).  The  present  study  shows  that
IgG2a is greater in IL-4Rα
-/- mice at day 21 post infection compared with WT
mice. In  contrast  to  the  WT  mice,  IL-4Rα
-/-  mice  displayed reduced  IgG1  Ab
production at day 47. These findings may indicate that in the absence of IL-4 and
IL-13  regulation,  Ab-dependent  protective  immunity  against P.  chabaudi  AS
could still be mediated by Th1-dependent IgG2a Ab.65
In  summary,  IL-4Rα
-/-  mice  have  increased  early  resistance  and  diminished
resistance during chronic infection compared with wild-type mice when infected
with P.  chabaudi  AJ  strain  parasites.  This  is  roughly  concomitant  with  an
enhanced Th1 response as measured by IFN-γ early and diminished Th2 response
as measured by IgG1/IgG2a levels late in infection.
In particular,  we  have  shown  that  the  IL-4Rα
-/-  mice  showed  greater
susceptibility to P. chabaudi AJ infection in comparison to their WT counterparts
as measured by elevated recrudescence suggesting that IL-4 and IL-13 cytokines
provide  a  protective  function  during  the  chronic  stage  of P.  chabaudi  AJ
infection  of  female  mice.  These  findings  are in  agreement  with  previous
observations made in our group using P. chabaudi AS strain. Consequently, our
results  provide  evidence  that  the  immunological  effects  of  infection  are  not
parasite strain-specific as infection with both strains of the parasite produced a
similar impaired Th2 immune response during chronic protection in the IL-4Rα
-/-
mice.  Thus,  the  effect  of  the  absence  of  IL-4/IL-13  is  the  same  with  the
different parasite strains. Secondly, our current findings in which female mice
were  utilized  produced  the  same  disease phenotype  as  was  previously  shown
using male mice indicating that the observation obtained was not dependent on
the  host  gender,  the  male  and  female  mice  demonstrated  a  similar  disease
profile.66
Chapter Four
A comparison of the course of Plasmodium chabaudi AS erythrocyte
infection in wild-type (WT) and global IL-4R-alpha-deficient
(IL-4Rα
-/-) male and female mice.67
4.1 Abstract
Findings in Chapter 3 using female BALB/c mice infected with P. chabaudi AJ
indicated that the IL-4Rα
-/- mice were more susceptible than WT controls during
chronic  infection  and  that  these  findings  were  similar  to  what  has  been
previously obtained using the P. chabaudi AS strain. In this Chapter, with the
availability of P. chabaudi AS strain, we firstly wanted to utilize the original P.
chabaudi AS model system in male mice to further investigate the role of IL-4Rα
signalling during murine malaria infection. However, we found that male mice,
compared  with  female  mice  were  extremely  susceptible  to  infection  with
greater mortality observed. As a consequence, experiments using male IL-4Rα
-/-
and  equivalent  number  of  WT  control mice were  terminated  at  day  14.
Nevertheless, lower survival rates were obtained in IL-4Rα
-/- mice compared with
their WT counterparts suggesting yet again the protective potential of IL-4/IL-
13. As a result of the extreme susceptibility of male mice, we opted for the use
of  female  mice  infected  with P.  chabaudi  AS  as  a  more  suitable  model  for
subsequent investigations. Female IL-4Rα
-/- mice in comparison to WT controls
demonstrated an early delay in the onset of acute parasitaemia but were more
susceptible  to P.  chabaudi  AS  infection  as  measured  by  the  severity  of  the
recrudescent infection. There was evidence of an enhanced Th1 response early in
the infected IL-4Rα
-/- mice as measured by increased ConA stimulated splenic
IFN-γ. This followed by a diminished Th2 response in IL-4Rα
-/- mice during the
chronic-stage infection as measured by reduced splenic IL-10 and IL-4 cytokine
responses following ConA stimulation and reduced serum IgG1 antibody titres at
day 48. In conclusion, these results are similar to that obtained using the AJ
strain of P. chabaudi.68
4.2 Introduction
The optimal immune response to malaria infection comprises the rapid induction
of  inflammatory  anti-parasitic  responses  that  is  followed  by  equally  rapid
resolution of inflammation that is mediated by anti-inflammatory cytokines to
prevent immunopathology (Artavaris-Tsakonas et al., 2003).
Protective  immunity  during  the  initial  ascending  and  peak  parasitaemias is
controlled through innate NK and macrophage responses and CD4
+Th1 T cells,
with IL-12, IFN-γ, TNF-α, ROI and NO candidates in parasite control (Langhorne
et al., 2004). IL-12 (Su and Stevenson, 2002) and IFN-γ-deficient (Balmer et al.,
2000)  or  depleted  mice display increased peak parasitaemia and  an impaired
capacity  to  clear  the  infection.  Th2  protection  is correlated  to  antibody
production.  Clearance of the acute primary parasitaemia occurs at the time
corresponding  to  the  switch  from  Th1  to  Th2  biased  immunity:  B  cells  are
essential for the switch to occur (Taylor-Robinson and Phillips, 1994). The exact
mechanism inducing the biphasic T cell switch is, however, not as clear but may
involve a gradual alteration in APC identity from DC’s and macrophages to B-
cells,  and  also  IL-4/IL-13  may  play  a  role.    An  IL-4  driven  Th2  response  and
associated  cytokines  such  as  IL-13  counter-regulate  Th1  responses  and
consequently Th2 responses control the chronic infection. The decline of IL-12
production as infection develops along with IL-10 production has been suggested
as contributing to the T-cell switch (Taylor-Robinson and Phillips, 1994).  IgG2a
associated with a Th1 response has been demonstrated to be important in the
control of infection as depletion of IgG2a and using IL-12
-/- mice, which display
reduced IgG2a responses, reduces the protective capacity of anti-sera (Cavinato
et al., 2001). A number of recrudescent episodes occur during P. chabaudi AS
chronic infection, which is the result of antigenic switching of variant antigen
types (VAT) and modulation of the immune response by the parasite (Phillips et
al., 1997).69
It  has  been  shown  in  previous  studies  that  hormonal  and  immunological
differences mediate sex differences in parasitic infections (Klein, 2004). Females
typically  have  greater  immune  responses  than  males  (Klein,  2000,  Zuk  and
McKean, 1996) and in rodent malaria studies, mortality rates have shown to be
greater  in  males  than  females  and  may  involve  immunological  differences
between the sexes (Klein, 2004). In P. chabaudi (Wunderlich et al., 1991) and P.
berghei  (Kamis  and  Ibrahim,  1989)  infection  studies,  administration  of
testosterone  was  shown  to  increase  mortality  rates.  Consequently,  the
immunomodulatory  effects  of  testosterone  may  underlie  the  increased
susceptibility  to Plasmodium infections  in  males  compared  to females  (Klein,
2004).
With the availability later in the project of P. chabaudi AS, the present study
focused on using the original model as described by Couper (Couper, 2003) in
male BALB/c mice to determine the immune response to infection in IL-4Rα
-/-
mice compared to WT controls. However, we found that male mice were highly
susceptible  to  infection  and  suffered  severe  pathology  and  high  levels  of
mortality. Consequently, they were not appropriate for further experimentation.
Female mice were less susceptible and were used in all subsequent experiments.
Moreover, the disease and immunological phenotypes produced in IL-4Rα
-/- and
wild-type BALB/c mice infected with P. chabaudi AS strain were similar to that
using the AJ strain (previous chapter).70
4.3 Results
4.3.1 Disease phenotype and immunological responses in wild-type (WT) and
global  IL-4R-alpha-deficient  (IL-4Rα
-/-) male mice  following Plasmodium
chabaudi AS infection.
Mortality in the WT and IL-4Rα
-/- mice (Figure 4.1, A) occurred between days 10-
14 and coincided with the peak infection (Figure 4.1, B), maximum weight loss
(Figure 4.2, A) and P. chabaudi AS induced anaemia (Figure 4.2, B) observed.
However, parasite burdens around peak infection and upon termination of the
experiment at day 14 were not significantly different between the IL-4Rα
-/- and
WT  mice  (Figure  4.1,  B).  Maximal  weight  loss  occurred  between  days  10-12
(Figure  4.2,  A). WT  and  IL-4Rα
-/-  mice  displayed no  significant  difference  in
weight loss at the peak infection (Figure 4.2, A). Severe P. chabaudi AS induced
anaemia was observed in both groups between days 10-12 of the acute infection
(Figure 4.2, B). However, no significant differences in RBC count was observed
between the IL-4Rα
-/- and WT mice at peak infection (Figure 4.2, B).
While 54% of WT mice survived infection all remaining IL-4Rα
-/- mice had to be
sacrificed at day 14 because of severe pathology (Figure 4.1, A).
Immunological responses demonstrated that an enhanced Th1 response occurred
at day 10 of the peak infection in IL-4Rα
-/- mice as measured by increased ConA
stimulated splenic IFN-γ production compared to their WT counterparts (Figure
4.3,  A).  Furthermore,  day  10  splenic  IL-10  (Figure  4.3,  B)  levels  were
comparable  and  IL-4  (Figure  4.3,  C)  levels  showed  no  significant  differences
between the IL-4Rα
-/- and WT control groups. Similarly, at day 10 IgG2a (Figure
4.4, A) and IgG1 (Figure 4.4, B) antibody titres were comparable between the
groups.71
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Figure 4.1: (A) Comparison of the survival rates of P. chabaudi AS infection in WT and IL-4Rα
-/-
male mice on a BALB/c background. (B) Comparison of the disease parasitaemias of P. chabaudi
AS infection in WT and IL-4Rα
-/- male mice on a BALB/c background. Results are displayed as a
log  %  of  parasitaemia  levels.  Data  are  representative  of two  independent  studies,  n=4-8. †,
experiment was terminated because of severe pathology displayed by male IL-4Rα
-/- mice.72
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Figure 4.2: Comparison of (A) weight loss and (B) malaria induced anaemia during the course of
P.  chabaudi AS  infection  in  WT  and  IL-4Rα
-/- male  mice  on  a  BALB/c  background.  Data  are
representative of two independent studies, n=3-4.73
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Figure 4.3: Comparison of day 10 splenic (A) IFN-γ, (B) IL-10 and (C) IL-4 production
in P. chabaudi AS infected WT and IL-4Rα
-/- male mice on a BALB/c background.
Data are representative of two independent studies, n=3-4. * denotes p<0.05.74
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Figure 4.4: Comparison of the (A) IgG2a and (B) IgG1 antibody responses of
P. chabaudi AS infected WT and IL-4Rα
-/- male mice on a BALB/c background.
Data are representative of two independent studies, n=3-4. * denotes p<0.05.75
4.3.2 Comparison of the survival rates and disease phenotypes of wild-type
(WT)  and  global  IL-4R-alpha-deficient  (IL-4Rα
-/-) female mice  following
Plasmodium chabaudi AS infection.
The IL-4Rα
-/- mice displayed an enhanced mortality rate of 17% at day 12 and a
further 33% at day 36 post-infection when compared to the WT mice where no
deaths  were  recorded (Figure 4.5,  A).  Parasite  burdens  at  day  3  were
significantly greater in the WT mice compared to the IL-4Rα
-/- mice while peak
parasitaemia  was  comparable  between  the  groups  (days  7-12).  However,  an
elevated recrudescent episode was observed in the IL-4Rα
-/-  mice that were
unable to effectively clear and control the infection compared to the WT mice
on days 17, 22 and 28 (Figure 4.5, B) thus highlighting an exacerbated infection
in  the  absence  of  IL-4  and  IL-13  signalling.  Following  day  28,  IL-4Rα
-/- mice
suppressed  the  infection  and  were  subsequently  able  to control  the  chronic
infection until termination of the experiment on day 48 in a comparable manner
to the WT counterparts.
WT  and  IL-4Rα
-/-  mice  displayed  similar  weight  loss  during  infection  with no
significant differences between the groups at peak and post infection (Figure
4.6, A). Maximal weight loss occurred on day 10 post infection and following
parasite control a recovery in weight was observed in the WT and IL-4Rα
-/-  mice
(Figure 4.6, A).
During the early stage of infection at day 5, RBC counts were significantly higher
in the IL-4Rα
-/- mice compared to the WT mice (Figure 4.6, B) corresponding to
the lower parasitaemia levels observed in the IL-4Rα
-/- mice around this time
(Figure 3.1, B). Severe anaemia was observed in both groups at day 9-10 post
infection  (Figure 4.6,  B)  corresponding  to  peak  parasitaemia  (Figure 4.6,  B).
Following parasite control, no consistent difference in malarial induced anaemia
was observed during chronic infection between the WT and IL-4Rα
-/- mice (Figure
4.6, B).76
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Figure 4.5: (A) Comparison of the survival rates of P. chabaudi AS infection in WT and IL-4Rα
-/-
female mice on a BALB/c background. (B) Comparison of the disease phenotype of P. chabaudi
AS infection in WT and IL-4Rα
-/- female mice on a BALB/c background. Results are displayed as a
% and as a log % of parasitaemia levels. Data are representative of two independent studies. WT
n=14 and IL-4Rα
-/- n=18. * denotes p<0.05.77
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Figure 4.6: Comparison of (A) weight loss and (B) malaria induced anaemia during the course of
P. chabaudi AS infection in WT and IL-4Rα
-/- female mice on a BALB/c background. Data are
representative of two independent studies, n=14. * denotes p<0.05.78
4.3.3 The influence of chronic disease on splenomegaly in wild-type (WT) and
global  IL-4Rα-deficient  (IL-4Rα
-/-) female mice  infected  with Plasmodium
chabaudi AS.
Whole spleen weights of non-infected and infected WT and IL-4Rα
-/- mice were
measured  to  determine  the  severity  of  splenomegaly  during  the  course  of P.
chabaudi AS infection between the respective groups. It is clear that P. chabaudi
AS parasites directly cause splenomegaly in the infected groups compared to no
spleen enlargement observed in non-infected mice throughout the duration of
the  disease  (Figure 4.7).  Furthermore,  a  slight  decrease  but  not  significant
difference in spleen weight was observed in the IL-4Rα
-/- mice when compared
to the WT mice on day 10 (Figure 4.7, A) and day 17 (Figure 4.7, B). Similarly, no
significant difference in the severity of splenomegaly was observed between the
WT and IL-4Rα
-/- mice at day 48 post-infection (Figure 4.7, C).79
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Figure 4.7: Comparison of the whole spleen tissue weights of non-infected and P. chabaudi AS
infected WT and IL-4Rα
-/- female mice on a BALB/c background on (A) day 10 (B) day 17 and (C)
day 48. Data are representative of two independent studies, n=5-6. * denotes p<0.05.80
4.3.4 Comparison of the splenic cytokine production in wild-type (WT) and
global IL-4Rα-deficient (IL-4Rα
-/-) female mice following Plasmodium chabaudi
AS infection.
IFN-γ production by WT derived splenocytes was significantly lower than IL-4Rα
-/-
derived splenocytes following ConA stimulation from day 10 infected mice while
IFN-γ production was comparable following stimulation with antigen (Figure 4.8,
A). IL-12 production by WT and IL-4Rα
-/- derived splenocytes was comparable
following  all in  vitro  stimulation  methods  (Figure 4.8,  B).  In  contrast,  a
significantly  elevated  IL-10  response  was  observed  following P.  chabaudi  AS
antigen (200µg) stimulation by IL-4Rα
-/- derived splenocytes compared with WT
derived splenocytes (Figure 4.8, C). Peak IL-4 production was induced by ConA
stimulation in both groups (Figure 4.8, D).
At  day  17,  IFN-γ  production  was  significantly  reduced  by  IL-4Rα
-/-  derived
splenocytes  following  ConA  stimulation  compared  to  WT  derived  splenocytes
(Figure 4.9,  A).  IFN-γ  production  was  not  witnessed  for  any  of  the  other
stimulation methods. Furthermore, IL-12 production was below the sensitivity of
the  ELISA  in  the  IL-4Rα
-/-  derived  splenocytes  compared  to  the  WT  derived
splenocytes (Figure 4.9, B). A significantly reduced IL-10 response by IL-4Rα
-/-
derived  splenocytes  compared  with  WT  derived  splenocytes  was  observed
following ConA stimulation. No IL-10 production was witnessed following any of
the other stimulation methods (Figure 4.9, C). No significant differences in IL-4
production were obtained in WT and IL-4Rα
-/- derived splenocytes following ConA
stimulation.  No  IL-4  production  was  witnessed  following  any  of  the  other
stimulation methods in the IL-4Rα
-/- derived splenocytes (Figure 4.9, D).81
At day 48, no significant differences in IFN-γ production was observed between
the WT and IL-4Rα
-/- derived splenocytes following stimulation with any of the
stimulation  methods  (Figure 4.10,  A).  IL-12  production  by  WT  and  IL-4Rα
-/-
derived splenocytes was comparable following in vitro stimulation (Figure 4.10,
B). IL-10 production was significantly reduced in IL-4Rα
-/- derived splenocytes
following ConA stimulation when compared to WT derived splenocytes while IL-
10 production was comparable following the other stimulation methods (Figure
4.10,  C).  IL-4  production  was significantly  reduced  in  IL-4Rα
-/- derived
splenocytes following ConA stimulation but showed significantly increased IL-4
production following P. chabaudi AS antigen stimulation when compared to WT
derived splenocytes (Figure 4.10, D).82
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Figure 4.8: Comparison of day 10 splenic (A) IFN-γ, (B) IL-12,(C) IL-10 and (D) IL-4 production in
P.  chabaudi  AS  infected  WT  and  IL-4Rα
-/- female  mice  on  a  BALB/c  background.  Data  are
representative of two independent studies, n=3-5. ND indicates not detected within the standard
curve range of the ELISA. * denotes p<0.05.83
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Figure 4.9: Comparison of day 17 splenic (A) IFN-γ, (B) IL-12, (C) IL-10 and (D) IL-4 production in
P.  chabaudi  AS  infected  WT  and  IL-4Rα
-/- female  mice  on  a  BALB/c  background.  Data  are
representative of two independent studies, n=3-5. ND indicates not detected within the standard
curve range of the ELISA. * denotes p<0.05.84
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Figure 4.10: Comparison of day 48 splenic (A) IFN-γ, (B) IL-12, (C) IL-10 and (D) IL-4 production
in P.  chabaudi  AS infected WT and IL-4Rα
-/- female mice on a BALB/c background. Data are
representative of two independent studies, n=3-6. ND indicates not detected within the standard
curve range of the ELISA. * denotes p<0.05.85
4.3.5 Comparison of the IgG2a and IgG1 antibody responses in wild-type (WT)
and global IL-4Rα-deficient (IL-4Rα
-/-) mice following Plasmodium chabaudi AS
infection.
Significantly increased IgG2a antibody responses were observed from day 10 WT
infected mice compared to the IL-4Rα
-/- mice (Figure 4.11, A). At day 17 post
infection,  comparable  IgG2a  antibody  responses  were  observed between  both
groups (Figure 4.11, B). However, IgG2a antibody responses at day 48 were then
significantly increased in the IL-4Rα
-/- mice compared to their WT counterparts
(Figure 4.11, C).
IgG1 antibody responses were significantly increased in the WT infected mice
compared  to  the  IL-4Rα
-/-  mice  on  days  10  and  17  (Figure 4.12,  A,  B).  IgG1
antibody responses at day 48 were significantly reduced in the IL-4Rα
-/- mice
compared to their WT counterparts (Figure 4.12, C).86
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Figure 4.11: Comparison of the IgG2a antibody responses of P. chabaudi AS infected WT
and IL-4Rα
-/- female mice on a BALB/c background on (A) day 10 (B) day 17 and (C) day
48. Data are representative of two independent studies, n=4-6. * denotes p<0.05.87
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Figure 4.12: Comparison of the IgG1 antibody responses of P. chabaudi AS infected WT
and IL-4Rα
-/- female mice on a BALB/c background on (A) day 10 (B) day 17 and (C) day
48. Data are representative of two independent studies, n=4-6. * denotes p<0.05.88
4.4 Discussion
In this study, male IL-4Rα
-/- mice presented higher fatalities to P. chabaudi AS
infection  than the  WT  control  and  could  not  survive  the  duration  of  the
experiment. However, no significant phenotypic differences were observed in
parasitaemia levels, RBC counts and weight loss in the IL-4Rα
-/- mice compared
to the WT controls. There was evidence of an enhanced Th1 immune response at
day 10 in the IL-4Rα
-/- mice as measured by increased ConA stimulated splenic
IFN-γ production but IgG1 and IgG2a Ab titres remain comparable. It was evident
that the magnitude of the immunological response in the infected male mice
was greater than what had previously been found in female mice (chapter 3 and
4).  An  explanation  for  this  finding  was  attributed  to  the  fact  that  the
immunomodulatory  effects  of  testosterone,  a  male  hormone,  may  underlie
increased susceptibility to Plasmodium infection in males compared to females.
It has been shown before in a P. chabaudi model that exposure of adult female
mice to testosterone reduces Ab production, decreases MHC II cells in the spleen
and increases CD8
+ T-cells in the spleen (Benten et al., 1997) thereby increasing
susceptibility  to  infection.  Another  study  showed  that  it  was  possible  for
testosterone to modulate Th1/Th2 function in the protection against P. chabaudi
chabaudi AS infection (Zhang et al., 2000). IFN-γ
-/- and IL-4
-/- mice reveal that
the effects of IFN-γ and IL-4 on survival were more pronounced in males than
females.  Male  IFN-γ
-/-  and  IL-4
-/-  mice  have  shorter  survival  times  than  their
male  WT  counterparts.  In  contrast,  no  differences  were  obtained  between
female IFN-γ
-/- and IL-4
-/- mice and WT counterparts (Zhang et al., 2000).
As a result of the extreme susceptibility of male BALB/c mice and particularly
male IL-4Rα
-/- mice to infection with P. chabaudi AS, female mice were used in
all subsequent studies. Female IL-4Rα
-/- mice infected with P. chabaudi AS did
not display elevated peak parasitaemia compared to the WT control so the lack
of  IL-4/IL-13  function  does  not  affect  iRBC  clearance.  However,  the  IL-4Rα
-/-
mice displayed reduced parasitaemia levels at day 5 compared to the WT control
indicating that Th1 mechanisms and parasite control were possibly enhanced in
the absence of IL-4/IL-13. A significantly enhanced recrudescent episode was
displayed in the IL-4Rα
-/- mice compared with the WT control indicating that the
absence of IL-4/IL-13 function resulted in an impaired Th2 protective immune89
response  during  the  chronic  stage  of  the  disease.  Furthermore,  there  was
evidence of early Th1 associated cytokine control in the IL-4Rα
-/- mice compared
to  the  WT  control  as  measured  by  increased  IFN-γ  production  from  ConA
stimulated  spleens.  Following  the  declining  parasitaemia,  an  impaired  Th2
immune response was characterized by reduced IL-10 and IL-4 production from
ConA  stimulated  spleens  and  reduced  IgG1  Ab  titres  from  IL-4Rα
-/-  mice  in
comparison  to  the  WT  control  indicating  that  adequate  protection  was
compromised in the IL-4Rα
-/- mice.
The results of the female P. chabaudi AS infection model are in agreement with
previous findings obtained using P. chabaudi AS strain from our group (Couper,
2003)  and  with  that  obtained  in  chapter  3  using P.  chabaudi  AJ  strain.  It  is
evident that a significant role for IL-4Rα exists in the protective response against
P. chabaudi AS infection that requires further investigation. IL-4 and IL-13 are
Th2 cytokines whose biological functions are induced through a common IL-4Rα
chain. The IL-4 receptor consists of two chains, the IL-4Rα chain and the IL-2Rγ
chain (Hart et al., 1999).  The IL-13 receptor is a complex of the IL-4Rα chain
and the IL-13Rα1 chain.  Effective IL-13 signalling occurs only through the IL-4Rα
chain and IL-13Rα1 chain.  Thus, IL-4Rα is a common component of the receptor
complexes for IL-4 and IL-13. Accordingly, IL-4 and IL-13 have many functional
properties in common including the modulation of Th2 cell development, type 2
Ig class switching in B cells and inflammatory responses due to the regulation of
macrophage functions (Brombacher, 2000). Of note is that murine lymphocytes
do not have IL-13 receptors.
In conclusion, we have shown that a role for IL-4 and IL-13 exists for protection
against P.  chabaudi AS  infection  in  male and  female  BALB/c mice.  However,
male mice succumbed to infection at a greater extent than the female mice due
to  possible  immunomodulatory  effects  of  sex  hormones.  Although  no  major
differences were found between WT and IL-4Rα
-/- mice at peak parasitaemia,
there was a significant early delay in the onset of peak parasitaemia in the
IL-4Rα
-/- compared to the WT control mice. However, in comparison to the WT
control, recrudescence was only evident in the IL-4Rα
-/- mice, which indicated
impairment in the Th2 immune response, which was demonstrated by reduced90
serum  IgG1 antibody responses  and  discussed  in  more  depth  in  the  previous
chapter.
IL-4 and IL-13 are pleotrophic cytokines and numerous cell types are responsive
to signalling via IL-4Rα. Recently, Brombacher and colleagues have generated a
number of tissue specific deficient mice (Bryson et al., 2011, Mc Farlane et al.,
2011, Brombacher et al., 2009, Dewals et al., 2009, Keating et al., 2009, Michels
et al., 2009, Horsnell et al., 2007, Radwanska et al., 2007, Leeto et al., 2006,
Herbert et al., 2004). This is achieved by the use of tissue specific promoters
and a Cre/loxP-specific site-specific recombination technique (see Methodology,
Chapter 2). Using such mice will ultimately allow dissection of the cell types
responding to IL-4/IL-13 that mediate protection/susceptibility to P. chabaudi
infection.
In chapter five, I shall examine whether the protective modulatory capacity of
IL-4/IL-13  functions  via  IL-4Rα  signalling on  macrophages/neutrophils  by
utilization  of  macrophage/neutrophil-specific  IL-4Rα  gene  deficient  mice
(LysM
creIL-4Rα
-/lox).91
Chapter Five
The role of IL-4/IL-13 responsiveness by macrophages and neutrophils
during Plasmodium  chabaudi  AS  erythrocyte  infection  in  female
mice.92
5.1 Abstract
Differently activated macrophages display distinct biological features. Previous
investigations have shown that IL-4, IL-13, IL-10, TGF-β, immune complexes and
apoptotic cells elicited during protozoan infections induce alternative activation
states of macrophages thereby affecting the disease outcome. Disease outcome
is affected on the one hand, by promoting parasite survival and proliferation and
on the other hand, by limiting collateral tissue damage because of excessive Th1-
type  inflammation.  Thus,  modulation  of  macrophage  activation  may  be
instrumental in allowing parasite persistence and long-term host survival. In the
present  study, macrophage/neutrophil-specific  IL-4Rα
-/-  (LysM
creIL-4Rα
-/flox)
female  mice  were  generated  to  understand  the  role  of  IL-4/IL-13  mediated
functions  on  macrophages/neutrophils  to  determine  whether  the  alternate
activation of these cells provides long-term protective immunity in a P. chabaudi
AS  infection  model.  Our  data  showed  that LysM
creIL-4Rα
-/flox  mice  developed
protective immunity against Plasmodium chabaudi AS infection. Wild-type (WT)
and LysM
creIL-4Rα
-/flox mice demonstrated similar disease profiles. The
LysM
creIL-4Rα
-/flox mice showed no mortality, no recrudescent parasitaemias and
recovered  from  infection  more  effectively  compared  with  the IL-4Rα
-/-  mice.
Furthermore,  induced  Th1  (IFN-γ)  and  Th2  (IL-10  and  IL-4)  spleen  cytokine
production, upon antigenic stimulation, and the induction of serum IgG2a and
IgG1  antibody  responses  were  similar  to  wild-type  mice  and  presumably
contributed to control of parasitaemia and long lasting protective immunity in
the LysM
creIL-4Rα
-/flox mice.  In  contrast,  IL-4Rα
-/- mice  were  extremely
susceptible to P. chabaudi AS infection with greater mortality and recrudescent
parasitaemia observed. Additionally, Th2 cytokines and antibody responses in the
IL-4Rα
-/-  mice  were  impaired  during  the  chronic  stage  of  infection.  Taken
together,  our  results  indicate  that the  alternate  activation  of
macrophages/neutrophils  by  IL-4  and  IL-13  are  not  essential  for  long-term
protective immunity towards P. chabaudi AS infected mice.93
5.2 Introduction
The Th2 cytokines IL-4 and IL13 are closely related cytokines that share common
biological properties with overlapping, yet distinct, functions.  Consequently,
IL-4 and IL-13 are important regulators of disease. The functional similarities are
explained by both cytokines sharing the same IL-4Rα chain (Brombacher, 2000,
Zurawski and de Vries, 1994). Signalling for both cytokines is dependent upon
the IL-4Rα chain in association with either the common γ chain as well as via the
type 2 receptor, a heterodimer between the IL-4R chain and the IL-13Rα1 chain.
The  type  2  receptor  is  the  only  functional  IL-13R.    IL-4Rα  responsiveness
therefore provides an effective strategy for protection against parasites such as
Nippostrongylus  brasiliensis, Schistosoma  mansoni, Trichuris muris,  and
Trichinella spiralis. However, in allergic disease, IL-4 and IL-13 activation can
have  fatal  consequences  for  the  host  (Brombacher,  2000).  In Plasmodium
studies, the effect of IL-4Rα signalling on macrophages/neutrophils for long-term
protection is not well understood. Taken together, IL-4Rα signalling can confer
protection or promote inflammation and tissue injury depending on the antigenic
stimulus and the type of cell expressing the receptor.
Depending on the type of antigenic stimuli or cytokine environment, activation
of macrophages can develop into two distinct pathways (Mantovani et al., 2002,
Goerdt  and  Orfanos, 1999;  Munder et  al.,  1988).  Classically  activated
macrophages (caMø) (activated by Th1-type signals such as IFN- γ) serve a vital
role  in  response  to  bacterial  stimuli  such  as  LPS  (Brombacher et  al.,  2009,
Gordon,  2003).  caMø  produce  Reactive  Nitrogen  Intermediates  (RNI)  and
proinflammatory cytokines such as TNF and IL-12. Thus, caMø are indispendable
effector cells of protective immunity against intracellular pathogens including
Mycobacterium  tuberculosis  (M.Tb)  and Leishmania  major  (Brombacher et
al.,2009, Gordan, 2003, Holscher et al., 2001, Louis et al., 1998). Although caMø
provide  a  beneficial  role  in  host  defense,  proinflammatory  responses can  be
detrimental to the host tissue if persistant escalation of inflammation occurs and
can result in immunopathology. Thus, an alternate pathway of Mø activation has
been  proposed  as  a  mechanism  for  attenuation  of  excessive  inflammation
(Brombacher et al., 2009, Gordan, 2003, Goerdt and Orfanos, 1999). Alternate
activation of macrophages (aaMø) are induced by the Th2 cytokines, namely,94
IL-4 and IL-13 via the shared IL-4Rα chain (Brombacher et al., 2009, Gordon,
2003). aaMø attenuates excessive inflammation and secretes anti-inflammatory
mediators  to  resolve  inflammation  (Brombacher et  al.,  2009, Gordon,  2003;
Goerdt and Orfanos, 1999). IL-10 is often co-induced with the Th2 cytokines in
the course of an immune response. It is not appropriate to classify IL-10 together
with IL-4 and IL-13 as an alternative activator of macrophages. IL-10 acts on a
distinct  plasma-membrane  receptor  (IL-10R consisting  of  the  ligand-binding
subunit, IL-10R1 and the accessory subunit, IL-10R2) (Moore et al., 2001) to those
for  IL-4  and  IL-13.  Its  effects  on  macrophage  gene  expression  are  different,
involving  a  more  profound  inhibition  of  a  range  of  antigen-presenting  and
effector functions, together with the activation of selected genes or functions.
IL-10 clearly has actions on macrophages that are distinct from those of IL-4 and
IL-13 (Gordon, 2003).
It is known that immunity to P. chabaudi is complex and involves both innate
and adaptive cellular and humoral responses (Namazi and Phillips, 2010, Couper
et al., 2005; Phillips et al., 1997; Mohan et al., 1997; Taylor-Robinson, 1995).
CD4
+ Th1 and Th2 cells play important protective, but functionally different roles
during malaria infection (Namazi and Phillips, 2010, Smith and Taylor-Robinson,
2003, Taylor-Robinson, 1995, Langhorne, 1989). Reports have shown that initial
control against P. chabaudi infection is by innate cellular (such as macrophages
and NK cells) and Th1 responses whereby protection is associated with IFN-γ,
TNF-α and NO production (Couper et al., 2005; Taylor-Robinson et al., 1993;
Taylor-Robinson and Phillips, 1992; Langhorne et al., 1989). Th2 response rises
when the infection becomes chronic and protection is largely dependent on B-
cell and antibody production (Couper et al., 2005; Smith and Taylor-Robinson et
al., 2003; Langhorne et al., 1989) and could play a role in the elimination of the
infection (Namazi and Phillips, 2010, McDonald and Phillips, 1980). While IL-4 is
an important cytokine driving the Th2 response, little is known about the cellular
mechanisms orchestrating the Th1-Th2 switch and the involvement of alternative
macrophage activation during Plasmodium infection. Therefore, the emphasis of
the  present  study  was  to  elucidate  whether  alternative  activation  of
macrophages/neutrophils via IL-4Rα signalling was necessary for long-term host
protection during P. chabaudi AS infection.95
Functional studies on the role of aaMø in experimental mouse models of human
diseases have been aided by the use of macrophage/neutrophil-specific IL-4Rα
-/-
mice established by Brombacher and colleagues (McFarlane et al., 2011, Michels
et  al.,  2009,  Keating et  al.,  2009,  Brombacher et  al.,  2009,  Herbert et  al.,
2004).  To  determine the role  of  IL-4Rα  signalling  in  macrophages/neutrophils
during P. chabaudi AS infection, mice were engineered with a loxP-flanked IL-
4Rα  allele  and  Cre-recombinase  expression  under  control  of  the  regulatory
region for the lysozyme M gene (LysM
Cre mice) (Clausen et al., 1999) and thereby
restricting  Cre-mediated loxP  recombination  to  only  macrophages  and
neutrophils (McFarlane et al., 2011, Michels et al., 2009, Keating et al., 2009,
Brombacher et al., 2009, Herbert et al., 2004). We report here that the role for
IL-4/IL-13  activated  macrophages/neutrophils  during  Th2  responses  of P.
chabaudi AS infected LysM
creIL-4Rα
-/lox mice was not critical for host survival or
disease susceptibility.96
5.3 Results
5.3.1 Comparison of the survival rates and disease phenotypes of wild-type
(WT),  global  IL-4Rα  gene  deficient  (IL-4Rα
-/-) and macrophage/neutrophil-
specific IL-4Rα-deficient  (LysM
creIL-4Rα
-/lox)  female  mice  following
Plasmodium chabaudi AS infection.
WT  and  LysM
creIL-4Rα
-/lox  mice  survived  the  acute  stage  infection  with  no
mortalities observed whereas the IL-4Rα
-/- mice displayed an enhanced mortality
rate  of  17% on day  12  (Figure  5.1).  During  the  chronic-stage  infection,  25%
mortality was observed in the WT strain on day 22 while the majority of deaths,
at 33% mortality, was observed in the IL-4Rα
-/- mice at day 36 (Figure 5.1). In
contrast, no deaths were seen in the LysM
creIL-4Rα
-/lox mice during the course of
infection (Figure 5.1).
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Figure 5.1: Comparison of the survival rates of P. chabaudi AS infection in WT (IL-4Rα
lox/-),
IL-4Rα
-/- and LysM
creIL-4Rα
-/lox female mice on a BALB/c background. n=6. Data are
representative of two independent studies.97
Parasite burden around peak infection (day 7) showed no significant differences
between  the  groups  (Figure 5.2).  Furthermore,  no  significant  differences
occurred between the WT and LysM
creIL-4Rα
-/lox mice (Figure 5.2). The IL-4Rα
-/-
mice demonstrated significantly greater recrudescent parasitaemia on days 19,
22,  28  and  33 post  infection  compared  to  the  WT and LysM
creIL-4Rα
-/lox  mice
(Figure 5.2).
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Figure 5.2: Comparison of the disease parasitaemias of P. chabaudi AS infection in WT
(IL-4Rα
lox/-),  LysM
creIL-4Rα
-/lox  and  IL-4Rα
-/-  female  mice  on  a  BALB/c  background.  Results  are
displayed as a (A) % and  as a (B) log % of parasitaemia levels in these groups. n=6;  * and
#
denotes  p<0.05  (* WT  versus  IL-4Rα
-/-  and * LysM
creIL-4Rα
-/lox versus  IL-4Rα
-/-). Data  are
representative of two independent studies.98
Contrary to infected mice, non-infected mice showed a steady weight gain over
the 48 day period (Figure 5.3, A). Maximal weight loss was reached at day 10 of
the peak infection but no significant differences occurred between the
LysM
creIL-4Rα
-/lox mice and their WT counterparts (Figure 5.3, A). On the other
hand, the IL-4Rα
-/- mice showed a significant drop in weight on day 10 when
compared to the LysM
creIL-4Rα
-/lox mice (Figure 5.3, A). Following recovery, all
mice showed an increase in weight while a significant increase in weight was
only observed in the WT and LysM
creIL-4Rα
-/lox mice when compared to the
IL-4Rα
-/-  mice  on  days  12  and  14.  Furthermore,  weight  gain  was  significantly
lower in the IL-4Rα
-/- mice on day 17 when compared to the LysM
creIL-4Rα
-/lox
mice (Figure 5.3, A). LysM
creIL-4Rα
-/lox mice survived Plasmodium chabaudi AS
infection. In contrast, WT and IL-4Rα
-/- mice were more susceptible to infection
as measured by mortality.
In contrast to non-infected mice, severe anaemia peaked in all groups at day 10
post  infection  with  a  significant  drop  in  RBC  counts  (Figure  5.3,  B)  which
corresponded to peak parasitaemia observed (Figure 5.2). At peak infection, no
differences in RBC counts were observed between the groups. Following parasite
control during the chronic stage of infection, a significant increase in RBC count
was observed in the WT mice compared to the IL-4Rα
-/- mice on day 14 while no
significant  differences  occurred  between  the  WT  and  LysM
creIL-4Rα
-/lox mice
(Figure 5.3, B). RBC counts were significantly increased in the WT and
LysM
creIL-4Rα
-/lox mice on days 19 when compared to the IL-4Rα
-/- mice (Figure
5.3, B) and coincided with the reduced parasitaemia observed in these groups at
the same time (Figure 5.2). In contrast, RBC counts in the WT and
LysM
creIL-4Rα
-/lox mice were significantly lower at day 33 compared to IL-4Rα
-/-
mice but levelled off in all the groups as time progressed (Figure 5.2).99
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Figure 5.3: Comparison of (A) weight loss and (B) malaria induced anaemia during the course of
P.  chabaudi AS  infection  in  WT  (IL-4Rα
lox/-),  IL-4Rα
-/- and  LysM
creIL-4Rα
-/flox  female  mice  on  a
BALB/c background. n=6; * denotes p<0.05 (*WT versus IL-4Rα
-/-, *LysM
creIL-4Rα
-/loxversus
IL-4Rα
-/-). Data are representative of two independent studies.100
5.3.2 The influence of chronic disease on splenomegaly in macrophage/
neutrophil  IL-4Rα-deficient  (LysM
creIL-4Rα
-/lox)  female  mice  infected  with
Plasmodium chabaudi AS.
Whole spleen weights of non-infected and infected WT, IL-4Rα
-/- and
LysM
creIL-4Rα
-/lox mice were measured to determine the severity of splenomegaly
during the course of P. chabaudi AS infection between the respective groups. P.
chabaudi  AS  parasite  directly  causes  splenomegaly  in  the  infected  groups
compared  to  no  enlargement  of  spleens  observed  in  non-infected  mice
throughout the duration of the disease (Figure 5.4). Furthermore, no significant
decrease in spleen weight was observed in the infected IL-4Rα
-/- and
LysM
creIL-4Rα
-/lox mice when compared to the infected WT mice on day 10 (Figure
5.4, A). Although no significant difference was seen between the infected WT
and infected IL-4Rα
-/- mice at day 17, a significant decrease in splenomegaly was
observed in the infected LysM
creIL-4Rα
-/lox mice when compared to the infected
WT control mice (Figure 5.4, B). Furthermore, no significant difference in the
severity of splenomegaly was observed between the infected WT, IL-4Rα
-/- and
LysM
creIL-4Rα
-/lox groups at day 48 post-infection (Figure 5.4, C).101
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Figure 5.4: Comparison of the whole spleen tissue weights of non-infected and P. chabaudi AS
infected WT (IL-4Rα
lox/-), IL-4Rα
-/- and LysM
creIL-4Rα
-/flox female mice on a BALB/c background.
(A) Day 10 (B) Day 17 and (C) Day 48. n=5-6. * indicates non-infected versus the knock-out mice
and
# indicates infected WT versus the infected LysM
creIL-4Rα
-/lox mice, and denotes p<0.05. Data
are representative of two independent studies.102
5.3.3  Comparison  of  the  splenic  cytokine  production  in  wild-type  (WT),
Macrophage/Neutrophil-specific IL-4Rα-deficient (LysM
creIL-4Rα
-/lox) and global
IL-4Rα-deficient  (IL-4Rα
-/-)  female  mice  following Plasmodium  chabaudi  AS
infection.
IFN-γ  production  by  WT  and LysM
creIL-4Rα
-/lox  derived  splenocytes  were
significantly lower than IL-4Rα
-/- derived splenocytes following ConA stimulation
from day 10 infected mice (Figure 5.5, A). IL-12 and IL-10 production by WT and
LysM
creIL-4Rα
-/lox derived splenocytes could not be detected whilst no significant
differences in IL-4 production by ConA stimulated splenocytes occurred between
these groups (Figure 5.5, B). IL-4 production by ConA stimulated splenocytes was
significantly  increased  in  IL-4Rα
-/-  mice  compared  to  the  WT  control  and
LysM
creIL-4Rα
-/lox mice (Figure 5.5, B).
IFN-γ  production,  at  day  17,  was  significantly  greater in  the  WT  control  and
LysM
creIL-4Rα
-/lox ConA stimulated splenocytes but IFN-γ production from antigen-
specific stimulated splenocytes was only significantly increased in
LysM
creIL-4Rα
-/lox mice compared to WT and IL-4Rα
-/- mice (Figure 5.6, A). IL-12
production  was  below  the  sensitivity  of  the  ELISA  in  the  IL-4Rα
-/-  derived
splenocytes and IL-12 production was comparable with no differences observed
in WT and LysM
creIL-4Rα
-/lox mice (Figure 5.6, B). A significant increase in IL-10
production occurred in WT and LysM
creIL-4Rα
-/lox derived splenocytes upon ConA
stimulation compared to IL-4Rα
-/- derived stimulated splenocytes (Figure 5.7, A).
Furthermore, IL-10 production from antigen-specific stimulated splenocytes from
the LysM
creIL-4Rα
-/lox mice was significantly higher than the IL-4Rα
-/- mice (Figure
5.7,  A).    Significantly,  greater  IL-4  production  was  obtained  following  ConA
stimulation of IL-4Rα
-/- derived splenocytes compared to the WT counterpart and
LysM
creIL-4Rα
-/lox derived splenocytes (Figure 5.7, B). However, IL-4 production
from antigen-specific stimulation of LysM
creIL-4Rα
-/lox derived splenocytes were
significantly increased compared to the IL-4Rα
-/- and WT mice (Figure 5.7, B).103
At day 48, IL-4Rα
-/- mice displayed a significantly reduced IFN-γ production from
ConA  stimulated  splenocytes  compared  to  the  WT  and LysM
creIL-4Rα
-/lox mice
whilst  IFN-γ  production  from  antigen-specific  stimulated  IL-4Rα
-/-  derived
splenocytes was significantly increased compared to the WT and
LysM
creIL-4Rα
-/lox mice (Figure 5.8, A). IL-12 production was comparable with no
differences observed in WT, IL-4Rα
-/- and LysM
creIL-4Rα
-/lox mice (Figure 5.8, B).
WT  and LysM
creIL-4Rα
-/lox mice  displayed  comparable  IL-10  production  with
significantly  increased  ConA  and  antigen-specific  stimulation  of  splenocytes
(Figure 5.9, A). IL-4 production was significantly reduced in the ConA stimulated
splenocytes of IL-4Rα
-/- and LysM
creIL-4Rα
-/flox mice compared to WT mice (Figure
5.9, B). In addition, IL-4 production by ConA stimulated splenocytes in
LysM
creIL-4Rα
-/lox mice was also significantly reduced when compared to the
IL-4Rα
-/-  mice  (Figure  5.9,  B). However,  IL-4  production  by  antigen-specific
stimulated IL-4Rα
-/- derived splenocytes was significantly increased compared to
the WT and LysM
creIL-4Rα
-/lox mice (Figure 5.9, B).104
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Figure 5.5: Comparison of day 10 splenic (A) IFN-γ and (B) IL-4 production in P. chabaudi AS
infected WT (IL-4Rα
lox/-), IL-4Rα
-/- and LysM
creIL-4Rα
-/lox female mice on a BALB/c background. ND
indicates not detected within the standard curve range of the ELISA. n=4-5 and * denotes p<0.05.
Data are representative of two independent studies.105
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Figure 5.6: Comparison of day 17 splenic (A) IFN-γ and (B) IL-12 production in P. chabaudi AS
infected WT (IL-4Rα
lox/-), IL-4Rα
-/- and LysM
creIL-4Rα
-/lox female mice on a BALB/c background. ND
indicates  not  detected  within  the  standard  curve  range  of  the  ELISA  and  n=4-5. Data  are
representative of two independent studies.106
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Figure 5.7: Comparison of day 17 splenic (A) IL-10 and (B) IL-4 production in P. chabaudi AS
infected WT (IL-4Rα
lox/-), IL-4Rα
-/- and LysM
creIL-4Rα
-/lox female mice on a BALB/c background.
n=4-5 and * denotes p<0.05. ND indicates not detected within the standard curve range of the
ELISA. Data are representative of two independent studies.107
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Figure 5.8: Comparison of day 48 splenic (A) IFN-γ and (B) IL-12 production in P. chabaudi AS
infected WT (IL-4Rα
lox/-), IL-4Rα
-/- and LysM
creIL-4Rα
-/lox female mice on a BALB/c background.
n=4-5. Data are representative of two independent studies.108
A.
      IL-10 (D48)
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100 g)

AS Ag (200
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100 g)

AS Ag (200
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100 g)

AS Ag (200
0.0
2.5
5.0
7.5
10.0
LysM
creIL-4R
-/lox
WT (IL-4R
lox/-)
IL-4R
-/-
* * *
ND
n
g
/
m
l
B.
      IL-4 (D48)
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100
g)

AS Ag (200
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100
g)

AS Ag (200
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100
g)

AS Ag (200
0.00
0.02
0.04
0.06
0.08
0.1
0.3
0.5
0.7
0.9
1.1
LysM
creIL-4R
-/lox
WT (IL-4R
lox/-)
IL-4R
-/-
*
* * *
n
g
/
m
l
Figure 5.9: Comparison of day 48 splenic (A) IL-10 and (B) IL-4 production in P. chabaudi AS
infected WT (IL-4Rα
lox/-), IL-4Rα
-/- and LysM
creIL-4Rα
-/lox female mice on a BALB/c background.
n=4-5. Data are representative of two independent studies.109
5.3.4  Comparison  of  the  IgG2a  and  IgG1  antibody  responses  of
macrophage/neutrophil  IL-4Rα-deficient  (LysM
creIL-4Rα
-/lox)  female  mice
following Plasmodium chabaudi AS infection.
Peak  parasitaemia  levels  demonstrated  no  significant  differences  in  IgG2a
antibody levels between the respective groups at day 10 of the infection (Figure
5.10, A). WT and LysM
creIL-4Rα
-/lox showed comparable IgG2a antibody responses,
which were significantly greater than the IL-4Rα
-/- mice at day 17 post infection
(Figure  5.10,  B).  However,  at  day  48,  IgG2a  antibody  responses  showed  no
respective significant differences between the groups (Figure 5.10, C).
On days 10 and 17, IgG1 antibody levels were comparable between the WT and
LysM
creIL-4Rα
-/lox mice  but  were  significantly  higher  compared  to  the  IL-4Rα
-/-
mice (Figure 5.11, A and B). On the contrary, no significant differences in IgG1
antibody levels were observed between the groups on day 48 (Figure 5.11, C).110
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Figure 5.10: Comparison of the IgG2a antibody responses of P. chabaudi AS infected WT
(IL-4Rα
lox/-), IL-4Rα
-/- and LysM
creIL-4Rα
-/lox female mice on a BALB/c background on (A)
day 10 (B) day 17 and (C) day 48. n=5-6 and * denotes p<0.05. Data are representative of
two independent studies.111
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Figure 5.11: Comparison of the IgG1 antibody responses of P. chabaudi AS infected WT
(IL-4Rα
lox/-), IL-4Rα
-/- and LysM
creIL-4Rα
-/lox female mice on a BALB/c background on (A)
day 10 (B) day 17 and (C) day 48. n=5-6 and * denotes p<0.05. Data are representative of
two independent studies.112
5.4 Discussion
We used the Plasmodium chabaudi AS disease model in which host protection or
pathology  was  dependent  on  Th1  and  Th2  responses  to  investigate  the
importance of alternate macrophage activation on disease outcome. This study
provided evidence that long-term protection of LysM
creIL-4Rα
-/flox mice infected
with P. chabaudi AS did not require the presence of IL-4 and IL-13 activation of
macrophages. Thus, the increased susceptibility of IL-4Rα
-/- mice compared with
WT  mice  must  depend  on  IL-4Rα  signalling  cell  populations  other  than
macrophages/neutrophils.
The disease profile of LysM
creIL-4Rα
-/lox mice was very similar to that of the WT
control apart from the fact that the WT mice demonstrated only a 25% mortality
rate  at  day  22  post  infection.  Acute  parasitaemia  in  both  these  groups
corresponded to the reduced RBC count and weight loss observed in the groups
around this time. On the other hand, IL-4Rα
-/- mice displayed greater mortality
and  greater  recrudescent  parasitaemia  to  the  WT  and  LysM
creIL-4Rα
-/lox  mice.
Furthermore, peak infection correlated with the significantly reduced weight in
IL-4Rα
-/-  mice  compared  to  the  WT  control  and  LysM
creIL-4Rα
-/lox  mice  and
following primary infection, weight loss and RBC counts were significantly lower
in this group compared to the WT and LysM
creIL-4Rα
-/lox mice. Taken together,
these results show that in the absence of IL-4/IL-13 activation of macrophages,
the LysM
creIL-4Rα
-/lox mice are able to survive the P. chabaudi AS infection and
control chronic infection more effectively than the IL-4Rα
-/- mice.
Cell-mediated  responses  during  the  acute  stage  (day  10)  of  infection
demonstrated reduced IFN-γ production from ConA stimulated splenocytes in WT
and LysM
creIL-4Rα
-/lox mice compared with the IL-4Rα
-/- mice. This may explain
why no mortality was observed in the LysM
creIL-4Rα
-/lox mice due to no over-
production of IFN-γ compared to IL-4Rα
-/- mice. The detrimental effect of IFN-γ
production in malaria was documented. Essentially, excessive production of a
strong  proinflammatory  type  I  immune  response  and  the  resulting  cytokines
produced,  namely  IFN-γ,  may  directly  contribute  to  severe  disease  such  as
severe anaemia, cerebral malaria and organ damage (Couper et al., 2010, Good
et al., 2005, Schofield and Grau, 2005). IgG1 antibody levels around this time
were significantly higher in the WT and LysM
creIL-4Rα
-/flox mice and may have113
resulted from IL-4 stimulation of other cell types (CD4
+ Th2 cells) which in turn
activate  B-cell  differentiation  into  Th2-type  antibody  production.  Following
recovery from primary infection (day 17), the cytokine profile in the WT and
LysM
creIL-4Rα
-/flox mice  showed  a  mixed  Th1-Th2  phenotype.  IFN-γ  production
from antigen-specific stimulated splenocytes in WT and LysM
creIL-4Rα
-/flox mice
were significantly greater than IL-4Rα
-/- mice and correlated to the increased
IgG2a antibody levels at this time. In addition, IL-10 and IL-4 production from
antigen-specific stimulated splenocytes were significantly greater than IL-4Rα
-/-
mice and correlated to the increased IgG1 antibody levels around this time. The
presence of IL-12 was not detected in IL-4Rα
-/- mice and not significant in WT
and LysM
creIL-4Rα
-/floxmice. Previous studies in malarial anaemia have also shown
that suppression  of  IL-12  decreases  production  of  IFN-γ and  IFN-α  and  the
suppression  of  IL-12  appears  to  be  a  consequence  of  the induction  of  IL-10,
which in turn is stimulated by infection (Ouma et al., 2008; Keller et al ., 2006).
Following  termination  of  the  experiment  at  day  48,  a  Th2  phenotype  was
dominant in the WT and LysM
creIL-4Rα
-/flox mice with increased IL-10 and reduced
IFN-γ production. Taken together these results indicate the presence of Th1 and
Th2-type cytokine and antibody responses in LysM
creIL-4Rα
-/flox mice controlling
P.chabaudi  AS  chronic  infection  in  the  absence  of  IL-4Rα  signalling  on
macrophages/neutrophils.
Results from the LysM
creIL-4Rα
-/flox mice in the present study are in contrast to
data found in previous work (Couper, 2003). These are the first two studies,
which have utilized cell-specific gene deficient mice to provide data regarding
IL-4Rα signalling via macrophages/neutrophils in a P.chabaudi AS infected mouse
model. Couper showed that LysM
creIL-4Rα
-/flox mice displayed a similar disease
course to IL- 4Rα
-/- mice with enhanced mortality and recrudescent infection and
impaired  Type  2  protective  immunity  to  WT  mice  (data  not  shown).  He
concluded  that IL-4  and  IL-13 protection might  be  via  regulation  of
macrophage/neutrophil  function. An  explanation  for  the  differences  observed
between the two studies is the fact that Couper used male mice and the present
study utilized female mice. Several studies have illustrated that immunological
differences exist between the sexes and linked with circulating steroid hormones
(Klein, 2004; Roberts et al., 2001; Klein, 2000; Zuk and McKean, 1996). Human
studies have shown that increased susceptibility to infection is thought to be one114
of the leading causes of increased death rates amoung men as compared with
women (Klein, 2004; Owens, 2002; Klein, 2000). Rodent studies reveal that sex
differences are present and may be mediated by endocrine-immune interactions.
Castration  of  male  mice  reduces,  whereas  exogenous  administration  of
testosterone increases mortality following P. chabaudi or P. berghei infection
(Klein, 2004; Wunderlich et al., 1991; Kamis and Ibrahim, 1989). In addition,
male mice recover slower from P. chabaudi-induced weight loss, anaemia and
hypothermia and have lower antibody responses than female mice (Klein, 2004).
The  phenotypic  differences  between  the  sexes  in  response  to P.  chabaudi
infection may be mediated by sex differences in the expression of genes that
modulate  pro-inflammatory  and  Th1  responses  during  infection. The
immunomodulatory effects of testosterone may underlie increased susceptibility
to Plasmodium infections in males compared with females. Exposure of adult
female mice to testosterone reduces antibody production, decreases MHC II and
increases CD8
+ T-cells in the spleen (Klein, 2004; Benten et al., 1997). Another
study aimed to determine why females were less susceptible than males and
measured  the  effects  of  estrogen  and  progesterone  responses  in  malaria
infection  (Klein et  al.,  2008).  Results  of  the P.  chabaudi  infected  C57BL/6
female  mice  showed  that  the  physiological  levels  of  estrogen  rather  than
progesterone enhanced immunity (IFN-γ and IL-10) and could possibly protect
females  from  disease  symptoms  during  malaria infection (Klein et  al.,  2008).
Furthermore, Bryson and colleagues (Bryson et al., 2011) identified a dichotomy
between the sexes in a disease model in an attempt to identify which cell types
cause  IL-4/IL-13  induction  resulting  in  a  non-healing Leishmania  mexicana
disease. They infected mice lacking IL-4Rα expression on CD4
+ T-cells
(Lck
CreIL-4Rα
-/lox)  with L.  mexicana  and  monitored  disease  progression.  They
found  that  the  Lck
CreIL-4Rα
-/lox  female  mice  developed  small  lesions,  which
subsequently healed, and a strong Th1 response was manifested compared to the
controls.  In  contrast,  the  male  Lck
CreIL-4Rα
-/lox  mice  developed  small  lesions,
which  persisted,  and  a  strong  Th1  response  was  elicited  but  IL-4  was  also
elevated independent of CD4
+ T-cell IL-4 responsiveness and not the case in the
female  mice  (Bryson et  al.,  2011).  They  suggest  a  significant  effect  of  sex
hormones  on  CD4
+  T-cell  function  whereby  infected  male  but  not  female
Lck
CreIL-4Rα
-/lox  mice  can  drive  IL-4  production  independently  of  IL-4Rα115
signalling.  Hence,  their  finding  also  provides  evidence  for  male  and  female
immunological differences that can exist during similar parasitic infections.
In addition, the role of aaMø in various disease models utilizing LysM
CreIL-4Rα
-/lox
mice show differences in disease susceptibility or protection. For example, the
induction of IL-4/IL-13 by Mø’s are required in a Schistosoma mansoni infection
for  protection  against  organ  injury  through  douwnregulation  of  egg-induced
inflammation  (Herbert et  al.,  2004).  Similarly,  IL-4Rα-responsive  Mø’s  are
essential  promoters  of  protection  in  experimental  autoimmune
encephalomyelitis  (EAE)  (Keating et  al.,  2009).  Keating  and  colleagues  also
highlighted the importance of T-regs since the IL-4Rα
-/- mice showed lower EAE
incidence and LysM
CreIL-4Rα
-/lox mice were protected from EAE. They concluded
that  Mø  activation  in  the  absence  of  Th2  cytokines  can  promote  disease
suppression  by  T-regs  (Keating et  al.,  2009).  On  the  other  hand,  protection
against infection can be independent of IL-4Rα responsive macrophages as is the
case in the present study and similarly shown in other disease models of aaMø.
For example, in Trichinella spiralis (Michels et al., 2009), Leishmania donovani
(McFarlane et al., 2011) and Leishmania mexicana (Bryson et al., 2011) infection
studies utilizing LysM
CreIL-4Rα
-/lox mice, protection was shown to be independent
of aaMø.
In conclusion, we have shown that a role for IL-4 and IL-13 alternate activation
of  macrophages/neutrophils  is  not  crucial  for  host  survival  during  chronic P.
chabaudi AS infection in female BALB/c mice. IL-4 and IL-13 may therefore exert
their protective functions via IL-4Rα signalling on different T-helper cell types
such as CD4
+ and CD8
+ T-cells in P. chabaudi AS infection, which will be the
focus of the next chapters.116
Chapter Six
The role of IL-4/IL-4Rα signalling on CD4
+ T-cells during Plasmodium
chabaudi AS erythrocyte infection in female BALB/c mice.117
6.1 Abstract
A feature of P. chabaudi infection compared to other parasitic infections is that
both  Th1  and  Th2  CD4
+  T-cells  play  an  important  protective  role.  CD4
+ Th2-
dependent control of P. chabaudi infection immediately following acute primary
parasitaemia  is  known  to  involve  IL-4  and antibody-dependent mechanisms.
Further work in the previous chapters showed that mice deficient in the IL-4Rα,
with  abrogated  IL-4  and  IL-13  function,  were  more  susceptible  to  infection
during the chronic phase with impaired Th2 protective responses. Additionally,
our  previous  work  on macrophage/neutrophil-specific  IL-4Rα-deficient  BALB/c
mice demonstrated that these mice did not succumb to infection and were able
to resolve infection as effectively as the WT controls. In the present study, CD4
+
T-cell-specific  IL-4Rα deficient (Lck
creIL-4Rα
-/lox) BALB/c  mice  were  generated
and characterized to elucidate the importance of IL-4/IL-13 responsive CD4
+ T-
cells in a model of P. chabaudi AS infection. The data presented here, indicate
that  together  with  the  WT  control, Lck
creIL-4Rα
-/lox  mice  provided  initial  Th1
control  at  day  10 as  measured  by  splenic  IFN-γ  production  and  serum  IgG2a
antibody responses. Subsequent Th1-Th2 control around day 17 was demonstrated
in the Lck
creIL-4Rα
-/lox mice as measured by increased splenic IFN-γ and IL-10
production  and  the  induction  of  serum  IgG1 antibodies.  Following  day  17,
Lck
creIL-4Rα
-/lox mice experienced a recrudescent parasitaemia similar to the
IL-4Rα
-/- mice with reduced RBC count and increased mortality at days 36 and 40
while weight loss was not significant. Of note is that mortality was greater in the
Lck
creIL-4Rα
-/lox than in the IL-4Rα
-/- mice. Th2 responses were down-regulated in
the Lck
creIL-4Rα
-/lox mice  as  measured  by  reduced  splenic  IL-10  and  IL-4
production and increased IFN-γ from ConA stimulated splenocytes accompanied
by increased serum IgG2a antibody responses. Together, our results indicate that
Lck
creIL-4Rα
-/lox and IL-4Rα
-/- BALB/c mice were susceptible to chronic-stage P.
chabaudi AS infection and that the effector functions of IL-4 responsiveness on
CD4
+ T-cells are vital to clear and control the infection.118
6.2 Introduction
Of the major T-cell subpopulations, the central involvement of CD4
+ T-cells are
recognized  as  essential  for immune  protection  against  asexual  erythrocytic-
stages in both murine and human malaria. In Plasmodium chabaudi infection of
mice,  the  importance  of  CD4
+  T-cells  in  parasite  immunity originates  from
experiments with thymectomized mice (Leke et al., 1981; McDonald and Phillips,
1975) and has been demonstrated by selective depletion of different lymphocyte
subsets in vivo (Taylor-Robinson et al., 1993; Podoba and Stevenson, 1991; Süss
et al., 1988) and by adoptive transfer of T-cells or CD4
+ T-cell lines and clones to
immunodeficient hosts (Taylor-Robinson and Phillips, 1994; Taylor-Robinson and
Phillips,  1993;  Taylor-Robinson et  al.,  1993;  Meding  and  Langhorne,  1991).
Purified CD4
+ T-cells or parasite-specific CD4
+ T-cell lines transferred to severe
combined  immunodeficiency  or  lethally  irradiated  mice,  respectively, cleared
the infection only in the presence of B cells (Taylor-Robinson and Phillips, 1993;
Meding  and  Langhorne,  1991),  indicating  a  requirement  for  B  cells  for  final
elimination  of  parasites. CD4
+  T-cells can  be  differentiated  into  two  major
subsets,  namely,  Th1  and  Th2  cells.  This  differentiation  is  based  upon  the
specific cytokine environment that will prime naïve T-cells into specific CD4
+ Th1
or Th2 cells, which in turn produce distinct cytokine profiles that indicate their
function (Mosmann and Coffman, 1989, 1987). Th1 cells produce IL-2, IFN-γ, and
TNF-alpha  and  consequently  activate  macrophages  and  mediate  delayed-type
hypersensitivity responses and provide B-cell help through IgG2a Ab stimulation.
Th2 cells produce IL-4, IL-5, IL-6, and IL-10 and provide help for B-cell antibody
responses (Brombacher, 2000; Mosmann and Coffman, 1989, 1987). Th1 and Th2
cells therefore mediate distinct immune functions, containing non-overlapping
and often counter regulatory cell-mediated and humoral responses. One of the
characteristics  of P.  chabaudi  blood-stage  infection  of  immunologically
competent mice is that it generates a host protective immune response that is
characterized by both CD4
+ Th1 and Th2 responses (Taylor-Robinson et al., 1993;
Langhorne, 1989). The levels of these two subsets of cells change during the
course of infection (Taylor-Robinson and Phillips, 1992; Langhorne et al., 1989)
where Th1 cells predominate during the acute phase and Th2 cells predominate
during the later phases of infection. The factors that regulate the differentiation
of naïve T-cells into cells of either Th1 or Th2 phenotype following activation are119
not clearly understood. These regulatory factors may include secreted cytokines
(Abehsira-Amar et  al.,  1992;  Swain et  al.,  1991),  the  nature  of  the  antigen-
presenting  cell  involved  (Terrazas et  al.,  2010;  Quin  and  Langhorne,  2001;
Dekruff et al., 1992; Gajewski et al., 1991; Schmitz et al., 1993), the processing
of the antigen for presentation to the T-cell (Terrazas et al., 2010; Sponaas et
al., 2006; Quin and Langhorne, 2001; Soloway et al., 1991), and the antigenic
load (Abehsira-Amar et al., 1992).
Studies have shown that IL-4 is necessary for Th2 responses in malaria infection.
IL-4 is an important cytokine as it drives differentiation of naïve CD4
+ T-cells
into CD4
+ Th2 T-cells that would subsequently eliminate the infection, while in
its  absence  these  cells  preferentially  become  IFN-γ  producing  cells  (Gordon
2003; Brombacher, 2000; Barner et al, 1998; Paul, 1997). P. chabaudi studies
have previously shown that mice deficient in IL-4 production did not alter the
outcome of the infection significantly but they did display significantly elevated
peak  parasitaemia  compared  to  the  WT  control  mice  and  extended
recrudescenses with sustained Th1 responses (Balmer et al., 2000; Phillips et al.,
1997). Although these mice produced a delayed Th2 response, it was not absent
and protection was speculated to occur via IL-13 function. Further investigations
lead to utilization of IL-4Rα
-/- mice that effectively could not respond to IL-4 or
IL-13, which proved that IL-13 does play a role in compensating for the absence
of IL-4 to confer protection against Leishmania (Mohrs et al., 1999). In our group
we have also shown that P. chabaudi AS infected IL-4Rα
-/- mice succumbed to
infection more so than the WT control mice (Chapter 3). The different signalling
pathways induced by IL-4 still remain controversial and are yet to be clarified in
malaria infection. The intricacy of IL-4 and IL-13 responsiveness can further be
attributed to the wide range of cell types expressing IL-4Rα (Nelms et al., 1999);
hence the need to address signalling of the receptor on specific cell types and
their role in parasite immunity.120
While, the specific functional role of IL-4/IL-13 responding CD4
+ T-cells during P.
chabaudi  infection  remain  poorly  understood,  the  availability  of  CD4
+  cell
specific IL-4Rα
-/- mice will enable us to clarify this role. In other disease models
for example, it has been shown that deletion of IL-4Rα on CD4
+ T-cells renders
BALB/c mice resistant to Leishmania mexicana (Bryson et al., 2011), Leishmania
major (Radwanska et al, 2007) infection and therefore indicate a major role for
IL-4/IL-13  function  via  CD4
+  T-cells  in  rendering  these  mice  susceptible  to
infection.  The effect  of  IL-4Rα  signalling  via  CD4
+  T-cells  in P.  chabaudi
infections is the focus of the present study.
We  have  thus  generated  Lck
creIL-4Rα
-/lox  mice  to  determine  what  effector
functions IL-4/IL-13 have on CD4
+ T-cell function during P. chabaudi AS infection
and whether the IL-4Rα signalling cascade results in long-term protection.  Our
finding, which is novel regarding the use of CD4
+ T-cell IL-4Rα
-/- mice in malaria,
illustrated  that  the  absence  of  IL-4  signalling  via  IL-4Rα  on  these  cell  types
rendered  mice  more  susceptible  to  infection  and are therefore important
effectors in the second phase of P. chabaudi AS infection.121
6.3 Results
6.3.1 Comparison of the survival rates and disease phenotypes of wild-type
(WT),  global  IL-4Rα-deficient  (IL-4Rα
-/-)  and CD4
+  T-cell  IL-4Rα-deficient
(Lck
creIL-4Rα
-/lox) female mice following Plasmodium chabaudi AS infection.
WT  and Lck
creIL-4Rα
-/lox  mice  survived  the  acute  stage  infection  with  no
mortalities observed whereas the IL-4Rα
-/- mice displayed an enhanced mortality
rate of 17% at day 12 (Figure 6.1). During the chronic-stage infection, mortality
was observed in the IL-4Rα
-/- mice at day 36 with 33% mortality and with the
majority of deaths observed in the Lck
creIL-4Rα
-/lox mice at day 36, 25% mortality
and day 40, 50% mortality (Figure 6.1).
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Figure 6.1: Comparison of the survival rates of P. chabaudi AS infection in (A) WT
(IL-4Rα
lox/-), IL-4Rα
-/- and Lck
creIL-4Rα
-/lox female mice on a BALB/c background. WT n=14,
IL-4Rα
-/- n=18 and Lck
creIL-4Rα
-/lox n=13 and. Data are representative of two independent
studies.122
Parasite burdens were significantly higher in the Lck
creIL-4Rα
-/lox mice on days 22
and 28 compared to their WT counterparts during chronic-stage infection while
no  significant  differences  occurred  around  peak  parasitaemia  between  the
groups (Figure 6.2).
At day 3 of the early stage infection, parasite burdens were significantly lower in
the IL-4Rα
-/- mice compared to the Lck
creIL-4Rα
-/lox and WT mice. Furthermore,
the IL-4Rα
-/- mice demonstrated recrudescent parasitaemia on days 17, 22 and
28 post infection while no episode of recrudescence occurred in the WT mice
(Figure 6.2).
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Figure 6.2: Comparison of the disease parasitaemias of P. chabaudi AS infection in WT
(IL-4Rα
lox/-), IL-4Rα
-/- and Lck
creIL-4Rα
-/lox female mice on a BALB/c background. WT n=14,
IL-4Rα
-/-  n=14  and  Lck
creIL-4Rα
-/lox,  n=12. Results  are  displayed  as  a  %  and  as  a  log  %  of
parasitaemia levels in these groups. Data are representative of two independent studies. * (WT
vs IL-4Rα
-/-),
# (IL-4Rα
-/- vs Lck
creIL-4Rα
-/lox) and
x (WT vs Lck
creIL-4Rα
-/lox) denotes p<0.05.123
No  significant  differences  in  weight  loss  occurred  around  peak  parasitaemia
between the groups: maximal weight loss occurred on day 10 (Figure 6.3, A).
Following recovery, a significant increase in weight occurred in the
Lck
creIL-4Rα
-/lox mice on days 12, 14 and 17 post infection when compared to its
WT counterpart (Figure 6.3, A). This increase in weight was also observed in the
IL-4Rα
-/-  mice  on  day  17  when  compared  to  the  WT  mice  (Figure  6.3,  A).
Furthermore, no significant differences in weight loss were observed from day 17
in all groups.
At day 5 post infection, RBC counts were significantly higher in the IL-4Rα
-/- mice
when  compared  to  the  WT  and Lck
creIL-4Rα
-/lox mice  (Figure  6.3,  B)
corresponding to the decreased parasite burdens observed in the IL-4Rα
-/- mice
at this time (Figure 6.2). Severe anaemia was observed in both groups at day 10
post  infection  (Figure  6.3,  B)  corresponding  to  peak  infection  (Figure  6.2).
Following parasite control, a significant increase in RBC counts occurred in the
Lck
creIL-4Rα
-/lox mice when compared to their WT counterparts and the IL-4Rα
-/-
mice (Figure 6.3, B). In contrast, RBC counts were significantly decreased in the
Lck
creIL-4Rα
-/lox mice on day 22 when compared to the WT and IL-4Rα
-/- mice
(Figure 6.3, B), corresponding to the recrudescent parasitaemia observed in this
group at that time (Figure 6.2).124
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Figure 6.3: Comparison of (A) weight loss and (B) malaria induced anaemia during the
course of P. chabaudi AS infection in WT(IL-4Rα
lox/-), IL-4Rα
-/- and Lck
creIL-4Rα
-/lox female
mice on a BALB/c background. WT(IL-4Rα
lox/-) n=14, IL-4Rα
-/- n=14 and Lck
creIL-4Rα
-/lox
n=12. (A) * (WT vs IL-4Rα
-/- and Lck
creIL-4Rα
-/lox),
# (WT vs Lck
creIL-4Rα
-/lox) and
x (WT and
Lck
creIL-4Rα
-/lox vs IL-4Rα
-/-) (B) * (WT vs IL-4Rα
-/-) and
# (Lck
creIL-4Rα
-/lox vs IL-4Rα
-/- and
WT) denotes p<0.05. Data are representative of two independent studies.125
6.3.2 The influence of chronic disease on splenomegaly in CD4
+ IL-4Rα-
deficient (Lck
creIL-4Rα
-/lox) female mice infected with Plasmodium chabaudi
AS.
During  the  course  of P.  chabaudi  AS infection,  whole  spleen weights  of  non-
infected  and  infected  WT as  well  as gene-deficient  mice  were  measured  to
determine  the  severity  of  splenomegaly  between  the  respective  groups.
Splenomegaly is a direct cause of P. chabaudi AS infection as was evident in the
gene-deficient mice compared to no enlarged spleens observed in non-infected
mice  throughout  the  duration  of  the  disease  (Figure  6.4).  Furthermore,  no
significant increase in spleen weights of the gene-deficient mice were observed
in comparison to the WT control throughout the course of the infection and up
to the termination of the experiment at day 48 (Figure 6.4).126
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Figure  6.4: Comparison  of  the  whole  spleen  tissue  weights  of  non-infected  and P.
chabaudi  AS  infected  WT(IL-4Rα
lox/-),  IL-4Rα
-/-  and  Lck
creIL-4Rα
-/lox  female  mice  on  a
BALB/c background on (A) day 10 (B) day 17 and (C) day 48. Data are representative of
two independent studies, n= 4-6. * denotes p<0.05.127
6.3.3 Comparison of the splenic cytokine production in wild-type (WT), global
IL-4Rα-deficient (IL-4Rα
-/-) and CD4
+ T-cell IL-4Rα-deficient (Lck
creIL-4Rα
-/lox)
female mice following Plasmodium chabaudi AS infection.
Th1-type  associated  cytokine, IFN-γ,  was  significantly  reduced  in  WT  and
Lck
creIL-4Rα
-/lox  derived  splenocytes  following  ConA  stimulation  from  day  10
infected mice compared to IL-4Rα
-/- derived splenocytes (Figure 6.5, A). IL-12
production  was  comparable  between  the  groups  with  no  striking  differences
(Figure 6.5,  B). Th2-type  associated  IL-10  cytokine  levels  were  significantly
greater  in  WT  and  IL-4Rα
-/-  derived  splenocytes  stimulated  with  specific P.
chabaudi  AS  antigen  compared  to Lck
creIL-4Rα
-/lox  derived  splenocytes  (Figure
6.6, A). Furthermore, IL-4 production was only significantly increased in the IL-
4Rα
-/- derived splenocytes following ConA stimulation (Figure 6.6, B).
On  day  17  post-infection,  IFN-γ  production  was  significantly  greater  in  the
Lck
creIL-4Rα
-/lox ConA and antigen-specific stimulated splenocytes compared to
WT and IL-4Rα
-/- derived splenocytes (Figure 6.7, A). IL-12 production was only
observed  in  the  WT  stimulated  splenocytes:  IL-12  levels  were  below  the
sensitivity of the ELISA in the Lck
creIL-4Rα
-/lox and IL-4Rα
-/- derived splenocytes
(Figure  6.7,  B). A  significant  increase  in  IL-10  production,  seen  in  ConA
stimulated splenocytes, occurred in WT mice compared to Lck
creIL-4Rα
-/loxand
IL-4Rα
-/-  derived  splenocytes  (Figure  6.8,  A).  However,  Lck
creIL-4Rα
-/lox ConA
stimulated  splenocytes  produced  greater  IL-10  cytokine  levels than  IL-4Rα
-/-
derived splenocytes at this time (Figure 6.8, A). In addition, significantly greater
IL-4 production occurred in WT and IL-4Rα
-/- derived splenocytes stimulated with
ConA compared to Lck
creIL-4Rα
-/lox derived splenocytes (Figure 6.8, B).128
At  day  48, Lck
creIL-4Rα
-/lox mice  displayed  significantly  increased  IFN-γ
production from ConA stimulated splenocytes compared to the WT and IL-4Rα
-/-
mice whilst IFN-γ production from antigen-specific stimulated WT and IL-4Rα
-/-
derived splenocytes was significantly increased compared to the Lck
creIL-4Rα
-/lox
derived splenocytes (Figure 6.9, A). IL-12 production was comparable with no
significant differences observed between the groups (Figure 6.9, B).
LckM
creIL-4Rα
-/lox mice  displayed  comparable  IL-10  production  with  IL-4Rα
-/-
derived  splenocytes  following  ConA  stimulation  but  IL-10  production  in  these
groups was significantly lower compared to WT derived splenocytes stimulated
with ConA (Figure 6.10, A). IL-4 production was significantly reduced in the ConA
stimulated splenocytes of LckM
creIL-4Rα
-/lox and IL-4Rα
-/- mice compared to the
WT  control  (Figure  6.10,  B).  On  the  other  hand,  IL-4  production  by  antigen-
specific  stimulated Lck
creIL-4Rα
-/lox  and  IL-4Rα
-/-  derived  splenocytes  was
significantly increased compared to the WT mice (Figure 6.10, B).129
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Figure  6.5: Comparison  of  day  10  splenic (A)  IFN-γ  and (B) IL-12  production  in P.
chabaudi  AS  infected  WT(IL-4Rα
lox/-),  IL-4Rα
-/-  and Lck
creIL-4Rα
-/lox female  mice  on  a
BALB/c  background.  Data  are  representative  of  two  independent  studies, n=4-5.  ND
indicates not detected within the standard curve range of the ELISA. * denotes p<0.05.130
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Figure 6.6: Comparison of day 10 splenic (A) IL-10 and (B) IL-4 production in P. chabaudi
AS  infected  WT(IL-4Rα
lox/-),  IL-4Rα
-/-  and Lck
creIL-4Rα
-/lox female  mice  on  a  BALB/c
background. Data are representative of two independent studies, n=4-5. ND indicates not
detected within the standard curve range of the ELISA. * denotes p<0.05.131
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Figure  6.7: Comparison  of  day  17  splenic (A)  IFN-γ  and (B) IL-12  production  in P.
chabaudi  AS  infected  WT(IL-4Rα
lox/-),  IL-4Rα
-/- and Lck
creIL-4Rα
-/lox female  mice  on  a
BALB/c  background.  Data  are  representative  of  two  independent  studies, n=4-5.  ND
indicates not detected within the standard curve range of the ELISA. * denotes p<0.05.132
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Figure 6.8: Comparison of day 17 splenic (A) IL-10 and (B) IL-4 production in P. chabaudi
AS  infected  WT(IL-4Rα
lox/-), IL-4Rα
-/-  and Lck
creIL-4Rα
-/lox female  mice  on  a  BALB/c
background. Data are representative of two independent studies, n=4-5. ND indicates not
detected within the standard curve range of the ELISA. * denotes p<0.05.133
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Figure  6.9: Comparison  of  day  48  splenic (A)  IFN-γ  and (B) IL-12  production  in P.
chabaudi  AS  infected  WT(IL-4Rα
lox/-),  IL-4Rα
-/-  and Lck
creIL-4Rα
-/lox female  mice  on  a
BALB/c  background.  Data  are  representative  of  two  independent  studies, n=4-5.  ND
indicates not detected within the standard curve range of the ELISA. * denotes p<0.05.134
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Figure  6.10: Comparison  of  day  48  splenic (A)  IL-10  and (B) IL-4  production  in P.
chabaudi  AS  infected  WT(IL-4Rα
lox/-),  IL-4Rα
-/-  and Lck
creIL-4Rα
-/lox female  mice  on  a
BALB/c  background.  Data  are  representative  of  two  independent  studies, n=4-5.  ND
indicates not detected within the standard curve range of the ELISA. * denotes p<0.05.135
6.3.4 Comparison of the IgG2a and IgG1 antibody responses of CD4
+ IL-4Rα-
deficient (Lck
creIL-4Rα
-/lox) female mice following Plasmodium chabaudi AS
infection.
Primary parasitaemia and peak infection demonstrated a significant increase in
Th1-type (IgG2a) antibody levels in WT and Lck
creIL-4Rα
-/lox compared to IL-4Rα
-/-
mice (Figure 6.11, A). All groups showed comparable IgG2a antibody responses
at day 17 post infection (Figure 6.11, B). However, at day 48, IgG2a antibody
levels showed a significant decrease in IgG2a levels in WT and Lck
creIL-4Rα
-/lox
compared to IL-4Rα
-/- mice (Figure 6.11, C).
Th2-type antibody (IgG1) levels on days 10 and 17 were significantly increased in
the WT and Lck
creIL-4Rα
-/lox compared to IL-4Rα
-/- mice (Figure 6.12, A and B). In
contrast,  IgG1  antibody  levels  were  subsequently  significantly  reduced  in  the
gene-deficient mice  compared  to  the  WT  control  on  day  48  of  the  infection
(Figure 6.12, C).136
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Figure 6.11: Comparison  of the IgG2a antibody responses of P. chabaudi AS infected
WT(IL-4Rα
lox/-), IL-4Rα
-/- and Lck
creIL-4Rα
-/flox female mice on a BALB/c background on (A)
day 10 (B) day 17 and (C) day 48. Data are representative of two independent studies,
n=4-6. * denotes p<0.05.137
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Figure  6.12: Comparison  of  the  IgG1  antibody  responses  of P.  chabaudi  AS  infected
WT(IL-4Rα
lox/-), IL-4Rα
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creIL-4Rα
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day 10 (B) day 17 and (C) day 48. Data are representative of two independent studies,
n=4-6. * and
# denotes p<0.05.138
6.4 Discussion
CD4
+ T-cells play a central role in protective immunity to Plasmodium infection
(Stephens et  al.,  2005,  Langhorne et  al., 2002).  Although  signal  transduction
triggered by IL-4 has been extensively studied on CD4
+ T-cells in various disease
models, the exact signalling events induced by IL-4/IL-13 via IL-4Rα specifically
on CD4
+ T-cells have not yet been characterized in a model of murine malaria.
To our knowledge, this report constitutes the first comprehensive analysis of the
immunological events that shape a CD4
+ T-cell response to IL-4 and IL-13 during
chronic P. chabaudi AS infection. Our findings specifically demonstrate that the
abrogation  of  IL-4Rα  signalling  of  CD4
+  T-cells  resulted  in  the  suppression  of
protective responses during chronic-stage disease. CD4
+ T-cell-specific IL-4Rα
-/-
(Lck
creIL-4Rα
-/lox) mice generated, have a null mutation of IL-4Rα on CD4
+ T-cells,
an  incomplete  deletion  on  CD8
+  T-cells  and  other  T-cell  subpopulations,  and
normal  expression  on  non-T-cells  (Bryson et  al.,  2011,  Michels et  al.,  2009,
Radwanska et al., 2007, Leeto et al., 2006). Our hypothesis was confirmed when
the Lck
creIL-4Rα
-/lox mice, in response to P. chabaudi AS infection, were unable
to induce an effective chronic protective Th2-type immune response that was
observed within the WT mice. Protection was therefore mainly dependent on
CD4
+ T-cells responsiveness to IL-4.
The disease phenotype of the acute-stage infection in the Lck
creIL-4Rα
-/lox mice
was  comparable  to  that  of  the  WT  control.  However,  the  profile  changed
following day 17 when the Lck
creIL-4Rα
-/lox mice demonstrated greater mortality
on  days  36  and  40  and  recrudescence  was  evident  on  days  17,  22  and  28
corresponding  to  the  reduced  RBC  count  at  day  22.  Weight  loss  was  not  a
significant factor at this point but these mice did however, gain weight faster
than  the  WT  control  mice  (days  12,  14,  17).  The  IL-4Rα
-/- mice  induced  an
impaired  Th2 immune  response reminiscent  of  studies  consistently  shown  by
ourselves  and  others  (Couper,  2003).  The  absence  of  the  IL-4Rα  subunit  was
hallmarked  by  observations  of  recrudescent  parasitaemia, increased mortality
and impaired Th2-type immunity during the chronic stage. P. chabaudi blood-
stage infection in the Lck
creIL-4Rα
-/lox in comparison to the IL-4Rα
-/- mice were
characterized  by significantly  elevated  parasitaemia  at  day  3  and  greater
number of deaths during the chronic-stage of the disease. Anaemia is one of the
major presentations of hyperreactive malarial splenomegaly while splenomegaly139
is  defined  as  reticuloendothelial  and  lymphoid  hyperplasia  due  to  chronic
malaria infection (del Portillo et al., 2011, Bryceson et al., 1983). Splenomegaly
between  the  groups  was  comparable  throughout  the  course  of  infection
suggesting that parasitaemia alone does not account for the increase in spleen
size  but  does  demonstrate  the  crucial  importance  of  the  spleen  in  parasite
clearance  (del  Portillo et  al.,  2011).  This  was  similarly  shown  in  human P.
falciparum  infections  where  splenectomised  patients  invariably  showed  an
increase in parasitaemia during infection regardless of anti-malarial agents used
(del Portillo et al., 2011, Bachmann et al., 2009). Taken together, the IL-4Rα
-/-
and  Lck
creIL-4Rα
-/lox  mice  seemed  to  control  the  initial  acute-stage  infection
adequately but struggled to maintain protection and were susceptible to long-
term disease, evidenced with increased mortality, compared to the WT mice.
The complete absence of IL-4Rα responsiveness versus cell-specific deletion of
IL-4Rα  on  CD4
+  T-cells  suggested  that  non-CD4
+  T-cell  IL-4Rα-dependent
responses were  insufficient  to  induce  protection  to  chronic  P.  chabaudi  AS
infection.
At peak infection (day 10 post-infection), IFN-γ production from ConA stimulated
splenocytes, although significantly lower than the WT control, correlated with
IgG2a  antibody  responses  from  stimulated  B-cells. Accumulating  evidence
indicates  that  activated  CD4
+ T  cells  release  factors,  including IFN-γ,  which
induce  downstream  mechanisms  to  kill  parasites  (Stephens et  al.,  2005,
Langhorne et al., 2002, Li and Langhorne, 2000; Troye-Blomberg et al., 1999;
Mohan and Stevenson, 1998). IFN-γ is produced by natural killer (NK) cells, γδ T-
cells, and CD4
+ T-cells (Seixas et al., 2002; Mohan et al., 1997), all of which may
play some role in controlling parasitemia, but it is the CD4
+ T-cells together with
B-cells that are crucial for the development of protective immunity (Stephens et
al., 2005, Langhorne et al., 2002, Langhorne et al., 1998; von der Weid et al.,
1996). The results seen in our experiments give further evidence that it is via
IL-4Rα signalling on CD4
+ T-cells that is crucial for the development of protective
P. chabaudi AS immunity. Much of the pathogenesis of the acute blood-stage
malaria infection in  this  model  has  been  attributed  to  pro-inflammatory
responses induced in part by IFN-γ from Th1 CD4
+ T-cells (Li et al., 2001).140
Following the acute infection and declining parasitaemia, at day 17, CD4
+ T-cell
responses where characterized by a marked IFN-γ increase following ConA and
antigen-specific stimulated splenocytes in the Lck
creIL-4Rα
-/lox mice compared to
the WT and IL-4Rα
-/- mice. It may be suggested that the presence of non-CD4
+ T-
cells  responding  to  IL-4Rα  signalling  is  responsible  for  the  induction  of  an
elevated IFN-γ response in the Lck
creIL-4Rα
-/lox mice compared to the WT and
IL-4Rα
-/- mice since it has been established that IL-4/IL-13 can not only counter-
regulate Th1 responses but can also actually drive or facilitate the promotion of
Th1 responses (Alexander and McFarlane, 2008). Compared to the WT control,
reduced  IL-10  production  of  ConA  stimulated  splenocytes  was  evident  in  the
gene  deficient  mice but  IL-10  was  significantly  greater in the Lck
creIL-4Rα
-/lox
mice compared to the IL-4Rα
-/- mice at this stage. The elevated IL-10 levels in
the Lck mice compared to the IL-4Rα
-/- mice may have occurred as a result of
the significantly elevated IFN-γ response observed at that time which required a
greater suppressive action of the proinflammatory responses. IL-10 is known as
an  anti-inflammatory  cytokine that  plays  an  important  role  in  regulating
proinflammatory responses in malaria (Niikura et al., 2011). In contrast to the
WT  and  IL-4Rα
-/-  groups,  Lck
creIL-4Rα
-/lox  mice  demonstrated  reduced  IL-4
cytokine production upon ConA stimulation but IgG1 antibody levels were still
significantly higher in this group. These findings suggest an alternative route of
IL-4  production  from  non-CD4
+  Th2  cells  resulting  in  B-cell  activation  of  IgG1
humoral responses. Furthermore, another explanation for the presence of a mild
Th2  antibody  response  is  the  role  of  CD8
-  DCs.  These  DCs  can  induce  the
proliferation of MSP-1 specific transgenic CD4
+ T-cells and thereby induce IL-4
and IL-10 production as investigated previously (Sponaas et al., 2006).
Upon termination of the experiment, at day 48, the immunological response in
the gene-deficient mice yielded a greater Th1-type response. A marked IFN-γ
increase following ConA stimulated splenocytes in the Lck
creIL-4Rα
-/lox mice was
still evident compared to the WT control and IL-4Rα
-/- mice. However, this was
reduced  upon  antigen-specific  stimulation.  Th2-type  responses  in  the  gene-
deficient mice were significantly impaired characterized by reduced IL-10 and
IL-4  production  following  ConA  stimulated  splenocytes  corresponding  to
significantly  reduced  IgG1  antibody  levels.  The  importance  of  IL-10  as  a
regulatory cytokine due to its anti-inflammatory capabilites as mentioned before141
(Niikura et al., 2011) again provides additional evidence that the reduced IL-10
levels observed coincided with the increased IFN-γ response. As a result of the
abrogation  of  IL-4Rα  signalling  in  IL-4Rα
-/-  and  Lck
creIL-4Rα
-/lox  mice,  the
immunological response was biased toward a Th1 phenotype but which failed to
adequately provide complete protection in these gene-deficient mice. Together,
these  findings  indicate  that  due  to  a  dysregulated  Th2  protective  immune
response, the IL-4Rα
-/- and Lck
creIL-4Rα
-/lox mice are increasingly susceptible to
the infection. In conclusion, we demonstrate that a major role exists for CD4
+ T-
cell responsiveness to IL-4 during chronic murine malaria disease.
Findings in the present study have for the first time, provided evidence for the
importance of IL-4Rα signalling on CD4
+ T-cells during chronic murine malaria
disease.  We  show  that  initial  control  of  acute  infection  relies  on
proinflammatory  Th1-type  responses,  which  have  been  well  documented  and
supported by our data. However, during the chronic stage, it is clear from the
data  presented here  that  Th2-type  responses  are  necessary  for  adequate
protection  but  mainly  dependent  on  IL-4Rα  activated  CD4
+  T-cells.  In  various
infectious  disease  models,  the  effects  of  IL-4  responsive  CD4
+  T-cells  do  not
always  provide  resistance  to infection  but  rather  increases  susceptibility.  For
example, in a more recent study by Bryson and colleagues where they infected
Lck
creIL-4Rα
-/lox  mice  with L. mexicana,  it  was demonstrated  that  these  mice
developed  small  lesions  that  subsequently  healed  indicating  that  progressive
infection was dependent on CD4
+ T-cell responsive to IL-4 (Bryson et al., 2011).
Similarly,  during L.  major  infection  of  Lck
creIL-4Rα
-/lox  mice,  mice  were
completely resistant to infection indicating no role for protection from CD4
+ T-
cells responsive to IL-4 (Dewals et al., 2009, Radwanska et al., 2007).
These novel findings within a murine model of malaria infection have provided
some insight into the mechanisms governing Th2 immunity during chronic-stage
P.  chabaudi  AS  infection.  We next  (Chapter  7)  wanted  to  extend  our
investigation further by looking at the effects of abrogation of IL-4Rα signalling
on all T-cell populations in our model. With the availability of CD4
+CD8
+ T-cell
IL-4Rα-deficient (iLck
creIL-4Rα
-/lox) mice, we were able to determine whether
IL-4Rα–dependent  pathways  of  CD4
+CD8
+  T-cell  activation was  required  for
protective immunity during the chronic stage of P. chabaudi AS infection.142
Chapter Seven
The  role  of  IL-4Rα  signalling  on  CD4
+ and CD8
+  T-cells  during
Plasmodium  chabaudi  AS  erythrocyte  infection  in  BALB/c  female
mice.143
7.1 Abstract
The  role  of  IL-4Rα  signalling  via  CD4
+  and CD8
+  T-cell  populations  during P.
chabaudi AS infection was determined using a novel mouse model lacking the IL-
4Rα  expression  specifically  on  all  T-cells  (iLck
creIL-4Rα
-/lox). Here,  we
demonstrate that iLck
creIL-4Rα
-/lox mice infected with P. chabaudi AS were not as
susceptible  to  infection  as  IL-4Rα
-/-  mice  as  measured  by  survival  and
recrudescent  infections  during  the  course  of  the  experiment.  In  addition,
iLck
creIL-4Rα
-/lox mice  had  comparable  parasitaemia  levels  to  the  WT  control
throughout the infection. Significant weight loss was obtained in the iLck
creIL-
4Rα
-/lox  mice  at  day  22  with  increased  anaemia  observed  at  days  17  and  22
compared  to  the  IL-4Rα
-/-  mice.  Interestingly,  splenomegaly  was  significantly
lower  in  the  iLck
creIL-4Rα
-/lox mice  at  days  10  and  17  but  then  significantly
increased at day 48 compared to the WT and IL-4Rα
-/- mice. The immunology of
infection in iLck
creIL-4Rα
-/lox mice was characterized by an early Th1 phenotype
as  measured  by  splenic  IFN-γ  and  increased  serum  IgG2a antibody  titres,
similarly found in the IL-4Rα
-/- mice. Subsequently, during the latter part of the
infection, Th2 responses were impaired with significantly reduced splenic IL-4
and IL-10 cytokine production in both gene-deficient mice compared to the WT
control.  Although,  no  mortalities  were  observed in the iLck
creIL-4Rα
-/lox  mice,
there was some evidence of a delayed impaired Th2-type immune response in
these mice. In conclusion, the results indicated that iLck
creIL-4Rα
-/lox mice were
more resistant to infection compared to the IL-4Rα
-/- mice but still displayed a
diminished  Th2  protective  immune  response  compared  with  WT  mice  later  in
infection.144
7.2 Introduction
It  is  well  established  that  immunity  against  the  pre-erythrocytic  stages  of
Plasmodium infection depends on CD8
+ T-cell responses (Lundie et al., 2008,
Good and Doolan, 1999).  On the contrary, immunity to the erythrocytic stages is
largely dependent on CD4
+ T-cell and humoral responses. Although CD8
+ T-cells
were shown to not protect against erythrocytic stages of infection, evidence in
murine models have indicated that CD8
+ T-cells contribute to the pathology of
experimental cerebal malaria (ECM) (Lundie et al., 2008, Renia et al., 2006).
IL-4 is a crucial mediator of CD4
+ Th2 cell differentiation and suppression of
IFN-γ producing CD4
+ Th1 cells (de Sa Pinheiro et al., 2007, Nelms et al., 1999).
This cytokine also plays a pivotal role in the differentiation of B-cells controlling
the specificity of IgG class switching and the development of memory B-cells.
Several studies have also indicated that IL-4 helps to sustain the growth and
prolongs survival of CD4
+ T and B-cells (Nelms et al., 1999). Furthermore, IL-4
modulates important functions of CD8
+ T-cells, which compared with CD4
+ T-
cells  undergo  distinct  differentiation  pathways  and  exhibit  vastly  different
functional  properties.  Previous in  vitro  studies  have  described  a  number  of
effects  of  IL-4  on  CD8
+  T-cells  including  the  induction  of  IL-4  secretion  and
enhancement of IL-2 induced proliferation (Kienzle et al., 2002, Miller et al.,
1990, Acres et al., 1988). Further studies have suggested a role for IL-4 in the in
vitro  development  of  cytotoxic  T-cells  (Trenn et  al.,  1988,  Palacious et  al.,
1987) and some studies indicated that IL-4 could decrease cytolytic activity in
vitro (Falchetti et al., 1996). IL-4 was also shown to be necessary for the in vitro
generation  of  memory  CD8
+  T-cells  (Huang et  al.,  2000).  de  Sa  Pinheiro  and
colleagues have revealed a role for IL-4 in the generation of memory CD8
+ T-cells
against the pre-erythrocytic stages of the parasite in a P. yoelii mouse model
using  parasite-specific  transgenic  CD8
+  T-cells  (de  Sa  Pinheiro et  al.,  2007).
Using IL-4R
-/- mice, they demonstrated that IL-4 acts directly on activated anti-
parasitic  CD8
+  T-cells  through  the  IL-4R  and  promote  the  survival  of  memory
CD8
+ T-cells (de Sa Pinheiro et al., 2007).145
The  generation  of  macrophage/neutrophil IL-4Rα  deficient  (LysM
creIL-4Rα
-/lox)
mice in chapter 5 has shown that the alternate activation of macrophages was
not  a  requirement  for  chronic  protective  immunity  during P.  chabaudi  AS
infection. Furthermore, the utilization of CD4
+ T-cell specific IL-4Rα
-/- mice has
demonstrated  a  significant  role  for  IL-4  signalling  via  CD4
+  T-cells  in  limiting
recrudescent  episodes  in  chronic  infections.  However,  CD8
+  T-cells  were  still
able  to  respond  to  IL-4  in  these  mice.  In  order  to  determine  whether  IL-4
signalling via CD8
+ T-cells also played a role in control, we studied the course of
P. chabaudi AS infection by utilizing iLck
creIL-4Rα
-/lox mice (Bryson et al., 2011,
Dewels et al., 2009) that had a pan T-cell deletion of IL-4Rα.146
7.3 Results
7.3.1 Comparison of the survival rates and disease phenotypes of wild-type
(WT), CD4
+CD8
+ T-cell IL-4Rα-deficient (iLck
creIL-4Rα
-/flox) and global IL-4Rα-
deficient (IL-4Rα
-/-) female mice following Plasmodium chabaudi AS infection.
WT  and  iLck
creIL-4Rα
-/lox  mice  survived  the  acute  stage  infection  with  no
mortalities observed whereas the IL-4Rα
-/- mice displayed an enhanced mortality
rate of 17% at day 12 post infection, as shown previously in chapter 4, (Figure
4.1). During the chronic-stage infection, 17% mortality was observed in the WT
mice on day 33 and again the majority of deaths were observed in the IL-4Rα
-/-
mice  at  day  36,  33%  mortality  (Figure  7.1).  In  contrast,  no  fatalities  were
observed in the iLck
creIL-4Rα
-/lox mice during the course of the study (Figure 7.1).
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Figure 7.1: Comparison of the survival rates of P. chabaudi AS infection in WT
(IL-4Rα
lox/-), IL-4Rα
-/- and iLckM
creIL-4Rα
-/flox female mice on a BALB/c background.
WT (IL-4Rα
lox/-) n=9, IL-4Rα
-/- n=6 and iLck
creIL-4Rα
-/lox n=7.147
Parasite burden at day 3 was significantly higher in the WT and iLck
creIL-4Rα
-/lox
mice compared  to  IL-4Rα
-/-  mice  (Figure  7.2)  while peak  infection  (day  7)
showed no significant differences between the groups (Figure 6.2). Furthermore,
no  significant  differences in  parasite  load  occurred  between  the  WT  and
iLck
creIL-4Rα
-/lox mice throughout the duration of the disease. Only the IL-4Rα
-/-
mice demonstrated significantly greater recrudescent parasitaemias during the
course of the disease (Figure 7.2).
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Figure  7.2: Comparison  of  the  disease  parasitaemias  of P.  chabaudi AS  infection  in  WT  (IL-
4Rα
lox/-),  IL-4Rα
-/- and  iLck
creIL-4Rα
-/lox  female  mice  on  a  BALB/c  background.  Results  are
displayed as a (A) % and as a (B) log % of parasitaemia levels in these groups. n=6. * denotes
p<0.05.148
Non-infected mice showed a steady weight gain over the 48 day period (Figure
7.3, A). Maximal weight loss in the infected IL-4Rα
-/- mice was reached earlier at
day  10  compared  to  the  infected  WT  and  iLck
creIL-4Rα
-/lox mice  which
demonstrated maximal weight loss at day 12 (Figure 7.3, A). Following recovery,
all mice showed an increase in weight while a significant increase in weight was
only observed in the WT and iLck
creIL-4Rα
-/lox mice when compared to the
IL-4Rα
-/- mice at day 22 (Figure 7.3, A).
Contrary to non-infected mice, severe anaemia was reached in all groups at day
10 post-infection with a significant drop in RBC counts (Figure 7.3, B). At day 10
of the peak infection, no differences in RBC counts were observed between the
groups.  However,  at  day  12,  RBC  counts  were  significantly  reduced  in  the
iLck
creIL-4Rα
-/lox mice compared to the WT control and IL-4Rα
-/- mice (Figure 7.3,
B).  Following  parasite  control  during  the  latter  stage  of  the  infection,  a
significant  increase  in  RBC  count  was  observed  in  the  iLck
creIL-4Rα
-/lox mice
compared  to  the IL-4Rα
-/- mice  on  day  14  while  no  significant  differences
occurred  between  the  WT  and  iLck
creIL-4Rα
-/lox mice  (Figure  7.3,  B).
Furthermore, the RBC count then dropped in the iLck
creIL-4Rα
-/lox mice on days
17 and 22 compared to the IL-4Rα
-/- mice (Figure 7.3, B) but seemed to level off
in all the groups as time progressed (Figure 7.3, B).149
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Figure 7.3: Comparison of (A) weight loss and (B) malaria induced anaemia during the course of
P.  chabaudi AS  infection  in  WT  (IL-4Rα
lox/-),  IL-4Rα
-/-  and  iLck
creIL-4Rα
-/flox  female  mice  on  a
BALB/c background. WT (IL-4Rα
lox/-) n=5-9, IL-4Rα
-/- n=6 and iLck
creIL-4Rα
-/flox n=7. Results are a
representative of two separate experiments. * denotes p<0.05.150
7.3.2 The influence of chronic disease on splenomegaly in CD4
+CD8
+ T-cell
IL-4Rα-deficient (iLck
creIL-4Rα
-/lox) female BALB/c mice infected with
Plasmodium chabaudi AS.
Whole spleen weights of non-infected and infected WT, IL-4Rα
-/- and
iLck
creIL-4Rα
-/lox mice were measured to determine the severity of splenomegaly
during the course of P. chabaudi AS infection between the respective groups. It
was apparent that P. chabaudi AS parasite directly causes splenomegaly in the
infected WT and IL-4Rα
-/- groups compared to non-enlarged spleens observed in
the  non-infected  mice  throughout  the  duration  of  the  disease  (Figure  7.4).
Interestingly, no increase in whole spleen weight was observed in the infected
iLck
creIL-4Rα
-/lox mice compared to the non-infected group at day 10 (Figure 7.4,
A) whilst a significant increase was seen in the infected WT and IL-4Rα
-/- groups.
As  the  infection  progressed,  all  infected  groups  demonstrated  splenomegaly
compared  to  non-infected  mice  at  day  17  post-infection  (Figure  7.4,  B).
However,  iLck
creIL-4Rα
-/lox  mice  again  showed  a  significant  decrease  in  whole
spleen weight when compared to the infected WT and IL-4Rα
-/- mice (Figure 7.4,
B).  Furthermore,  at  day  48,  no  significant  difference  in  the  severity  of
splenomegaly was observed between the infected WT control and IL-4Rα
-/- mice
but a striking increase was observed in the iLck
creIL-4Rα
-/lox group at this time
(Figure 7.4, C).151
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Figure 7.4: Comparison of the whole spleen tissue weights of non-infected and P. chabaudi AS
infected WT (IL-4Rα
lox/-), IL-4Rα
-/- and iLck
creIL-4Rα
-/lox female mice on a BALB/c background on
(A) day 10 (B) day 17 and (C) day 48. n=5-8. * Infected vs non-infected mice and
# iLck
creIL-4Rα
-/flox vs WT (IL-4Rα
lox/-) and IL-4Rα
-/- mice. *and
#denotes p<0.05.152
7.3.3 Comparison of the splenic cytokine production in wild-type (WT), global
IL-4Rα-deficient (IL-4Rα
-/-) and CD4
+CD8
+ T-cell IL-4Rα-deficient
(iLck
creIL-4Rα
-/lox) female  BALB/c mice  following Plasmodium  chabaudi  AS
infection.
IFN-γ production, was significantly reduced by WT derived splenocytes following
ConA  stimulation  from  day  10  infected  mice  compared  to  the  gene-deficient
mice (Figure 7.5, A). On the other hand, IFN-γ production from ConA stimulated
splenocytes was significantly lower in the iLck
creIL-4Rα
-/lox group compared to
the IL-4Rα
-/- mice (Figure 7.5, A). IL-12 production was comparable between the
groups with no striking differences (Figure 7.5, B). Th2 biased IL-10 cytokine
levels were significantly greater in the WT derived splenocytes stimulated with
ConA compared to gene-deficient mice derived splenocytes (Figure 7.6, A) while
IL-4  production  demonstrated  no  significant  differences  between  the  groups
(Figure 7.6, B).
IFN-γ production, at day 17 post-infection, was significantly greater in the WT
and iLck
creIL-4Rα
-/lox ConA and antigen-specific stimulated splenocytes compared
to the IL-4Rα
-/- derived splenocytes (Figure 7.7, A). IL-12 production was only
observed in the WT and iLck
creIL-4Rα
-/lox stimulated splenocytes and was below
the sensitivity of the sensitivity of the ELISA in the IL-4Rα
-/- derived splenocytes
(Figure  7.7,  B). No  significant  differences  in  IL-10  production  was  observed
between the groups (Figure 7.8, A) while IL-4 production from ConA stimulated
splenocytes of IL-4Rα
-/- mice were significantly greater than the WT and
 iLck
creIL-4Rα
-/lox stimulated splenocytes (Figure 7.8, B).
At day 48, WT and iLck
creIL-4Rα
-/lox mice displayed significantly increased IFN-γ
production  from  ConA  stimulated  splenocytes  compared  to  the IL-4Rα
-/- mice
whilst  IFN-γ  production  from  antigen-specific  stimulated  IL-4Rα
-/-  derived
splenocytes was significantly increased compared to the WT and iLck
creIL-4Rα
-/lox
derived splenocytes (Figure 7.9, A). IL-12 production was not significant although
it seemed greater in the IL-4Rα
-/- mice (Figure 7.9, B). WT and gene-deficient
mice displayed comparable IL-10 production following ConA stimulation but IL-10
production were significantly greater in the WT and IL-4Rα
-/- derived splenocytes
stimulated  with antigen  compared  to  the  iLck
creIL-4Rα
-/lox derived  splenocytes153
(Figure 7.10, A). Furthermore, IL-4 production from ConA stimulated splenocytes
was significantly reduced in the gene-deficient mice compared to the WT control
(Figure 7.10, B). In addition, IL-4 was significantly elevated in the
iLck
creIL-4Rα
-/lox  derived  splenocytes  following  ConA  and  antigen-specific
stimulation compared to the IL-4Rα
-/- mice (Figure 7.10, B).154
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Figure 7.5: Comparison of day 10 splenic (A) IFN-γ and (B) IL-12 production in P. chabaudi AS
infected WT (IL-4Rα
lox/-), IL-4Rα
-/- and iLck
creIL-4Rα
-/flox female mice on a BALB/c background.
n=4-5. ND indicates not detected within the standard curve range of the ELISA. * denotes p<0.05.155
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Figure 7.6: Comparison of day 10 splenic (A) IL-10 and (B) IL-4 production in P. chabaudi AS
infected WT  (IL-4Rα
lox/-),  IL-4Rα
-/- and iLck
creIL-4Rα
-/flox female mice on a BALB/c background.
Results  are  a  representative  of  two  separate  experiments, n=5-9.  ND  indicates  not  detected
within the standard curve range of the ELISA. * denotes p<0.05.156
A.
     IFN- (D17)
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100
g)

AS Ag (200
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100
g)

AS Ag (200
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100
g)

AS Ag (200
0.0
0.2
0.4
0.6
0.8
1.0
8
16
24
32
40
48
WT (IL-4R
lox/-)
IL-4R
-/-
iLck
creIL-4R
-/lox
ND ND ND ND ND ND
*
n
g
/
m
l
   B.
     IL-12 (D17)
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100
g)

AS Ag (200
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100
g)

AS Ag (200
Negative
ConA
g)

RBC Ag (100
g)

RBC Ag (200
g)

AS Ag (100
g)

AS Ag (200
0
1
2
3
IL-4R
-/-
iLck
creIL-4R
-/lox
WT (IL-4R
lox/-)
ND
n
g
/
m
l
Figure 7.7: Comparison of day 17 splenic (A) IFN-γ and (B) IL-12 production in P. chabaudi AS
infected WT (IL-4Rα
lox/-), IL-4Rα
-/- and iLck
creIL-4Rα
-/flox female mice on a BALB/c background.
n=5-9. ND indicates not detected within the standard curve range of the ELISA. * denotes p<0.05.157
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Figure 7.8 Comparison of day 17 splenic (A) IL-10 and (B) IL-4 production in P. chabaudi AS
infected  WT  (IL-4Rα
lox/-),  IL-4Rα
-/-  and  iLck
creIL-4Rα
-/lox female  mice  on  a  BALB/c  background.
n=5-9. ND indicates not detected within the standard curve range of the ELISA. * denotes p<0.05.158
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Figure 7.9 Comparison of day 48 splenic (A) IFN-γ and (B) IL-12 production in P. chabaudi AS
infected  WT  (IL-4Rα
lox/-),  IL-4Rα
-/-  and  iLck
creIL-4Rα
-/lox female  mice  on  a  BALB/c  background.
n=5-9. ND indicates not detected within the standard curve range of the ELISA. * denotes p<0.05.159
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Figure 7.10: Comparison of day 48 splenic (A) IL-10 and (B) IL-4 production in P. chabaudi AS
infected WT (IL-4Rα
lox/-), IL-4Rα
-/-and iLck
creIL-4Rα
-/lox female mice on a BALB/c background.
n=5-9. ND indicates not detected within the standard curve range of the ELISA. * denotes p<0.05.160
7.3.4 Comparison  of  the  serum  IgG2a  and  IgG1  antibody  responses  of
CD4
+CD8
+  T-cell IL-4Rα-deficient  (iLck
creIL-4Rα
-/lox)  female  BALB/c  mice
following Plasmodium chabaudi AS infection.
Peak  infection  at  day  10  demonstrated  no  significant  differences  in  Th1-type
(IgG2a) antibody levels in the respective groups (Figure 7.11, A). A day 17 of the
infection, IgG2a antibody levels were significantly increased in the WT and
iLck
creIL-4Rα
-/lox mice compared to the IL-4Rα
-/- mice (Figure 7.11, B). However,
at day 48, the IgG2a antibody levels were significantly reduced in the WT and
iLck
creIL-4Rα
-/lox mice compared to the IL-4Rα
-/- mice (Figure 7.11, C).
Th2 associated antibody levels, namely IgG1, at day 10 of the primary infection
was comparable between the groups (Figure 7.12, A).  At day 17 post infection,
IgG1 antibody levels were significantly increased in the WT control compared to
the gene-deficient mice and, IL-4Rα
-/- mice demonstrated greater IgG1 levels
compared to the iLck
creIL-4Rα
-/lox mice (Figure 7.12, B). Contrary to day 17, at
day 48 of the infection, IgG1 antibody levels were then significantly increased in
the WT and iLck
creIL-4Rα
-/lox mice compared to the IL-4Rα
-/- mice (Figure 7.12,
C).161
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Figure 7.11: Comparison of the IgG2a antibody responses of P. chabaudi AS infected WT
(IL-4Rα
lox/-), IL-4Rα
-/- and iLck
creIL-4Rα
-/lox female mice on a BALB/c background on (A)
day 10 (B) day 17 and (C) day 48. n=5-8. * denotes p<0.05.162
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Figure 7.12: Comparison of the IgG1 antibody responses of P. chabaudi AS infected WT
(IL-4Rα
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7.4 Discussion
Our understanding of how cell-specific IL-4Rα signalling co-ordinates Th2 type
immunity in malaria is relatively poor. Transgenic mouse models with the IL-4Rα
expression disrupted in defined cell populations have provided a valuable tool to
addressing our understanding of the signalling pathways and has highlighted key
cellular players in the control of infections where Th2 effector responses are
involved (Dewals et al., 2009). While IL-4 mediates multiple effects on T-cells,
murine  T  and  B  cells  do not  respond  to  IL-13  (Mohrs et  al.,  2000).  We  have
shown in the first instance that cell specific IL-4Rα
-/- mice demonstrated that
aaMac  were  not  crucial  for  protection  against  the  long-term  effects  of P.
chabaudi AS infected female BALB/c mice. Secondly, we provided evidence that
CD4
+ T-cells responsive to IL-4 played a significant protective role during chronic
disease.  We subsequently generated  a  mouse  specifically  impaired  for  IL-4Rα
expression  on  all  T-cell  populations  (iLck
creIL-4Rα
-/lox)  and  these  mice  were
compared  with  IL-4Rα
-/-  mice  after P.  chabaudi  AS  infection.  The  results
demonstrated  that  the  iLck
creIL-4Rα
-/lox  mice  were  not as  susceptible  to  the
infection as the IL-4Rα
-/- mice and displayed a similar disease phenotype to the
WT  controls.  However,  significant  weight  loss  and  reduced  RBC  counts  were
evident in the iLck
creIL-4Rα
-/lox mice compared to the IL-4Rα
-/- mice following the
patent parasitaemia suggesting a possible delayed response in this group.
The  immunological  profile  at  day  10  of  the  infection  showed  a  typical  Th1
response  in  both  gene-deficient  mice  which  was  significantly  enhanced
compared to the WT control as measured by increased splenic IFN-γ production.
Collectively,  these  data  support  previous  findings  in  which  Th1  responses  are
necessary  for  destroying  patent  parasitaemia  (Hafalla et  al.,  2011,  Taylor-
Robinson and Phillips, 1994). The significantly elevated splenic IFN-γ response in
the gene-deficient mice could be a result of an elevated innate proinflammatory
response.  The  significance  of  IFN-γ  as  a  key  role  player  in  early  protection
against  parasitaemia  in  humans  was  also  demonstrated  in  an in  vitro  model
exposing peripheral blood mononuclear cells (PBMCs) to P. falciparum infected
RBC (Hafalla et al., 2011, Artavanis-Tsakonas and Riley, 2002).164
Progression of the infection maintained protective Th1 responses in the
iLck
creIL-4Rα
-/lox  mice  by  day  17  with  increased  IgG2a  Ab  titres.  Splenic  IL-10
production was produced in all groups at this time and could have facilitated the
balance between Th1 pro-inflammatroy and anti-inflammatory responses. By day
48,  Th2  cytokine  responses  were  impaired  in  both  gene-deficient  groups  as
measured  by  reduced  IL-4  splenic  cytokine  production  compared  to  the  WT
control.  However,  at  day  48,  IL-4Rα
-/-  mice  demonstrated  elevated  levels  of
antigen-specific splenic IL-10 production compared to the iLck
creIL-4Rα
-/lox mice
suggesting  that  downregulaton  of  pro-inflammatory  responses  could  result  in
recurring parasitaemia, hence recrudescent infection observed in the IL-4Rα
-/-
mice. The role of anti-inflammatory cytokines (TGF-β and IL-10) was shown to
down-regulate the protective and potentially detrimental defence mechanisms
once  peripheral  parasitemia  has  been  brought  under  control.  This  delicate
balance between pro-inflammatory and anti-inflammatory responses appears to
be  a  major  determinant  of  the  clinical  outcome  of  a Plasmodium infection.
Studies  in  murine  malaria  suggest  an  important  role  for  TGF-β and  IL-10  in
regulating the overproduction of IFN-γ and TNF-α during erythrocytic infections
(Hafalla et al., 2011, Stevenson and Riley, 2004). Furthermore, in P. chabaudi
infection,  it  has  been  shown  that  IL-10  production  from  Tr1  and  Treg  are
associated  with  suppression  of  proinflammatory  cytokine  production  and
expansion of pathological Th1 responses (Niikura et al., 2011).
At  day  48,  in  the  iLck
creIL-4Rα
-/lox  mice,  increased IFN-γ,  reduced  IL-10  and
increased IL-4 splenic cytokine production was observed compared to the
IL-4Rα
-/-  mice.  However, a  Th1  immune  response  was  consistent  in  the  gene-
deficient mice, which resulted in detrimental effects in the IL-4Rα
-/- mice such
as increased mortality and recrudescence, not so in the iLck
creIL-4Rα
-/lox mice.
Furthermore, the reduced IgG1 Ab titres at day 48 was only evident in the
IL-4Rα
-/- mice indicating that the increased IgG1 Ab titres seen in the
iLck
creIL-4Rα
-/lox mice, comparable to the WT control, may be due to non-T-cell
IL-4 dependent mechanism of B-cell stimulation. These novel findings indicate
that non-T-cells responsive to IL-4/IL-13 activation could have facilitated chronic
P. chabaudi AS protection in the iLck
creIL-4Rα
-/lox mice compared to the IL-4Rα
-/-
group independent of T-cell IL-4Rα signalling. In a more recent study by Dewals
and colleagues utilizing pan-T-cell IL-4Rα-deficient mice, the role of non-T-cells165
responsive  to  IL-4  was  described  and  its  differing  effects  on  the  outcome  of
parasitic infections (Dewals et al., 2009). They showed that L. major infected
Lck
creIL-4Rα
-/lox  and  iLck
creIL-4Rα
-/lox  mice  developed  a  healer  phenotype  thus
implicating  a  role  for  IL-4Rα-responsive  non-T-cells  in  providing  protection
(Dewals et  al.,  2009).  On  the  contrary, S.  mansoni  infected Lck
creIL-4Rα
-/lox
mice, survived the infection while iLck
creIL-4Rα
-/lox mice succumbed to infection
indicating  that  IL-4Rα-responsive  non-CD4
+  T-cells  contribute  to  protection
(Dewals et al., 2009).
An  interesting  observation  occurred  when  measuring  whole  spleen  organs  for
comparison since splenomegaly is a clinical sign of chronic malarial disease. The
spleen  consists  of  micro-anatomical  zones  and  microcirculations  adapted  to
performing  different  functions  from  the  induction  of  adaptive  immunity,
recycling  of  iron  and  phagocytosis  of  erythrocytes  as  well  as  destruction  of
damaged or infected RBCs and pathogens including Plasmodium (del Portillo et
al., 2011). Spleen size has been used for many years as a tool to determine the
intensity of malaria transmission in endemic regions (del Portillo et al., 2011,
Chaves et al., 2011, Snow et al., 1989, Neva et al., 1970). During blood-stages
of malaria infection, the spleen is the main organ involved in the development
of the immune response and in elimination of iRBCs (del Portillo et al., 2011,
Engwerda et al., 2005). Splenomegaly develops when the infection persists or
when there is insufficient time to fully resolve the infection (Wilson et al., 2009,
Greenwood,  1987).  The  WT  control  and  IL-4Rα
-/-  mice  displayed  comparable
enlarged  spleens  while  iLck
creIL-4Rα
-/lox  mice  initially  displayed  significantly
smaller spleens than the WT and IL-4Rα
-/- mice. However, upon termination of
the experiment, iLck
creIL-4Rα
-/lox mice displayed significantly larger spleens than
the WT and IL-4Rα
-/- mice suggesting that splenomegaly was more pronounced in
the  iLck
creIL-4Rα
-/lox  mice  during  long-term  infection.  It  seems  that  in  the
absence of IL-4Rα signalling via T-cells, splenomegaly is delayed. However, this
was  not  the  case  in  the  IL-4Rα
-/-  mice,  which  would  suggest  that  non-T-cell
populations responding to IL-4/IL-13 are involved in delaying this phenomenon.
The role of the spleen in normal and pathological conditions caused by malaria
infection is still  to  be elucidated  but  recent  advances  in  bioengineering  and
microfluidics are paving the way to construct 3D organs-on-a chip, including the
spleen (Baker, 2011, Deplaine et al, 2011, del Portillo et al., 2011).166
In conclusion, the results using pan T-cell gene-deficient mice were intriguing
and  require  further  investigation.  Unfortunately,  in  the  duplicate  experiment
there was an accident resulting in the loss of the tissue specific group. Due to
time  constraints  and  availability  of  the  tissue-specific  mice,  this  experiment
could  not  be  repeated.  However,  some  of  the  observations  were  of  great
significance.  For  example,  the  role  of  non-T-cells  responsive  to  IL-4/IL-13  in
chronic P. chabaudi AS protection and the concept of delayed splenomegaly in
the absence of IL-4Rα signalling on all T-cells require further investigation.167
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8. General Discussion
Early studies presented in this thesis demonstrated that P. chabaudi AJ infected
female  IL-4Rα
-/-  mice  were  more  susceptible  to  infection  than  their  WT
counterparts as determined by greater recrudescent parasitaemia and severity
of chronic infection. These results were similar to those previously obtained in
our group in which male gene-deficient BALB/c P. chabaudi AS infected mice
were  used  (Couper,  2003).  Our  findings  indicated  that  the  immunological
response during chronic infection was not parasite strain dependent. In addition,
similar results were observed in female mice to those previously using male mice
suggesting that the enhanced recrudescence observed in the IL-4Rα
-/- mice was
also independent of host gender. With the availability of the P. chabaudi AS
strain  we  were  then  able  to  investigate  the  role  of  IL-4Rα-signalling  in  the
original model described by Couper (2003). That is, male BALB/c mice infected
with P. chabaudi AS parasite. Consequently, our experiments indicated that IL-
4Rα
-/- male mice were extremely susceptible to the infection characterized by
high mortality and such severe pathology that the experiment studies on these
mice had to be terminated at day 14. Consequently, all further studies utilized
the more resistant female BALB/c gene-deficient mice infected with P. chabaudi
AS. The results obtained using the female P. chabaudi AS infection model were
in agreement with previous findings (Couper, 2003) and with that obtained in
using the AJ strain of P. chabaudi. Overall a significant role for IL-4Rα signalling
in providing protective immunity against P. chabaudi AS chronic infection was
confirmed, and required further investigation.
We have demonstrated that IL-4Rα plays a major protective role during chronic
P.  chabaudi  AS  infection  in  male  and  female  BALB/c  mice  and  that  IL-4Rα
-/-
mice, unlike their WT counterparts, were unable to effectively clear and control
chronic infection characterized by increased mortality, enhanced recrudescent
parasitaemia  and  an  impaired  Th2  immune  response.  However,  male  mice
succumbed to infection at a greater extent than the female mice, infected with
the same P. chabaudi AS parasite, possibly due to immunomodulatory effects of
sex hormones. The influence of testosterone on disease susceptibility has been
described before for malaria (Klein, 2008, 2004) and other parasitic infections
(Bryson et  al.,  2011).  Collectively,  the  present  data  provided  evidence  that
abrogation of IL-4Rα signalling on all cell types resulted in an impairment of the169
protective Th2 phenotype in the IL-4Rα
-/- mice. Furthermore, a similar overall
effect in the disease profile and immunological response was observed in the
male  and  female  IL-4Rα
-/-  mice  infected  with  either P.  chabaudi AS  or  AJ
parasites respectively and therefore chronic disease was not strain-specific or
host gender dependent.
Having established  a suitable model, the effect of IL-4Rα signalling on certain
cell types during chronic malaria disease was studied. Our understanding of how
cell-specific  IL-4Rα  signalling  coordinates  Th2  immunity  in  murine  malaria  is
relatively  poor  and  with  the  use  of  transgenic  mouse  models  with  IL-4Rα
expression disrupted in defined cell populations we have been able to identify
key cellular players involved in controlling parasite infections involving Th2-type
responses. These novel investigations described here for P. chabaudi AS infection
will  prove  useful  in  our  understanding  of  protective  immune  mediated
mechanisms during chronic disease.
In  the  first  instance,  we  wanted  to  investigate  the  possible  role  of  IL-4Rα
signalling on macrophages/neutrophils using macrophage/neutrophil-specific
IL-4Rα
-/-  (LysM
creIL-4Rα
-/lox)  mice. We  found  that long-term  protection  of
LysM
creIL-4Rα
-/flox mice infected with P. chabaudi AS did not require the presence
of IL-4/IL-13 activated macrophages as a similar disease profile in these mice
was shown compared with the WT control. Consequently, we suggested that the
increased susceptibility of IL-4Rα
-/- mice compared with WT mice must depend
on  IL-4Rα  signalling  on  cell  populations  other  than  macrophages/neutrophils.
However, these results were contrary to that shown by Couper (Couper, 2003).
He showed that LysM
creIL-4Rα
-/flox male mice displayed a similar disease course to
IL-4Rα
-/-  mice,  namely  an  impaired  Type  2  protective  immune  response,
compared to WT mice. Couper hypothesized that IL-4/IL-13 protection might be
via  regulation  of  macrophage/neutrophil  function.  The  major  difference
between the two studies was that Couper utilized male mice and the present
study female mice. Previous studies have shown that susceptibility to infection
and  immunological  differences  between  sexes  can  be  influenced  by  gender
differences (hormonal) when infected with the same parasite (Klein et al., 2008,
Klein, 2004). Immunomodulatory effects of testosterone was shown to increase
susceptibility and mortality following P. chabaudi or P. berghei infection (Klein,170
2004; Wunderlich et al., 1991; Kamis and Ibrahim, 1989) and recovery is delayed
in male mice compared to female mice (Klein, 2004). A recent study using cell-
specific IL-4Rα
-/- female mice infected with L. mexicana showed that these mice
developed small lesions, which subsequently healed and was associated with a
strong Th1 phenotype while the male mice developed small lesions that persisted
and  associated  with  a  strong  Th1  response  but  significantly  elevated  IL-4
production as well (Bryson et al., 2011). IL-4 production independently of IL-4Rα
signalling has been observed in a number of immunological studies previously
(Alexander et al., 2002, Brewer et al., 1999, Mohrs et al., 1999). The work by
Bryson and colleagues represent for the first time a sex-associated influence on
this ability (Bryson et al., 2011). Our current data have consequently supported
their findings regarding this sex associated influence and IL-4Rα signalling but in
a  model  of P.  chabaudi  AS  infection.  Taken  together,  our LysM
creIL-4Rα
-/lox
infection  model  demonstrated  no  significant  role  for  IL-4Rα  signalling  via
macrophages/neutrophils  in  providing  significant  protection  during  chronic P.
chabaudi AS infection.
We then investigated the role of CD4
+ T-cells responsive to IL-4Rα signalling in P.
chabaudi AS infection since CD4
+ T-cells have been shown to play a major role
during innate and adaptive immunity to malaria infection (Stephens et al., 2005,
Langhorne et al., 2002). We generated a mouse deficient in IL-4Rα function via
CD4
+ Tcells (Lck
creIL-4Rα
-/flox) only. Our studies demonstrated that initial control
in the Lck
creIL-4Rα
-/lox mice was associated with a Th1 phenotype characterized
by  splenic  IFN-γ  production  and  serum  IgG2a  antibody  responses.  Subsequent
Th1-Th2 control in the Lck
creIL-4Rα
-/lox mice around day 17 was demonstrated as
measured by increased splenic IFN-γ and IL-10 production and the induction of
serum IgG1 antibodies. During chronic infection, recrudescence was evident in
the Lck
creIL-4Rα
-/lox mice similar to the IL-4Rα
-/- mice accompanied by reduced
RBC count and increased mortality at days 36 and 40. Th2 responses were down-
regulated  in  the Lck
creIL-4Rα
-/lox and  IL-4Rα
-/-  mice  characterized  by  reduced
splenic  IL-10  and  IL-4  production,  increased  IFN-γ  from  ConA  stimulated
splenocytes and increased serum IgG2a antibody responses. The importance of
IL-10 as a regulatory cytokine with anti-inflammatory functions (Niikura et al.,
2011) provides additional evidence that the reduced IL-10 levels observed in the171
gene-deficient  mice  coincided  with  the  increased  IFN-γ  response  observed.
Consequently, due to abrogation of IL-4Rα signalling in IL-4Rα
-/- and
Lck
creIL-4Rα
-/lox mice, protective immunity was biased toward a Th1 phenotype
but which failed to adequately provide complete protection during the chronic
phase. Strikingly, mortality was significantly greater in the Lck
creIL-4Rα
-/lox than
in  the  IL-4Rα
-/-  mice. IL-4  responsive  CD4
+  T-cells  do  not  always  provide
protection but rather increases susceptibility to infection such as in L. mexicana
infection in which non-healing progressively growing lesions are associated with
a  biased  Th2  response  in  BALB/c  mice  (Bryson et  al.,  2011). Bryson  and
colleagues  infected  Lck
creIL-4Rα
-/lox  mice  with L.  mexicana  and  demonstrated
that these mice developed small lesions that subsequently healed indicating that
progressive infection was dependent on CD4
+ T-cell responsive to IL-4 (Bryson et
al.,  2011).  Similarly,  during L.  major  infection  of  Lck
creIL-4Rα
-/lox  mice,
resistance to infection was achieved implicating no role for protective immunity
from  CD4
+  T-cells  responsive to  IL-4  (Dewals et  al.,  2009,  Radwanska et  al.,
2007). In summary, our findings present for the first time evidence that
Lck
creIL-4Rα
-/lox together with IL-4Rα
-/- BALB/c mice were susceptible to chronic-
stage P.  chabaudi AS  infection  and  that  the  effector  functions  of  IL-4
responsiveness on CD4
+ T-cells were critical for the clearance and control of the
infection.
While a significant role for CD4
+ T-cells responsive to IL-4/IL-13 stimulation in
chronic P. chabaudi AS infection was demonstrated, we wanted to determine
whether this biological effect was reflected in CD4
+CD8
+ T-cell IL-4Rα
-/- mice
(iLck
creIL-4Rα
-/lox).  The  role  of  IL-4  in  induction  of  a  wide-spectrum  of
intracellular signalling cascades in CD8
+ T-cells has been described before but
only in a model of P. yoelii liver-stage infection (de Sa Pinheiro et al., 2007,
Carvalho et  al.,  2002). Carvalho and  colleagues  have previously revealed  a
crucial role for IL-4 in the generation of memory CD8
+ T-cell responses against
liver-stages  of  the  parasite  (Carvalho et  al.,  2002). de  Sa  Pinheiro  have
subsequently  extended  their  investigations  and  identified  signalling  pathways
activated by IL-4 on CD8
+ T-cells and showed that IL-4 has a strong in vivo and in
vitro anti-apoptotic effect on activated and resting CD8
+ T-cells (de Sa Pinheiro
et al., 2007). In the present study, contrary to the Lck
creIL-4Rα
-/lox mice, the
iLck
creIL-4Rα
-/lox mice  did  not  succumb  to  infection  and  displayed  a  similar172
disease profile to the WT controls compared to the IL-4Rα
-/- mice. However, Th1
responses remained dominant during acute infection and declining parasitaemia
but  Th2  responses  were  diminished  during  the  latter  part  of  infection.
Interestingly, splenomegaly was delayed in the iLck
creIL-4Rα
-/lox mice compared
to the WT and IL-4Rα
-/- mice suggesting that non-T-cell populations responding
to  IL-4/IL-13  are  involved  in  this  delayed  response.  Overall,  these  findings
suggest that non-T-cells responsive to IL-4/IL-13 activation could have facilitated
protection  in  chronic P.  chabaudi  AS  infection  in  the  iLck
creIL-4Rα
-/lox  mice
compared to the IL-4Rα
-/- group independent of T-cell IL-4Rα signalling. The role
of non-T-cells in providing protection was suggested in parasitic studies. It is
known  that  both  IL-4  and  IL-13  promote  CD40L-induced  IL-12  production  by
macrophages and DCs (Bullens et al., 2001). This could indicate that DCs may be
the  IL-4/IL-13  responsive  cells  facilitating  protection  against, for  example,
L.major  in  the  absence  of  IL-4Rα  responsive  CD4
+  T-cells  in  BALB/c  mice
(Radwanska et al., 2007).
To conclude, utilizing cell-type specific IL-4Rα
-/- mice we demonstrate that upon
infection  with P.  chabaudi  AS,  initial  control  is  dependent  on  innate type-1
responses followed by adaptive immunity. Progressive infection and control of
recrudescent parasitaemia is dependent on Th2 responses. Hence CD4
+ T-cells
responsive to IL-4Rα signalling seem to be vital and the dominant role-player in
providing protection during chronic disease. Furthermore, we present no role for
aaMø  in  providing  protection  in  our  female  model  utilizing  LysM
creIL-4Rα
-/lox
mice. Intriguingly alternative macrophage activation may provide protection in
male  mice  suggesting  the  effect  is  host  gender  determined  suggesting  a
significant effect of sex hormones on macrophages/neutrophil function. The role
for CD8
+ T-cells during blood-stage malaria infection is not well established as
has  been  documented  for  pre-erythrocytic  stage malaria infections  (de  Sa
Pinheiro et al., 2007, Carvalho et al., 2002). Consequently, we could speculate
that in the absence of IL-4Rα signalling on CD4
+ T-cells, IL-4 responsive CD8
+ T-
cells may play a role in exacerbation of the disease. Interesting results from the
CD4
+ and CD8
+ T-cell IL-4Rα
-/- mice demonstrate a role for non-T-cells dependent
on  IL-4Rα  responsiveness  in  providing  protection  in  the  infected  mice  and
require further investigation.173
Future studies focusing on the major role-players involved in chronic protection,
namely  CD4
+  T-cells  would  provide  in  depth  understanding  of  the  control  of
malarial  infection.  This  can  be  achieved by  focusing  on  IL-4Rα  expression on
CD4
+  T-cells,  whether  it  is  upregulated  during  infection  using  specialized
techniques  (FACs  analysis)  and  whether  upregulation  is  concomitant  with  the
Th1-Th2 switch. Secondly, if this evidence is true for CD4
+ T-cells then we are
able  to  manipulate  the  cytokine  environment  by  upregulation  of  IL-4/IL-13
production from CD4
+ T-cells to facilitate protection and clearance of chronic
blood-stage infection. Thirdly, establishing which non-T-cells responsive to IL-
4/IL-13 are involved in providing protection during the chronic stage of malaria
infection. Perhaps with the availability of non-T-cell IL-4Rα
-/- mice (DC and B-
cell  IL-4Rα
-/-  mice)  a  better  understanding  of  immune  mechanisms  mediating
protective immunity in malaria infections will be accomplished.174
ADDENDUM ONE
A.
B.
C.
Addendum 1 Figure: (A) Comparison of the course of P. chabaudi AS erythrocyte infection in
WT,  IL-4
-/-  and  IL-4Rα
-/-  male  mice.  Comparison  of (B) weight  loss  and (C)  malaria  induced
anaemia in WT, IL-4
-/- and IL-4Rα
-/- male mice during infection. Results are representative of (A)
3 and (B +C) 2 similar experiments.175
ADDENDUM TWO
Couper et al., 2008. The Journal of Immunology. 180: 5771-5777.176
REFERENCES
Abehsira-Amar, O., Gibert, M., Joliy, M., Thèze, J. And Jankovic, D. L. (1992).
IL-4 plays a dominat role in the differential development of Th0 into Th1 and
Th2 cells. J Immunol, 148 (12), 3820-9.
Achidi, E. A., Apinjoh, T. O., Mbunwe, E., Besingi, R., Yafi, C., Wenjighe, A. N.,
Ajua, A. and Anchang, J. K. (2008). Febrile status, malarial parasitaemia and
gastro-intestinal helminthiases in schoolchildren resident at different altitudes,
in south-western Cameroon. Ann Trop Med Parasitol, 102 (2), 103-18.
Acres, R. B., Widmer, M. B., Grabstein, K. H. and Gillis, S. (1988). Regulation of
human  T-cell  proliferation  and  CTL  development  by  human  recombinant
interleukin-4. Ann N Y Acad Sci, 532, 1-7.
Adachi, K., Tsutsui, H., Kashiwanura, S., Seki, E., Nakano, H., Takeuchi, O.,
Takeda, K., Okumura, K., Van Kaer, L., Okamura, H., Akira, S. and Nakanishi, K.
(2001). Plasmodium berghei infection in mice induces liver injury by an IL-12-
and toll-like receptor/myeloid differentiation factor 88-dependent mechanism. J
Immunol, 167 (10), 5928-34.
Akpogheneta, O. J., Duah, N. O., Tetteh, K. K., Dunyo, S., Lanar, D.E., Pinder,
M. and Conway, D. J. (2008). Duration of naturally acquired antibody responses
to blood-stage Plasmodium falciparum is age dependent and antigen specific.
Infect Immun, 76 (4), 1748-55.
Alexander, J., Carter, K. C., Al-Fasi, N., Satoskar, A. and Brombacher, F. (2000).
Endogenous  IL-4  is  necessary  for  effective  drug  therapy  against  visceral
leishmaniasis. Eur J Immunol. 30 (10), 2935-43.
Alexander, J., Brombacher, F., McGachy, H. A., McKenzie, A. N., Walker, W. and
Carter, K. C. (2002).  An essential  role for  IL-13  in  maintaining  a non-healing
response  following Leishmania  mexicana  infection. Eur  J  Immunol, 32  (10),
2923-33.
Alexander,  J. and  McFarlane,  E.  (2008). Can  type-1  responses  against
intracellular  pathogens  be  T  helper  2  cytokine  dependent? Microbes  and
Infection, 10, 953-959.177
Al-Yaman, F., Genton, B., Anders, R. F., Falk, M., Triglia, T., Lewis, D., Hii, J.,
Beck, H. P. and Alpers, M. P. (1994). Relationship between humoral response to
Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a
highly endemic area of Papua New Guinea. Am J Trop Med Hyg, 51, 593-602.
Amino, R., Giovannini, D., Thiberge, S., Gueirard, P., Boisson, B., Dubremetz, J.
F., Prevost, M. C., Ishino, T., Yuda, M. and Menard, R. (2008). Host cell traversal
is important for progression of the malaria parasite through the dermis to the
liver. Cell Host Microbe, 3 (2), 88-96.
Arnot, D. E. and Jensen, A. T. (2011). Antigenic variation and the genetics and
epigenetics  of  the  PfEMP1 erythrocyte surface antigens  in Plasmodium
falciparum malaria. Adv Appl Microbiol, 74, 77-96.
Artavanis-Tsakonas,  K.  and  Riley,  E.  M.  (2002).  Innate  immune  response  to
malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium
falciparum-infected erythrocytes. J Immunol, 169, 2956-2963.
Artavanis-Tsakonas, K., Tongren, J. E. and Riley, E. M. (2003). The war between
the malaria parasite and the immune system: immunity, immunoregulation and
immunopathology. Clin Exp Immunol, 133 (2), 145-52.
Bachmann, A., Esser, C., Petter, M., Predehl, S., von Kalckreuth, V., Schmiedel,
S., Bruchhaus, I. and Tannich, E. (2009). Absence of erythrocyte sequestration
and lack of multicopy gen family expression in Plasmodium falciparum from a
splenectomized malaria patient. PLoS ONE, 4, e7459.
Baird, J. K. (1995). Host age as a determinant of naturally acquired immunity to
Plasmodium falciparum. Parasitol Today, 11, 105-111.
Baker, M. (2011). Tissue models: a living system on a chip. Nature, 471, 661-
665.
Balmer,  P.,  Alexander,  J.  and  Phillips,  R.  S.  (2000).  Protective  immunity  to
erythrocytic Plasmodium  chabaudi  AS  infection  involves  IFN gamma-mediated
responses and a cellular infiltrate to the liver. Parasitology, 121 Pt 5, 473-482.178
Balmer, P., Phillips, H. M., Maestre, A. E., McMonagle, F. A. and Phillips, R. S.
(2000b). The effect of nitric oxide on the growth of Plasmodium falciparum, P.
chabaudi and P. berghei in vitro. Parasite Immunol, 22, 97-106.
Banchereau, J. and Steinman, R. M. (1998). Dendritic cells and the control of
immunity. Nature, 1998, 392 (6673), 245-52.
Banchereau,  J.,  Briere,  F.,  Caux,  C.,  Davoust,  J.,  Lebecque,  S.,  Liu,  Y.  J.,
Pulendran, B. and Palucka, K. (2000). Immunobiology of dendritic cells. Annu
Rev Immunol, 18, 767-811.
Bannister, L. and Mitchell, G. (2003). The ins, outs and roundabouts of malaria.
Trends Parasitol, 19, 209-213.
Barner, M., Mohrs, M., Brombacher, F. and Kopf, M. (1998). Differences between
IL-4R  alpha-deficient  and  IL-4-deficient  mice  reveal  a  role  for  IL-13  in  the
regulation of Th2 responses. Curr Biol, 8 (11), 669-72.
Baum, J., Richard, D., Healer, J., Rug, M., Krnajski, Z., Gilberger, T., Green, J.
L., Holder, A. A. and Cowman, A. F. (2006). A conserved molecular motor drives
cell invasion  and gliding  motility  across  malaria  life  cycle  stages  and  other
apicomplexan parasites. J Biol Chem, 281 (8), 5197-5208.
Belnoue, E., Kayibanda, M., Vigario, A. M., Deschemin, J. C., van Rooijen, N.,
Viguier, M., Snounou, G. and Rénia, L. (2002). On the pathogenic role of brain-
sequestered  alphabeta  CD8+  T  cells  in  experimental  cerebral  malaria. J
Immunol, 169 (11), 6369-75.
Belz, G. T., Shortman, K., Bevan, M. J. and Heath, W. R. (2005). CD8 alpha+
dendritic cells selectively present MHC class I-restricted noncytolytic viral and
intracellular bacterial antigens in vivo. J Immunol, 175 (1), 196-200.
Benten, W. P., Ulrich, P., Kühn-Velten, W. N., Vohr, H. W. and Wunderlich, F.
(1997). Testosterone-induced  susceptibility  to Plasmodium chabaudi  malaria:
persistence after withdrawal of testosterone. J Endocrinol, 153 (2), 275-81.179
Bereczky, S., Montgomery, S. M., Troye-Blomberg, M., Rooth, I., Shaw, M. A. and
Farnert,  A.  (2004).  Elevated  anti-malarial  IgE  in  asymptomatic  individuals  is
associated with reduced risk for subsequent clinical malaria. Int J Parasitol, 34,
935-942.
Bernasconi,  N.  L.,  Traggiai,  E.  and  Lanzavecchia,  A.  (2002).  Maintenance  of
seroligical memory by polyclonal activation of human memory B cells. Science,
298, 2199-2202.
Bernasconi,  N.  L.,  Onai,  N.  and  Lanzavecchia,  A.  (2003). A  role  for  Toll-like
receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive
B cells and constitutive expression in memory B cells. Blood, 101, 4500-4504.
Beutlar,  B.  and  Cerami,  A.  (1988). Tumour  necrosis  cachexia  shock  and
inflammation: a common mediator. Ann Rev Biochem, 57, 505-518.
Biedermann,  T.,  Zimmermann,  S., Himmelrich,  H.,  Gumy,  A.,  Egeter,  O.,
Sakrauski, A. K., Seegmüller, I., Voigt, H., Launois, P., Levine, A. D., Wagner,
H., Heeg, K., Louis, J. A and Röcken, M. (2001). IL-4 instructs TH1 responses and
resistance  to  Leishmania  major in  susceptible  BALB/c  mice. Nat  Immunol, 2,
1054-60.
Bogdan, C., Stenger, S., Rollinghoff,  M.  and Solbach, W.  (1993). Cytokine
interactions in  experimental  cutaneous  leishmaniasis.  Interleukin  4  synergizes
with interferon-gamma to activate murine macrophages for killing of Leishmania
major amastigotes. Eur. J. Immunol, 21, 327-333.
Brewer,  J., Conacher,  M., Hunter, M.  C., Mohrs, M., Brombacher,  F.  and
Alexander,  J. (1999).  Aluminium  hydroxide  adjuvant  initiates  strong  antigen
specifc Th2 responses in the absence of IL-4 and IL-13 mediated signaling. J.
Immunol, 163, 6448-54.
Brombacher, F., Arendse, B., Peterson, R., Hölscher, A. and Hölscher, C. (2009).
Analyzing  classical  and  alternative  macrophage  activation  in
macrophage/neutrophil-specific IL-4 receptor-alpha-deficient mice. Methods Mol
Biol, 531, 225-52.180
Brombacher,  F.  (2000). The  role  of  interleukin-13  in  infectious  diseases  and
allergy. Bioessays, 22, 646-656.
Brown, A. E., Webster, H. K., Teja-Isavadharm, P. and Keeratithakul, D. (1990).
Macrophage  activation  in falciparum malaria  as  measured  by  neopterin  and
interferon-gamma. Clin Exp Immunol, 82, 97-101.
Bryson, K.J., Millington, O. R., Mokgethi, T., McGachy, H. A., Brombacher, F.
and Alexander, J. (2011). BALB/c mice deficient in CD4
+ T cell IL-4Rα expression
control Leishmania mexicana load although female but not male mice develop a
healer phenotype. J PLoS Negl Trop Dis, 5(1), e930.
Bullens,  D.  M.,  Kasran,  A.,  Thielemans,  K.,  Bakkus,  M.  and  Ceuppens,  J.  L.
(2001). CD40L-induced IL-12 production is further enhanced by the Th2 cytokines
IL-4 and IL-13. Scand J Immunol, 53, 455-63.
Burns,  J.  M., Flaherty,  P.  R.  and  Nanavati,  P.  and  Weidanz,  W.  P.  (2004).
Protection against Plasmodium chabaudi malaria induced by immunization with
apical membrane antigen 1 and merozoite surface protein 1 in the absence of
gamma interferon or interleukin-4. Infect Immun, 72 (10), 5605-5612.
Calle,  J.  M.,  Nardin,  E.  H.,  Clavijo,  P.,  Boudin,  C.,  Stuber,  D.,  Takacs,  B.,
Nussenzweig, R. S. and Cochrane, A. H. (1992). Recognition of different domains
of  the Plasmodium  falciparum  CS  protein  by  the  sera  of  naturally  infected
individuals  compared  with  those  of  sporozoite-immunized  volunteers. J
Immunol, 149, 2695-2701.
Cambridge, G., Leandro, M. J., Edwards, J. C., Ehrenstein, M. R., Salden, M.,
Bodman-Smith,  M.  and  Webster,  A.  D. (2003).  Serologic  changes  following  B
lymphocyte  depletion  therapy  for  rheumatoid  arthritis.  Arthritis  Rheum,  48,
2146-2154.
Carvalho, L. H., Sano, G., Hafalla, J. C., Morrot, A., Curotto de Lafaille, M. A.,
Zavala, F. (2002) IL-4-secreting CD4+ T cells are crucial to the development of
CD8+T-cell responses against malaria liver stages. Nat Med, 8, 166–170.181
Cavacini, L. A., Parke, L. A. and Weidanz, W. P. (1990). Resolution of acute
malarial infections by T cell-dependent non-antibody-mediated mechanisms of
immunity. Infect Immun, 58, 2946-2950.
Cavanagh, D. R., Elhassan, I. M., Roper, C., Robinson, V. J., Giha, H., Holder, A.
A.,  Hviid,  L.,  Theander,  T.  G.,  Arnot,  D.  E.  and  McBride,  J.  S.  (1998).  A
longitudinal study of type-specific antibody responses to Plasmodium falciparum
merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol,
161 (1), 347-59.
Cavanagh,  D.  R.,  Dodoo,  D.,  Hviid,  L.,  Kurtzhals,  J.  A.,  Theander,  T.  G.,
Akanmori, B. D., Polley, S., Conway, D. J., Koram, K. and McBride, J. S. (2004).
Antibodies  to  the  N-terminal  block  2  of  Plasmodium  falciparum  merozoite
surface protein 1 are associated with protection against clinical malaria. Infect
Immun, 72 (11), 6492-502.
Cavinato, R. A., Bastos, K. R., Sardinha, L. R., Elias, R. M., Alvarez, J. M. and
d'Império  Lima,  M. R.  (2001). Susceptibility  of  the  different  developmental
stages of the asexual (schizogonic) erythrocyte cycle of Plasmodium chabaudi
chabaudi  to  hyperimmune  serum,  immunoglobulin  (Ig)G1,  IgG2a  and  F(ab')2
fragments. Parasite Immunol. 23 (11), 587-97.
Celada, A., Cruchaud, A. and Perrin, L. H. (1982). Opsonic activity of human
immune serum on in vitro phagocytosis of Plasmodium falciparum infected red
blood cells by monocytes. Clin Exp Immunol, 47, 635-644.
Celada, A. (2009). Macrophage biology: The regulation of gene expression. IRB
Barcelona Scientific Report. 70-74.
Chan,  M.  M.,  Evans,  K.  W.,  Moore,  A.  R.  and  Fong,  D. (2010).  Peroxisome
Proliferator-Activated Receptor  (PPAR):  Balance  for  survival  in  parasitic
infections. J Biomed Biotechnol, 2010, 828951.
Charles, C. K., Parikh, S., Sun, J. C., Myrick, A., Lanier, L. L., Rosenthal, P. J.
and DeRisi, J. L. (2008). Experimental malaria infection triggers early expansion
of natural killer cells. Infect Immun, 76 (12), 5873-5882.182
Chaves,  L.  F.,  Taleo,  G.,  Kalkoa,  M.  and  Kaneko,  A.  (2011).  Spleen  rates  in
children: an old and new surveillance tool for malaria elimination initiatives in
island settings. Trans R Soc of Trop Med and Hyg, 105, 226-231.
Choudhury, H. R., Sheikh, N. A., Bancroft, G. J., Katz, D. R. and De Souza, J. B.
(2000).  Early  nonspecific  immune  responses  and  immunity  to  blood-stage
nonlethal Plasmodium yoelii malaria. Infect Immun, 68, 6127-6132.
Claasen, A., Lloberas, J. and Celada, A. (2009). Macrophage activation: classical
versus alternative. Methods Mol Biol, 531, 29-43.
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. and Forster, I. (1999).
Conditional gene targeting in macrophages and granulocytes using LysMcre mice.
Transgenic Res, 8, 265-77.
Coban, C., Ishii, K. J., Kawai, T., Hemmi, H., Sato, S., Uematsu, S., Yamamoto,
M., Takeuchi, O., Itagaki, S., Kumar, N., Horii, T. and Akira, S. (2005). Toll-like
receptor  9  mediates  innate  immune  activation  by  the  malaria  pigment
hemozoin. J Exp Med, 201, 19-25.
Coban, C., Ishii, K. J., Uematsu, S., Arisue, N., Sato, S., Yamamoto, M., Kawai,
T., Takeuchi, O., Hisaeda, H., Horii, T. and Akira, S. (2006). Pathological role of
Toll-like receptor signaling in cerebral malaria. International Immunol, 19 (1),
67-79.
Cohen,  J.,  Nussenzweig,  V.,  Nussenzweig,  R.,  Vekemans,  J.  and  Leach,  A.
(2010). From the circumsporozoite protein to the RTS, S/AS candidate vaccine.
Hum Vaccin, 6 (1), 90-6.
Colonna, M., Pulendran, B. and Iwasaki, A. (2006). Dendritic cells at the host-
pathogen interface. Nat Immunol, 7, 117-120.
Conway, D. J., Cavanagh, D. R., Tanabe, K., Roper, C., Mikes, Z. S., Sakihama,
N., Bojang, K. A., Oduola, A. M., Kremsner, P. G., Arnot, D. E., Greenwood, B.
M. and McBride, J. S. (2000). A principal target of human immunity to malaria
identified  by  molecular  population  genetic  and  immunological  analyses. Nat
Med, 6 (6), 689-92.183
Couper,  K.  N.  Immunological  studies  on  the  related  apicomplexan  parasites
Toxoplasma gondii and Plasmodium chabaudi AS. (PhD Thesis 2003). Pg 149-174.
Couper, K. N., Phillips, R. S., Brombacher, F. and Alexander J. (2005). Parasite-
specific IgM plays a significant role in the protective immune response to asexual
erythrocytic  stage Plasmodium  chabaudi  AS  infection. Parasite  Immunol, 27,
171-80.
Couper, K. N., Blount, D. G., de Souza, J. B., Suffia, I., Belkaid, Y. and Riley, E,
M. (2007). Incomplete depletion and rapid regeneration of Foxp3+ regulatory T
cells following anti-CD25 treatment in malaria-infected mice. J Immunol, 178,
4136-4146.
Couper,  K.  N.,  Blount,  D.  G.,  Wilson,  M.  S.,  Hafalla,  J.  C.,  Belkaid,  Y.,
Kamanaka, M., Flavell, R. A., de Souza, J. B. and Riley, E. M. (2008). IL-10 from
CD4
+CD25
-Foxp3
-CD127
- adaptive regulatory T cells modulates parasite clearance
and pathology during malaria infection. PLoS Pathogens, 4 (2), e1000004.
Couper, K. N., Barnes, T., Hafalla, J. C., Combes, V., Ryffel, B., Secher, T.,
Grau, G. E., Riley, E. M. and de Souza, J. B. (2010). Parasite-derived plasma
microparticles contribute significantly to malaria infection-induced inflammation
through potent macrophage stimulation. PLoS Pathogens, 6 (1), e1000744.
Cowman, A. F. and Crabb, B. S. (2006). Invasion of red blood cells by malaria
parasites. Cell, 124, 755-766.
Crompton, P. D., Mircetic, M., Weiss, G., Baughman, A., Huang, C. Y., Topham,
D. J., Treanor, J. J., Sanz, I., Lee, F. E., Durbin, A. P., Miura, K., Narum, D. L.,
Ellis, R. D., Malkin, E., Mullen, G. E., Miller, L. H., Martin, L. B. and Pierce, S. K.
(2009). The  TLR9  ligand  CpG  promotes  the  acquisition  of Plasmodium
falciparum-specific memory B cells in malaria-naïve individuals. J Immunol, 182
(5), 3318-26.
Crompton, P. D., Pierce, S. K. and Miller, L. H. (2010). Advances and challenges
in malaria vaccine development. J Clin Invest, 120 (12), 4168-78.184
Cross,  C.  E.  and  Langhorne,  J.  (1998). Plasmodium  chabaudi  chabaudi  (AS):
inflammatory cytokines and pathology in an erythrocytic-stage infection in mice.
Exp Parasitol, 90, 220-229.
D'Andrea,  A.,  Aste-Amezaga,  M.,  Valiante,  N.  M.,  Ma,  X.,  Kubin,  M.  and
Trinchieri, G. (1993). Interleukin 10 (IL-10) inhibits human lymphocyte interferon
gamma-production  by  suppressing  natural killer  cell  stimulatory  factor/IL-12
synthesis in accessory cells. J Exp Med, 178, 1041-1048.
D'Ombrain, M. C.,  Voss,  T. S.,  Maier,  A. G.,  Pearce,  J. A.,  Hansen,  D. S.,
Cowman,  A. F.  and  Schofield  L.  (2007). Plasmodium  falciparum  erythrocyte
membrane protein-1 specifically suppresses early production of host interferon-
gamma. Cell Host Microbe, 2 (2), 130-8.
D'Ombrain, M. C.,  Hansen,  D.  S.,  Simpson,  K.  M.  and  Schofield,  L.  (2007).
gammadelta-T cells  expressing NK  receptors  predominate  over NK  cells  and
conventional  T cells  in  the  innate  IFN-gamma  response  to  Plasmodium
falciparum malaria. Eur J Immunol, 1864-73.
D'Ombrain,  M.  C.,  Robinson, L.  J.,  Stanisic,  D.  I.,  Taraika,  J.,  Bernard,  N.,
Michon, P., Mueller, I. and Schofield, L. (2008). Association of early interferon-
gamma production with immunity to clinical malaria: a longitudinal study among
Papua New Guinean children. Clin Infect Dis, 47 (11), 1380-7.
D'Ombrain,  M.  C.,  Robinson,  L.  J.,  Mueller,  I.  and  Schofield,  L.  (2009).
Mechanisms underlying early interferon-gamma production in human Plasmodium
falciparum malaria. Clin Infect Dis, 48 (10), 1482-3.
de Sa Pinheiro, A., Morrot, A., Chakravarty, S., Overstreet, M., Bream, J. H.,
Irusta, P. M. and Zavala, F. (2007). IL-4 induces a wide-spectrum intracellular
signaling cascade in CD8+ T cells. J Leukoc Biol, 81 (4), 1102-10.
de Souza, J. B., Todd, J., Krishegowda, G, Gowda, D. C., Kwiatkowski, D. and
Riley,  E.  M. (2002). Prevalence  and  boosting  of  antibodies  to  Plasmodium
falciparum glycosylphophatidylinositols and evaluation of their association with
protection from mild and severe clinical malaria. Infect Immun, 2002, 70, 5045-
5051.185
Dechamps, S., Maynadier, M., Wein, S., Gannoun-Zaki, L., Maréchal, E. and Vial,
H, J. (2010). Rodent and nonrodent malaria parasites differ in their phospholipid
metabolic pathways. J Lipid Res, 51 (1), 81-96.
Defrance, T., Carayon, P., Billian, G., Guillemot, J. C., Minty, A., Caput, D. and
Ferrara, P. (1994). Interleukin 13 is a B cell stimulating factor. J Exp Med, 179
(1), 135-43.
DeKruyff, R. H., Fang, Y. and Umetsu, D. T. (1992). IL-4 synthesis by in vivo
primed keyhole limpet hemocyanin-specific CD4+ T cells. Influence of antigen
concentration and antigen-presenting cell type. J Immunol, 149 (11), 3468-76.
del Portillo, H. A., Ferrer, M., Brugat, T., Martin-Jaular, L., Langhorne, J. and
Lacerda, M. V. (2011). The role of the spleen in malaria. Cell Microbiol.
Deplaine, G., Safeukui, I., Jeddi, F., Lacoste, F., Brousse, V., Perrot, S., Biligui,
S., Guillotte, M., Guitton, C., Dokmak, S., Aussilhou, B., Sauvanet, A., Cazals
Hatem,  D.,  Paye,  F.,  Thellier,  M.,  Mazier,  D.,  Milon,  G.,  Mohandas,  N.,
Mercereau-Puijalon, O., David, P. H, Buffet, P. A. (2011). The sensing of poorly
deformable  red  blood  cells  by  the  human  spleen  can  be  mimicked  in  vitro.
Blood, 117 (8), e88-95.
Dewals, B., Hoving, J. C., Leeto, M., Marillier, R. G., Govender, U., Cutler, A.
J., Horsnell, G. C. and Brombacher, F. (2009). IL-4R responsiveness of non-CD4
T cells contributes to resistance in Schistosoma mansoni infection investigated in
pan-T cell-specific IL-4Rα-deficient mice. Am J Pathol, 175, 706-716.
Diggs, C. L., Hines, F. and Wellde, B. T. (1995). Plasmodium falciparum: passive
immunization  of  Aotus  lemurinus  griseimembra  with  immune  serum. Exp
Parasitol, 80, 291-296.
Doolan, D. L., Sedegah, M., Hedstrom, R. C., Hobart, P., Charoenvit, Y. and
Hoffman, S. L. (1996). Circumventing genetic restriction of protection against
malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and
nitric oxide-dependent immunity. J Exp Med, 183, 1739-1746.186
Doolan,  D. L.,  Wizel,  B.  and  Hoffman,  S. L.  (1996). Class  I  HLA-restricted
cytotoxic T lymphocyte responses against malaria--elucidation on the basis of
HLA peptide binding motifs. Immunol Res, 15 (4), 280-305.
Drakeley, C. J, Carneiro, I., Reyburn, H., Malima, R., Lusingu, J. P, Cox, J.,
Theander, T. G, Nkya, W. M., Lemnge, M. M. and Riley, E. M. (2005). Altitude-
dependent and -independent variations in Plasmodium falciparum prevalence in
northeastern Tanzania. J Infect Dis, 191, 1589–1598.
Egan, A. F., Morris, J., Barnish, G., Allen, S., Greenwood, B. M., Kaslow, D. C.,
Holder,  A.  A.  and  Riley,  E.  M.  (1996).  Clinical  immunity  to Plasmodium
falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal
fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis, 173, 765-769.
Engwerda, C. R., Beattie, L. and Amante, F. H. (2005). The importance of the
spleen in malaria. Trends Parasitol, 21, 75-80.
Falanga,  P.  B.,  Franco  da  Silveira,  J.  F.  and  Pereira  da  Silva,  L.  (1984).
Protective immune response to Plasmodium chabaudi, developed by mice after
drug controlled infection or vaccination with parasite extracts: analysis of stage
specific antigens from the asexual blood cycle. Parasite Immunol, 6, 529-543.
Falchetti, R., Lanzilli, G., Casalinuovo, I. A., Gaziano, R., Palamara, A.T., Di
Francesco, P., Ravagnan, G. and Garaci, E. (1996). Splenic CD4+ and CD8+ T
cells from influenza immune mice concurrently produce in vitro IL2, IL4, and
IFN-gamma. Cell Immunol. 170 (2), 222-9.
Favre,  N.,  Ryffel,  B.,  Bordmann,  G.  and  Rudin,  W.  (1997).  The  course  of
Plasmodium  chabaudi  chabaudi  infections  in  interferon-gamma  receptor
deficient mice. Parasite Immunol, 19, 375-383.
Flesch,  I.E., Wandersee,  A.  and  Kaufmann,  S.  H.  (1997). Effects  of  IL-13  on
murine listeriosis. Int Immunol, 9, 467-474.
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S.,
Clifford, T., Hunte, B., Lesley, R., Muchamuel, T., Hurst, S. D, Zurawski, G.,
Leach, M. W., Gorman, D. M. and Rennick, D. M. (2001). IL-25 induces IL-4, IL-5,
and IL-13 and Th2-associated pathologies in vivo. Immunity, 15 (6), 985-95.187
Fortin, A., Stevenson, M. M. and Gros, P. (2002). Susceptibility to malaria as a
complex trait: big pressure from a tiny creature. Hum Mol Genet, 11, 2469-
2478.
Franks, S., Koram, K. A., Wagner, G. E., Tetteh, K., McGuinness, D., Wheeler, J.
G., Nkrumah, F., Ranford-Cartwright, L. and Riley, E. M. (2001). Frequent and
persistent, asymptomatic Plasmodium falciparum infections in African infants,
characterized by multilocus genotyping. J Infect Dis, 183, 796-804.
Freire-De-Lima, C. G., Nascimento, D. O., Soares, M. B., Bozza, P. T., Castro-
Faria-Neto,  H.  C.,  de  Mello,  F.  G.,  DosReis,  G.  A.  and  Lopes,  M.  F.  (2000).
Uptake  of  apoptotic  cells  drives  the  growth  of  a  pathogenic  trypanosome  in
macrophages. Nature, 403 (6766), 199-203.
Freitas do Rosário, A. P., Muxel, S. M., Rodríguez-Málaga, S. M., Sardinha, L. R.,
Zago,  C.  A.,  Castillo-Méndez,  S.  I.,  Alvarez,  J.  M. and  D'Império  Lima,  M.  R.
(2008). Gradual  decline  in  malaria-specific  memory  T  cell  responses  leads  to
failure to maintain long-term protective immunity to Plasmodium chabaudi AS
despite persistence of B cell memory and circulating antibody. J Immunol, 181
(12), 8344-55.
Gajewski, T. F. and Fitch, F. W. (1991). Differential activation of murine Th1
and Th2 clones. Res Immunol, 142, 19–23.
Gajewski, T. F, Pinnas, M., Wong, T., Fitch, F. W. (1991). Murine Th1 and Th2
clones  proliferate  optimally  in  response  to  distinct  antigen-presenting cell
populations. J Immunol, 146, 1750–8.
O' Garra, A. and Vieira, P. (2007). TH1 cells control themselves by producing
interleukin-10. Nat Rev Immunol, 7 (6), 425-8.
Garvin, A. M., Abraham, K. M., Forbush, K. A., Farr, A. G., Davison, B. L. and
Perlmutter,  R.  M.  (1990).  Disruption  of  thymocyte  development  and
lymphomagnesis induced by SV40 T-antigen. Int Immunol, 2, 173-180.
Gatto, D., Martin, S.W., Bessa, J., Pellicioli, E., Saudan, P., Hinton, H. J. and
Bachmann,  M.  F.  (2007)  Regulation  of memory  antibody  levels:  the  role  of
persisting antigen versus plasma cell life span. J Immunol, 178, 67–76.188
Gazzinelli, R. T. and Denkers, E. Y. (2006). Protozoan encounters with Toll-like
receptor signalling pathways: implications for host parasitism. Nat Rev Immunol,
6, 895-906.
Goel, V. K., Li, X., Chen, H., Liu, S. C., Chishti, A. H. and Oh, S. S. (2003). Band
3 is a host receptor binding merozoite surface protein 1 during the Plasmodium
falciparum invasion of erythrocytes. Proc Natl Acad Sci U S A, 100, 5164-5169.
Goerdt, S. and Orfanos, C. E. (1999). Other functions, other genes: alternative
activation of antigen-presenting cells. Immunity, 10, 137-142.
Good, M. F. and Doolan, D. L. (1999). Immune effector mechanisms in malaria.
Curr Opin Immunol, 11, 412-419.
Good, M. F. (2001). Towards a blood-stage vaccine for malaria: are we following
all the leads? Nat Rev Immunol, 1, 117-125.
Good,  M.  F.,  Stanisic,  D.,  Xu,  H.,  Elliott,  S.  and  Wykes,  M.  (2004).  The
immunological challenge to developing a vaccine to the blood stages of malaria
parasites. Immunol Rev, 201, 254-67.
Good, M. F. (2005). Vaccine-induced immunity to malaria parasites and the need
for novel strategies. Trends Parasitol, 21 (1), 29-34.
Gordon,  S.  (2003).  Alternative  Macrophage  Activation. Nature  Reviews
Immunology, 3, 23-35.
Greenwood, B. M. (1987). Asymptomatic malaria infections – do they matter?
Parasitol Today, 3, 206–214.
Grun, J. L. and Weidanz, W. P. (1981). Immunity to Plasmodium chabaudi adami
in the B-cell-deficient mouse. Nature, 290, 143-145.
Grünig, G., Corry, D. B, Leach, M. W, Seymour, B. W, Kurup, V. P. and Rennick,
D. M. (1997). Interleukin-10 is a natural suppressor of cytokine production and
inflammation in a murine model of allergic bronchopulmonary aspergillosis. J
Exp Med, 185 (6), 1089-99.189
Gu, H., Marth, J. D., Orban, P. C., Mossmann, H. and Rajewsky, K. (1994).
Deletion of a DNA polymerase beta gene segment in T cells using cell type
specific gene targeting. Science, 265,103-6.
Gueirard, P., Tavares, J., Thiberge, S., Bernex, F., Ishino, T., Milon, G., Franke
-Fayard, B., Janse, C. J., Ménard, R. and Amino, R. Development of the malaria
parasite in the skin of the mammalian host. PNAS, 107 (43), 18640-18645.
Guermonprez,  P.,  Valladeau,  J.,  Zitvogel,  L.,  Thery,  C.  and  Amigorena,  S.
(2002). Antigen presentation and T cell stimulation by dendritic cells. Annu Rev
Immunol, 20, 621-667.
Hansen,  S.  G.,  Vieville,  C.,  Whizin,  N.,  Coyne-Johnson,  L.,  Siess,  D.  C.,
Drummond, D. D., Legasse, A. W., Axthelm, M. K., Oswald, K., Trubey, C. M.,
Piatak, M. Jr., Lifson, J. D., Nelson, J. A., Jarvis, M. A. and Picker, L. J. (2009).
Effector  memory  T  cell  responses  are  associated  with  protection  of  rhesus
monkeys from mucosal simian immunodeficiency virus challenge. Nat Med, 15
(3), 293-9.
Hafalla,  J.  C.,  Silvie,  O.  and  Matuschewski,  K.  (2011).  Cell  biology  and
immunology of malaria. Immunol Rev, 240, 297-316.
Hänscheid,  T.,  Egan,  T.  J.  and  Grobusch,  M.  P.  (2007).  Haemozoin:  from
melatonin  pigment  to  drug  target,  diagnostic  tool,  and  immune  modulator.
Lancet Infect Dis, 7 (10), 675-85.
Hart, P. H., Bonder, S. C., Balogh, J., Dickensheets, H. L., Donnelly, R. P. and
Finlay-Jones,  J.  J.  (1999). Differential  responses  of  human  monocytes  and
macrophages to IL-4 and IL-13. J Leukoc Biol, 66, 575–578.
Heddini, A. (2002). Malaria pathogenesis: a jigsaw with an increasing number of
pieces. Int J Parasitol, 32 (13), 1587-1598.
Herbert, D. R., Christoph Hölscher, C., Mohrs, M., Arendse, B., Schwegmann, A.,
Radwanska,  M.,  Leeto  M., Kirsch,  R.,  Hall,P., Mossmann,  H., Claussen,  B.,
Förster, I. and Frank Brombacher. (2004). Alternative macrophage activation is
essential  for  survival  during schistosomiasis  and downmodulates T  Helper  1
responses and immunopathology. Immunity, 20, 623-635.190
Hermsen, C., van de Wiel, T., Mommers, E., Sauerwein, R. and Eling, W. (1997).
Depletion  of  CD4+  or  CD8+  T-cells  prevents Plasmodium  berghei  induced
cerebral malaria in end-stage disease. Parasitology, 114 (Pt 1), 7-12.
Herrera, S., Perlaza, B. L., Bonelo, A. and Arevalo-Herrera, M. (2002). Aotus
monkeys:  their  great  value  for  anti-malaria  vaccines  and  drug  testing. Int  J
Parasitol, 32 (13), 1625-35.
Hochrein,  H., O’Keefe,  M., Luft,  T., Vandenabeele,  S., Grumont,  R.  J.,
Maraskovsky, E. and Shortman, K. (2000). Interleukin (IL-4) is a major regulatory
cytokine  governing  bioactive  IL-12  production  by  mouse  and  human dendritic
cells. J Exp Med, 192, 823-833.
Hoffmann, K. F., Cheever, A. W. and Wynn, T. A. (2000). IL-10 and the dangers
of immune polarization: excessive type 1 and type 2 cytokine responses induce
distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol,
164 (12), 6406-16.
Hölscher, C., Atkinson, R. A., Arendse, B., Brown, N., Myburgh, E., Alber, G. and
Brombacher,  F.  (2001).  A  protective  and  agonistic  function  of  IL-12p40  in
mycobacterial infection. J Immunol, 167, 6957-6966.
Hölscher,  C.,  Arendse,  B.,  Schwegmann,  A.,  Myburgh, E. and  Brombacher,  F.
(2006).  Impairment  of  alternative  macrophage  activation  delays  cutaneous
leishmaniasis in non-healing BALB/c mice. J Immunol, 176, 1115-21.
Horsnell, W. G., Cutler, A. J., Hoving, C. J., Mearns, H., Myburgh, E., Arendse,
B., Finkelman, F. D., Owens, G. K., Erle, D. and Brombacher, F. (2007). Delayed
goblet cell hyperplasia, acetylcholine receptor expression, and worm expulsion
in SMC-specific IL-4Rα-deficient mice. PLoS Pathog, 3 (1), e1.
http://www.wehi.edu.au/education/wehitv/malaria_lifecycle_part_1_human_h
ost/ (Drew Berry, Biomedical Animator, The Walter and Elisa Hall Institute of
Medical Research, WEHI-Tv, 2008)
http://www.niaid.nih.gov/.../pages/lifecycle.aspx. National Institute of Allergy
and Infectious Diseases (NIAID) website191
Huang, L. R., Chen, F. L., Chen, Y. T., Lin, Y. M. and Kung, J. T. (2000). Potent
induction of long-term CD8_ T cell memory by short-term IL-4 exposure during T
cell receptor stimulation. Proc Natl Acad Sci USA, 97, 3406–3411.
Hunt, N. H. and Grau, G. E. (2003). Cytokines: accelerators and brakes in the
pathogenesis of cerebral malaria. Trends Immunol, 24, 491-499.
Ing, R. and Stevenson, M. M. (2009). Dendritic cell and NK cell reciprocal cross
talk  promotes  gamma  interferon-dependent  immunity  to  blood-stage
Plasmodium chabaudi AS infection in mice. Infect Immun, 77 (2), 770-92.
John,  C.  C.,  Zickafoose,  J.  S.,  Sumba,  P.  O.,  King,  C.  L.  and  Kazura, J.  W.
(2003).  Antibodies  to  the  Plasmodium  falciparum  antigens  circumsporozoite
protein, thrombospondin-related adhesive protein, and liver-stage antigen 1 vary
by ages of subjects and by season in a highland area of Kenya. Infect Immun, 71
(8), 4320-5.
Joss, A., Akdis, M., Faith, A., Blaser, K. and Akdis, C. A. (2000). IL-10 directly
acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur J
Immunol, 30 (6), 1683-90.
Jung,  T.,  Schrader,  N.,  Hellwig,  M.,  Enssle,  K. H.  and  Neumann,  C.  (1999).
Soluble human interleukin-4 receptor is produced by activated T cells under the
control of metalloproteinases. Int Arch Allergy Immunol, 119 (1), 23-30.
Jung, T., Wagner, K., Neumann, C. and Heusser, C. H. (1999). Enhancement of
human IL-4 activity by soluble IL-4 receptors in vitro. Eur J Immunol, 29 (3),
864-71.
Kamis,  A. B.  and  Ibrahim,  J.  B.  (1989).  Effects  of  testosterone  on  blood
leukocytes in Plasmodium berghei-infected mice. Parasitol Res, 75 (8), 611-3.
Keating,  P.,  O'Sullivan,  D.,  Tierney,  J. B.,  Kenwright,  D., Miromoeini,  S.,
Mawasse, L., Brombacher, F. and La Flamme, A. C. (2009). Protection from EAE
by  IL-4Ralpha(-/-)  macrophages  depends  upon  T  regulatory  cell  involvement.
Immunol Cell Biol, 87 (7), 534-45.192
Keller  CC,  Yamo  O,  Ouma  C,  Ong'echa  JM,  Ounah  D,  Hittner  JB,  Vulule  JM,
Perkins  DJ. (2006). Acquisition  of  hemozoin  by  monocytes  down-regulates
interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-
10-dependent  mechanism:  in  vivo  and  in  vitro  findings  in  severe  malarial
anemia. Infect Immun, 74 (9), 5249-60.
Kienzle, N., Buttigieg, K., Groves, P., Kawula, T. and Kelso, A. (2002). A clonal
culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T
cells with low CD8, perforin, and granzyme expression. J. Immunol. 168, 1672–
1681.
Kim, C. C., Parikh, S., Sun, J. C., Myrick, A., Lanier, L. L., Rosenthal, P. J. and
DeRisi, J. L. (2008). Experimental malaria infection triggers early expansion of
natural killer cells. Infec Immun, 76 (12), 5873-82.
Kinyanjui,  S. M.,  Bull,  P.,  Newbold,  C.  I.  and  Marsh,  K.  (2003).  Kinetics  of
antibody  responses  to  Plasmodium  falciparum-infected  erythrocyte  variant
surgace antigens. J Infect Dis, 187 (4), 667-74.
Kinyanjui, S. M., Conway, D. J., Lanar, D. E. and Marsh, K. (2007). IgG antibody
responses to Plasmodium falciparum merozoite antigens in Kenyan children have
a short half-life. Malar J, 6, 82.
Kitaguchi, T., Nagoya, M., Amano, T., Suzuki, M. and Minami, M. (1996). Analysis
of roles of natural killer cells in defense against Plasmodium chabaudi in mice.
Parasitol Res, 82 (4), 352-7.
Klein,  S.  L.  (2000). Hormones  and  mating  system  affect  sex  and  species
differences in immune function among vertebrates. Behav Processes, 51 (1-3),
149-166
Klein, S. L. (2000). The effects of hormones on sex differences in infection: from
genes to behavior. Neurosci Biobehav Rev, 24 (6), 627-38.
Klein,  S.  L.  (2004).  Hormonal  and  immunological  mechanisms  mediating  sex
differences in parasite infection. Parasite Immunol, 26, 247-264.193
Klein, P. W, Easterbrook, J. D, Lalime, E. N. and Klein, S. L. (2008). Estrogen
and progesterone affect responses to malaria infection in female C57BL/6 mice.
Gend Med, 5 (4), 423-33.
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R., Clark, S., Chan, S., Loudon, R.,
Sherman, F. and Perussia, B. (1989). Identification and purification of natural
killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on
human lymphocytes. J Exp Med, 170, 827-845.
Krishnegowda, G., Hajjar, A. M., Zhu, J., Douglass, E. J., Uematsu, S., Akira, S.,
Woods, A. S. and Gowda, D. C. (2005). Induction of proinflammatory responses
in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum:
cell  signaling  receptors,  glycosylphosphatidylinositol  (GPI)  structural
requirement, and regulation of GPI activity. J Biol Chem, 280, 8606-8616.
Kropf, P., Freudenberg, M. A., Modolell, M., Price, H. P., Herath, S., Antoniazi,
S.,  Galanos,  C.,  Smith,  D.  F.  and  Müller,  I.  (2004).  Toll-like  receptor  4
contributes  to  efficient  control  of  infection  with  the  protozoan  parasite
Leishmania major. Infect Immun, 72 (4), 1920-8.
Kropf, P., Fuentes, J. M., Fähnrich, E., Arpa, L., Herath, S., Weber, V., Soler,
G.,  Celada,  A.,  Modolell,  M.  and  Müller,  I.  (2005). Arginase  and  polyamine
synthesis are key factors in the regulation of experimental leishmaniasis in vivo.
FASEB J, 19, 1000-2.
Kurtzhals, J. A., Adabayeri, V., Goka, B. Q., Akanmori, B. D., Oliver-Commey, J.
O., Nkrumah, F. K., Behr, C. and Hviid, L. (1998). Low plasma concentrations of
interleukin  10  in  severe  malarial  anaemia  compared  with  cerebral  and
uncomplicated malaria. Lancet, 351, 1768-1772.
Kwiatkowski, D., Bate, C. A., Scragg, I. G., Beattie, P., Udalova, I. and Knight,
J.  C.  (1997).  The  malarial  fever  response--pathogenesis,  polymorphism  and
prospects for intervention. Ann Trop Med Parasitol, 91, 533-542.
Langhorne,  J.  (1989).  The  role  of  CD4+  T-cells  in  the  immune  response  to
Plasmodium chabaudi. Parasitol Today, 5 (11), 362-4.194
Langhorne,  J.,  Meding,  S.  J.,  Eichmann,  K.  and  Gillard,  S.  S.  (1989).  The
response of CD4+ T cells to Plasmodium chabaudi chabaudi. Immunol Rev, 112,
71-94.
Langhorne,  J.,  Gillard,  S.,  Simon,  B.,  Slade,  S.  and  Eichmann,  K.  (1989).
Frequencies  of  CD4+  T  cells  reactive  with Plasmodium  chabaudi  chabaudi:
distinct  response  kinetics  for  cells  with  Th1  and  Th2  characteristics  during
infection. Int Immunol, 1, 416-424.
Langhorne, J., Cross, C., Seixas, E., Li, C. and von der Weid, T. (1998). A role
for B cells in the development of T cell helper function in a malaria infection in
mice. Proc Natl Acad Sci U S A, 95 (4), 1730-4.
Langhorne, J., Quin, S. J. and Sanni, L. A. (2002). Mouse models of blood-stage
malaria infections: immune responses and cytokines involved in protection and
pathology. Chem Immunol, 80, 204-228.
Langhorne, J., Albano, F. R., Hensmann, M., Sanni, L., Cadman, E., Voisine, C.
and  Sponaas,  A.  M.  (2004).  Dendritic  cells,  pro-inflammatory  responses,  and
antigen presentation in a rodent malaria infection. Immunol Rev, 201, 35-47.
Langhorne, J., Ndungu, F. M, Sponaass, A. M. and Marsh, K. (2008). Immunity to
malaria: more questions than answers. Nat Immunol, 9, 725-732.
Lean, I. S., McDonald, S. A., Bajaj-Elliott, M., Pollok, R. C., Farthing, M. J., and
McDonald, V.  (2003). Interleukin-4  and  transforming  growth factor-beta  have
opposing  regulatory  effects  on  gamma  interferon mediated inhibition  of
Cryptosporidium parvum reproduction, Infect. Immun, 71, 4580-4585.
Leeto,  M.,  Herbert,  D. R.,  Marillier,  R.,  Schwegmann,  A.,  Fick,  L.  and
Brombacher, F. (2006). TH1-dominant granulomatous pathology does not inhibit
fibrosis  or cause  lethality  during  murine  schistosomiasis. Am  J  Pathol, 169,
1701–1712
Leisewitz,  A. L., Rockett,  K. A., Gumede,  B., Jones,  M., Urban,  B.  and
Kwiatkowski, D. P. (2004). Response of the splenic dendritic cell population to
malaria infection. Infect Immun, 72 (7), 4233-9.195
Leke, R., Viens, P. and Davies, A. J. (1981). Interaction between Plasmodium
chabaudi and C57Bl mice with particular reference to the immune response. Clin
Exp Immunol, 45 (3), 627-32.
Li, C. and Langhorne, J. (2000). Tumor necrosis factor alpha p55 receptor is
important  for  development  of  memory  responses  to  blood-stage  malaria
infection. Infect Immun, 68 (10), 5724-30.
Li, C., E. Seixas, and J. Langhorne. 2001. Rodent malarias: the mouse as a model
for understanding immune responses and pathology induced by the erythrocytic
stages of the parasite. Med Microbiol Immunol, 189, 115–126
Li, C., Sanni, L. A., Omer, F., Riley, E. and Langhorne, J. (2003). Pathology of
Plasmodium  chabaudi  chabaudi  infection  and  mortality  in  interleukin-10-
deficient  mice  are  ameliorated  by  anti-tumor  necrosis  factor  alpha  and
exacerbated by anti-transforming growth factor beta antibodies. Infect Immun,
71, 4850-4856.
Liew, F. Y., Li, Y. and Millott, S. (1990). Tumor necrosis factor-alpha synergizes
with IFN-gamma in mediating killing of Leishmania major through the induction
of nitric oxide. J Immunol, 145, 4306-4310.
Limbach, K., Aguiar, J., Gowda, K., Patterson, N., Abot, E., Sedegah, M., Sacci,
J. and Richie, T. (2011). Identification of two new protective pre-erythrocytic
malaria vaccine antigen candidates. Malar J, 10, 65.
Louis, J., Himmelrich, H., Parra-Lopez, C., Tacchini-Cottier, F. and Launois, P.
(1998). Regulation  of  protective  immunity  against Leishmania  major  in  mice.
Curr Opin Immunol, 10 (4), 459-64.
Louis,  J. A.,  Conceiçao-Silva,  F.,  Himmelrich,  H.,  Tacchini-Cottier,  F.  and
Launois P. (1998). Anti-leishmania effector functions of CD4+ Th1 cells and early
events instructing Th2 cell development and susceptibility to Leishmania major
in BALB/c mice. Adv Exp Med Biol. 452, 53-60.196
Lundie, R. J., de Koning-Ward, T. F., Davey, G. M., Nie, C. Q., Hansen D. S.,
Lau,  L.  S.,  Mintern,  J.  D.,  Belz,  G.  T.,  Schofield,  L.,  Carbone.,  F.  R.,
Villadangos,  J.  A.,  Crabb,  B.  S.  and  Heath,  W.  R.  (2008).  Blood-stage
Plasmodium  infection  induces  CD8+  T  lymphocytes  to  parasite-expressed
antigens, largely regulated by CD8alpha+ dendritic cells. Proc Natl Acad Sci USA,
105 (38), 14509-14.
Luty, A. J., Lell, B., Schmidt-Ott, R., Lehman, L. G., Luckner, D., Greve, B.,
Matousek,  P.,  Herbich,  K.,  Schmid,  D.,  Migot-Nabias,  F.,  Deloron,  P.,
Nussenzweig, R. S. and Kremsner PG. (1999). Interferon-gamma responses are
associated with resistance to reinfection with Plasmodium falciparum in young
African children. J Infect Dis, 179 (4), 980-8.
Mannetti, R., Parronchi, P., Guidizi, M., Piccinni, M., Maggi, E., Trinchieri, G.
and Romangnani, S. (1993). Natural killer cell stimulatory factor (interleukin 12
[IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the
development of IL-4-producing Th cells. J Exp Med, 177, 1199-1204.
Mantovani,  A.,  Sozzani,  S.,  Locati,M.,  Allavena,  P.  and  Sica,  A. (2002).
Macrophage  polarization:  tumor-associated  macrophages  as  a  paradigm  for
polarized M2 mononuclear phagocytes. Trends Immunol, 23 (11), 549-55.
Manz, R. A. and Radbruch, A. (2002). Plasma cells for a lifetime? Eur J Immunol,
32, 923-927.
Manz, R. A., Thiel, A., Radbruch, A. (1997). Lifetime of plasma cells in the bone
marrow. Nature, 388, 133–134.
Marsh,  K.  and  Kinyanjui,  S.  (2006).  Immune  effector  mechanisms  in  malaria.
Parasite Immunol, 28, 51-60.
Marsh, K., Otoo, L., Hayes, R. J., Carson, D. C. and Greenwood, B. M. (1989).
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians
and their relation to protection against infection. Trans R Soc Trop Med Hyg, 83,
293-303.197
Martinez, F. O., Helming, L. and Gordon, S. (2009). Alternative activation of
macrophages: and immunologic functional perspective. Annu Rev Immunol, 27,
451-83.
Mazier, D., Beaudoin, R. L., Mellouk, S., Druilhe, P., Texier, B., Trosper, J.,
Miltgen, F., Landau, I., Paul, C. and Brandicourt, O., et al. (1985). Complete
development of hepatic stages of Plasmodium falciparum in vitro. Science, 227
(4685), 440-2.
McCaffrey, R. L., Fawcett, P., O'Riordan, M., Lee, K. D., Havell, E. A., Brown, P.
O. and Portnoy, D. A. (2004). A specific gene expression program triggered by
Gram-positive bacteria in the cytosol. Proc Natl Acad Sci USA, 101 (31), 11386-
91.
McCall, M. B., Roestenberg, M., Ploemen, I., Teirlinck, A., Hopman, J., de Mast,
Q., Dolo, A., Doumbo, O. K., Luty, A., van der Ven, A. J., Hermsen, C. C. and
Sauerwein,  R.  W.  (2010).  Memory-like  IFN-γ  responses  by  NK  cells  following
malaria infection reveals the crucial role of T-cells in NK cell activation by P.
falciparum. Eur J Immunol, 40 (12), 3472-7.
McDonald, V. and Phillips, R. S. (1975). Plasmodium chabaudi in mice: adoptive
transfer of immunity with enriched populations of spleen T and B lymphocytes.
Immunology, 34, 821-830.
McDonald, V. and Phillips, R. S. (1978). Plasmodium chabaudi in mice. Adoptive
transfer of immunity with enriched populations of spleen T and B lymphocytes.
Immunology, 34, 821-830.
McDonald, V. and Phillips, R. S. (1980). Plasmodium chabaudi: Adoptive transfer
of  immunity  with  different  spleen  cell  populations  and  development  of
protective  activity  in  the  serum  of  lethally  irradiated  recipient  mice. Exp
Parasitol, 49, 26-33.
McDonald, S. A., O'Grady, J. E., Bajaj-Elliott, M., Notley, C. A., Alexander, J.,
Brombacher,  F. and  McDonald,  V.  (2004).  IL-4  confers  protection  against  the
early  acute  phase  of Cryptosporidium  parvum  infection  by  promoting  Th1
cytokine expression. J Inf. Dis, 190, 1019-25.198
McFarlane, E., Carter, K. C., McKenzie, A., Kaye, P. M., Brombacher, F. and
Alexander, J. (2011). Endogenous IL-13 plays a crucial role in liver granuloma
maturation during Leishmania donovani infection via a macrophage independent
mechanism. Journal of Infectious Diseases, 204, 36-43.
McKenzie, A. N., Culpepper, J. A., de Waal Malefyt, R., Briere, F., Punnonen, J.,
Aversa,  G.,  Sato,  A.,  Dang,  W.,  Cocks,  B.  G.,  Menon,  S.  and  et  al.  (1993).
Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-
cell function. Proc Natl Acad Sci U S A, 90, 3735-3739.
McLean, S. A., Pearson, C. D. and Phillips, R. S. (1982). Plasmodium chabaudi:
antigenic variation during recrudescent parasitaemias in mice. Exp Parasitol, 54,
296-302.
Meding, S. J., Cheng, S. C., Simon-Haarhaus, B. and Langhorne, J. (1990). Role
of  gamma  interferon  during  infection  with Plasmodium  chabaudi  chabaudi.
Infect Immun, 58 (11), 3671-3678.
Meding, S. J. and Langhorne, J. (1991). CD4+ T cells and B cells are necessary
for the transfer of protective immunity to Plasmodium chabaudi chabaudi. Eur J
Immunol, 21 (6), 1433-8.
Melo, G. C., Reyes-Lecca, R. C., Vitor-Silva, S., Monteiro, W. M., Martins, M.,
Benzecry, S. G., Alecrim, M. and Lacerda, M. V. (2010). Concurrent helminth
infection protects schoolchildren with Plasmodium vivax from anemia. PLos ONE,
5 (6), e11206.
Mencacci, A., Del Sero, G., Cenci, E., d’Ostiani, C. F., Bacci, A., Montagnoli, C.,
Kopf,  M.  and  Romani,  L.  (1998). Endogenous  interleukin  4  is required  for
development of protective CD4þ T helper type 1 responses to Candida albicans. J
Exp Med, 187, 307-317.
Ménard, R. (2001). Gliding motility and cell invasion by Apicomplexa: insights
from the Plasmodium sporozoite. Cell Microbiol, 3 (2), 63-73.199
Menzies,  F.  M.,  Henriquez,  F.  L.,  Alexander,J.  and  Roberts,  C.  W.  (2010).
Sequential  expression  of  macrophage  anti-microbial/inflammatory  and  wound
healing markers following innate, alternative and classical activation. Clin Exp
Immunol, 160 (3), 369-79.
Metzger, W. G., Okenu, D. M., Cavanagh, D. R., Robinson, J. V., Bojang, K. A.,
Weiss, H. A., McBride, J. S., Greenwood, B. M. and Conway, D. J. (2003). Serum
IgG3  to  the Plasmodium  falciparum  merozoite  surface  protein  2  is  strongly
associated with a reduced prospective risk of malaria. Parasite Immunol, 25 (6),
307-12.
Michels,  C.  E.,  Scales,  H.  E.,  Saunders,  K.,  McGowan,  S.,  Brombacher,  F.,
Alexander, J. and Lawrence, C. E. (2009). IL-4Rα expression on neither CD4
+ T
cells, nor macrophages and neutrophils is required for protective immunity to
Trichinella spiralis. Immunology, 128, 385-94.
Miller, C. L., Hooton, J. W., Gillis, S. and Paetkau, V. (1990). IL-4 potentiates
the IL-2-dependent proliferation of mouse cytotoxic T cells. J Immunol, 144,
1331–1337.
Millington, O. R., Di Lorenzo, C., Phillips, R. S., Garside, P. and Brewer, J. M.
(2006).  Suppression  of  adaptive  immunity  to  heterologous  antigens  during
Plasmodium  infection  through  hemozoin-induced  failure  of  dendritic  cell
function. J Biol, 5, 5.
Minty, A., Chalon, P., Derocq, J. M., Dumont, X., Guillemot, J. C., Kaghad, M.,
Labit, C., Leplatois, P., Liauzun, P., Miloux, B. and et al. (1993). Interleukin-13
is  a  new  human  lymphokine  regulating  inflammatory  and  immune  responses.
Nature, 362, 248-250.
Mitchell, G. H., Thomas, A. W., Margos, G., Dluzewski, A. R. and Bannister, L. H.
(2004).  Apical  membrane  antigen  1,  a  major  malaria  vaccine  candidate,
mediates the close attachment of invasive merozoites to host red blood cells.
Infect Immun, 72 (1), 154.
Mohan, K., Moulin, P. and Stevenson, M. M. (1997). Natural killer cell cytokine
production,  not  cytotoxicity,  contributes  to  resistance  against  blood-stage
Plasmodium chabaudi AS infection. J Immunol, 159, 4990-4998.200
Mohan, K. and Stevenson, M. M. (1998). Dyserythropoiesis and severe anaemia
associated with malaria correlate with deficient interleukin-12 production. Br J
Haematol, 103 (4), 942-9.
Mohan, K. and Stevenson, M. M. (1998). Interleukin-12 corrects severe anemia
during  blood-stage Plasmodium  chabaudi  AS  in  susceptible  A/J  mice. Exp
Hematol, 26 (1), 45-52.
Mohrs, M.,  Ledermann,  G.,  Kohler,  A.,  Dorfmuller,  A.,  Gessner,  A.  and
Brombacher,  F.  (1999). Differences  between  IL-4-  and  IL-4  receptor  alpha-
deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor
signaling. J Immunol, 162, 7302-8.
Mohrs,  M.,  Holscher,  C.  and  Brombacher,  F.  (2000). Interleukin-4  Receptor
Alpha-Deficient  BALB/c  Mice  Show  an Unimpaired  T  Helper  2  Polarization  in
Response to Leishmania major Infection. Infection and Immunity, 68 (4) 1773-
1780.
Moore,  K.  W.,  de  Waal  Malefyt,  R.,  Coffman,  R.  L. and O’Garra,  A. (2001).
Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol, 19, 683–765.
Mosmann, T. R. and Coffman, R. L. (1987). Two types of mouse helper T-cell
clone: implications for immune regulation. Immunol Today, 8, 223-227.
Mosmann, T. R. and Coffman, R. L.  (1989). Thl and Th2 cells: different patterns
of  lymphokine  secretion  lead  to  different  functional properties. Annu  Rev
Immunol, 7, 145-173.
Mosser, D. M. (2003). The many faces of macrophage activation. J Leukoc Biol,
73 (2), 209-12.
Murray,  H.  M.,  Tsai,  C.  W.,  Liu,  J.  and  Ma,  X.  (2006). Visceral Leishmania
donovani infection in interleukin-13
-/- mice. Infect Immun, 74, 2487-2490.
Nacher, M., Gay, F., Singhasivanon, P., Krudsood, S., Treeprasertsuk, S., Mazier,
D., Vouldoukis, I. and Looareesuwan, S. (2000). Ascaris lumbricoides infection is
associated  with  protection  from  cerebral malaria. Parasite  Immunol, 22  (3),
107-13.201
Namazi, M. J. and Phillips, R. S. (2010). Immune responses of NIH mice infected
with  avirulent  and  virulent  strains  of  Plasmodium  chabaudi  adami  single  and
mixed infections. Korean J Parasitol, 48 (1), 23-33.
Nardin,  E.,  Zavala,  F.,  Nussenzweig,  V.  and  Nussenzweig,  R.  S.  (1999).  Pre-
erythrocytic  malaria  vaccine:  mechanisms  of  protective  immunity  and  human
vaccine trials. Parassitologia, 41, 397-402.
Narum, D. L. and Thomas, A. W. (1994). Differential localization of full-length
and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium
falciparum merozoites. Mol Biochem Parasitol, 67, 59-68.
Nau, G. J., Richmond, J. F., Schlesinger, A., Jennings, E. G., Lander, E. S. and
Young,  R.  A.  (2002).  Human  macrophage  activation  programs  induced  by
bacterial pathogens. Proc Natl Acad Sci USA, 99 (3), 1503-8.
Ndungu, F. M., Cadman, E. T., Coulcher, J., Nduati, E., Couper, E., McDonald,
D. W., Ng, D. and Langhorne, J. (2009). Functional memory B Cells and long-
lived plasma cells are generated after a single Plasmodium chabaudi infection in
mice. PloS Pathogens, 5 (12), e1000690.
Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J. and Paul, W. E. (1999). The
IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol,
17, 701-38.
Neva, F. A., Sheagren, J. N., Shulman, N. R. and Canfield, C. J. (1970). Malaria:
host-defense mechanisms and complications. Ann Intern Med, 73, 295-306.
Newman, K. C., Korbel, D. S., Hafalla, J. C. and Riley, E. M. (2006). Cross-talk
with  myeloid  accessory  cells  regulates  human  natural  killer  cell  interferon
gamma responses to malaria. PLoS Pathog, 2, e118.
Niikura, M., Inoue, S. and Kobayashi, F. (2011). Role of interleukin-10 in malaria:
focusing on coinfection with lethal and non-lethal murine malaria parasites. J
Biomed Biotechnol, 2011, 383962.202
Noble,  A.  and  Kemeny,  D.  M.  (1995). Interleukin-4  enhances  interferon-γ
synthesis but inhibits development of interferon-γ-producing cells. Immunology,
85, 357-363.
Noël, W., Raes, G., Hassanzadeh Ghassabeh, G., De Baetselier, P. and Beschin,
A.  (2004).  Alternatively  activated  macrophages  during  parasite  infections.
Trends Parasitol, 20 (3), 126-33.
Nussenzweig,  V.  and  Nussenzweig,  R.  S.  (1985). Circumsporozoite  proteins  of
malaria parasites. Cell, 42 (2), 401-3.
O'Donnell, R. A., Saul, A., Cowman, A. F. and Crabb, B. S. (2000). Functional
conservation  of  the  malaria  vaccine antigen  MSP-119across  distantly  related
Plasmodium species. Nat Med, 6, 91-95.
O'Donnell, R. A., de Koning-Ward, T. F., Burt, R. A., Bockarie, M., Reeder, J. C.,
Cowman, A. F. and Crabb, B. S. (2001). Antibodies against merozoite surface
protein (MSP)-1(19) are a major component of the invasion-inhibitory response in
individuals immune to malaria. J Exp Med, 193, 1403-1412.
Omer, F. M. and Riley, E. M. (1998). Transforming growth factor beta production
is  inversely  correlated  with  severity  of  murine  malaria  infection. J  Exp  Med,
188, 39-48.
Omer,  F.  M.,  Kurtzhals,  J.  A.  and  Riley,  E.  M.  (2000).  Maintaining  the
immunological  balance  in  parasitic  infections:  a  role  for  TGF-beta? Parasitol
Today, 16 (1), 18-23.
Omer, F. M., de Souza, J. B. and Riley, E. M. (2003). Differential induction of
TGF-beta  regulates  proinflammatory  cytokine  production  and  determines  the
outcome of lethal and nonlethal Plasmodium yoelii infections. J Immunol, 171,
5430-5436.
Ortaldo, J. R., Mason, A. T., O'Shea, J. J., Smyth, M. J., Falk, L. A., Kennedy, I.
C., Longo, D. L. and Ruscetti, F. W. (1991). Mechanistic studies of transforming
growth factor-beta inhibition of IL-2-dependent activation of CD3- large granular
lymphocyte  functions.  Regulation  of  IL-2R  beta  (p75)  signal  transduction. J
Immunol, 146, 3791-3798.203
Osier,  F.  H.,  Fegan, G.,  Polley,  S.  D.,  Murungi, L., Verra,  F., Tetteh, K.  K.,
Lowe, B., Mwangi, T., Bull, P. C., Thomas, A. W., Cavanagh, D. R., McBride, J.
S., Lanar, D. E., Mackinnon, M. J., Conway, D. J. and Marsh, K. (2008). Breadth
and  magnitude  of  antibody  responses  to  multiple Plasmodium  falciparum
merozoite antigens are associated with protection from clinical malaria. Infect
Immun, 76 (5), 2240-8.
Ouma, C., Davenport, G. C., Were, T., Otieno, M. F., Hittner, J. B., Vulule, J.
M., Martinson,  J., Ong'echa,  J. M., Ferrell,  R. E.  and Perkins,  D. J. (2008).
“Haplotypes  of IL-10  promoter  variants  are  associated  with  susceptibility to
severe  malarial  anemia  and  functional  changes  in  IL-10 production,” Human
Genetics, 124 (5), 515–524.
Owens, I. P. (2002). Ecology and evolution. Sex differences in mortality rate.
Science, 297 (5589), 2008–2009.
Paaijmans, K. P., Read, A. F. and Thomas, M. B. (2009). Understanding the link
between malaria risk and climate. Proc Natl Acad Sci USA, 106 (33), 13844-9.
Paaijmans,  K.  P.,  Blanford,  S.,  Bell,  A.  S.,  Blanford,  J.  I.,  Read,  A.  F.  and
Thomas, M, B. (2010). Proc Natl Acad Sci USA, 107 (34), 15135-9.
Palacios, R., Sideras, P., Boehmer, H. (1987). Recombinant interleukin 4/BSF-1
promotes growth and differentiation of intrathymic T cell precursors from fetal
mice in vitro. EMBO J. 6, 91–95.
Parham,  P.  E.  and  Michael,  E.  (2010). Modelling  climate  change  and malaria
transmission. Adv Exp Med Biol, 673, 184-99.
Parham,  P.  E.  and Michael,  E.  (2010). Modeling  the  effects  of  weather  and
climate change on malaria transmission. Environ Health Perspect, 118 (5), 620-
6.
Pasquetto,  V.,  Fidock,  D.  A.,  Gras,  H.,  Badell,  E.,  Eling,  W.,  Ballou,  W.  R.,
Belghiti, J., Tartar, A. and Druilhe, P. (1997). Plasmodium falciparum sporozoite
invasion is inhibited by naturally acquired or experimentally induced polyclonal
antibodies to the STARP antigen. Eur J Immunol, 27, 2502-2513.204
Paul, W. E. (1997). Interleukin 4: signalling mechanisms and control of T cell
differentiation. Ciba Found Symposium, 204, 208-16.
Peluffo,  G.,  Piacenza,  L.,  Irigoin,  F.,  Alvarez,  M.  N.  and  Radi,  R.  (2004).  L-
arginine  metabolism  during  interaction  of  Trypanosoma  cruzi  with  host  cells.
Trends Parasitol. 20 (8), 363-9.
Perlmann,  H.,  Helmby,  H.,  Hagstedt,  M.,  Carlson,  J.,  Larsson,  P. H.,  Troye-
Blomberg,  M.  and  Perlmann,  P.  (1994).  IgE  elevation  and  IgE  anti-malarial
antibodies in Plasmodium falciparum malaria: association of high IgE levels with
cerebral malaria. Clin Exp Immunol, 97, 284-292.
Perlmann,  P.,  Perlmann,  H.,  Looareesuwan, S.,  Krudsood,  S.,  Kano,  S.,
Matsumoto,  Y.,  Brittenham,  G.,  Troye-Blomberg,  M.  and  Aikawa,  M.  (2000).
Contrasting functions of IgG and IgE antimalarial antibodies in uncomplicated
and severe Plasmodium falciparum malaria. Am J Trop Med Hyg, 62, 373-377.
Perry,  J.  A., Rush,  A., Wilson,  R.  J.,  Olver,  C.  S.  and Avery,  A.  C. (2004).
Dendritic cells from malaria-infected mice are fully functional APC. J Immunol,
172, 475–482.
Phillips,  R.  S.,  Mathers,  K.  E.  and  Taylor-Robinson,  A.  W.  (1994). T  cells  in
immunity  to  Plasmodium  chabaudi  chabaudi:  operation  and  regulation  of
different pathways of protection. Res Immunol, 145 (6), 406-12.
Phillips,  R.  S.,  Brannan,  L.  R.,  Balmer,  P.  and  Neuville,  P.  (1997).  Antigenic
variation  during  malaria  infection--the  contribution  from  the  murine  parasite
Plasmodium chabaudi. Parasite Immunol, 19, 427-434.
Phillips, R. S. (2001). Current status of malaria and potential for control. Clin
Microbiol Rev, 14, 208-226.
Pichyangkul, S., Saengkrai, P., Yongvanitchit, K., Stewart, A. and Heppner, D. G.
(1997). Activation of gamma delta T cells in malaria: interaction of cytokines
and a schizont-associated Plasmodium falciparum antigen. J Infect Dis, 176 (1),
233-41.205
Pichyangkul, S., Yongvanitchit, K., Kum-arb, U., Hemmi, H., Akira, S., Krieg, A.
M., Heppner, D. G., Stewart, V. A., Hasegawa, H., Looareesuwan, S., Shanks, G.
D.  and  Miller,  R.  S.  (2004).  Malaria  blood  stage  parasites  activate  human
plasmacytoid  dendritic  cells  and  murine  dendritic  cells  through  a  Toll-like
receptor 9-dependent pathway. J Immunol, 172 (8), 4926-33.
Plebanski, M. and Hill, A. V. (2000). The immunology of malaria infection. Curr
Opin Immunol, 12 (4), 437-41.
Podoba, J. E. and Stevenson, M. M. (1991). CD4
+ and CD8
+ T lymphocytes both
contribute to acquired immunity to blood-stage Plasmodium chabaudi AS. Infect
Immun, 59 (1), 51-58.
Powrie, F., Menon, S. and Coffman, R. L. (1993). Interleukin-4 and interleukin-
10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol, 23 (11),
3043-9.
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J. and Anstey, N. M.
(2007). Vivax malaria: neglected and not benign. Am J Trop Med Hyg, 77, 79-87.
Price, R. N., Douglas, N. M. and Anstey, N. M. (2009). New developments in
Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.
Curr Opin Infect Dis, 22 (5), 430-5.
Pulendran, B., Smith, J. L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E.
and  Maliszewski,  C.  R.  (1999).  Distinct  dendritic  cell  subsets  differentially
regulate the class of immune response in vivo. Proc Natl Acad Sci U S A, 96,
1036-1041.
Punnonen, J., Aversa, G., Cocks, B. G., McKenzie, A. N., Menon, S., Zurawski,
G.,  de  Waal  Malefyt,  R.  and  de  Vries,  J.  E.  (1993).  Interleukin  13  induces
interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human
B cells. Proc Natl Acad Sci U S A, 90, 3730-3734.
Quin, S. J. and Langhorne, J. (2001). Different regions of the malaria merozoite
surface  protein  1  of Plasmodium  chabaudi  elicit  distinct  T-cell  and  antibody
isotype responses. Infect Immun, 69 (4), 2245-2251.206
Quin, S. J., Seixas, E. M., Cross, C. A., Berg, M., Lindo, V., Stockinger, B. and
Langhorne, J. (2001). Low CD4(+) T cell responses to the C-terminal region of
the malaria merozoite surface protein-1 may be attributed to processing within
distinct MHC class II pathways. Eur J Immunol, 31, 72-81.
Radwanska, M., Cutler, A. J., Hoving, J. C., Magez, S., Holscher, C., Bohms, A.,
Arendse, B., Kirsch, R., Hunig, T., Alexander, J., Kaye, P. and Brombacher, F.
(2007). Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to
Leishmania major infection. PLoS Pathog 3:e68-79.
Raes, G., Beschin, A., Ghassabeh, G. H. and De Baetselier, P. (2007).
Alternatively activated macrophages in protozoan infections. Curr Opin
Immunol, 19 (4), 454-9.
Ramanathan, S., de Kosak, Y., Saoudi, A., Goureau, O., Van der Meide, P. H.,
Druet, P. and Bellon, B. (1996). Recombinant IL-4 aggravates experimental
autoimmune uveoretinitis in rats. J Immunol, 157, 2209-2215.
Renia, L., Potter, S. M., Mauduit, M., Rosa, D. S., Kayibanda, M., Deschemin, J.
C., Snounou, G. and Grüner, A. C. (2006). Pathogenic T cells in cerebral malaria.
Int J Parasitol, 36 (5), 547-54.
Reyes, J. L. and Terrazas, L. I. (2007). The divergent roles of alternatively
activated macrophages in helminthic infections. Parasite Immunol, 29 (12), 609-
19.
Riley, E. M., Morris-Jones, S., Blackman, M. J., Greenwood, B. M. and Holder, A.
A. (1993). A longitudinal study of naturally acquired cellular and humoral
immune responses to a merozoite surface protein (MSP1) of Plasmodium
falciparum in an area of seasonal malaria transmission. Parasite Immunol, 15,
513-524.
Riley,  E.  M.  (1999).  Is  T-cell  priming  required  for  initiation  of  pathology  in
malaria infections? Immunol Today, 20, 228-233.207
Riley,  E.  M.,  Wahl,  S.,  Perkins,  D.  J.  and  Schofield,  L.  (2006).  Regulating
immunity to malaria. Parasite Immunol, 28, 35-49.
Roberts,  D.  W.,  Rank,  R.  G.,  Weidanz,  W.  P.  and  Finerty,  J.  F.  (1977).
Prevention  of  recrudescent  malaria  in  nude  mice by  thymic  grafting  or  by
treatment with hyperimmune serum. Infect Immun, 16, 821-826.
Roberts, C. W., Walker, W. and Alexander, J. (2001). Sex-associated hormones
and immunity to protozoan parasites. Clin Microbiol Rev, 14 (3), 476-88.
Robinson,  L.  J.,  D'Ombrain,  M.  C.,  Stanisic,  D.  I.,  Taraika,  J.,  Bernard,  N.,
Richards, J. S., Beeson, J. G., Tavul, L., Michon, P., Mueller, I. and Schofield, L.
(2009).  Cellular  tumor  necrosis  factor,  gamma  interferon,  and  interleukin-6
responses as correlates of immunity and risk of clinical Plasmodium falciparum
malaria in children from Papua New Guinea. Infect Immun, 77 (7), 3033-43.
Sabbatani, S., Fiorino, S. and Manfredi, R. (2010). The emerging of the fifth
malaria parasite (Plasmodium knowlesi). A public health concern? J Infect Dis,
14 (3), 299-309.
Sam, H. and Stevenson, M. M. (1999). Early IL-12 p70, but not p40, production by
splenic macrophages correlates with host resistance to blood-stage Plasmodium
chabaudi AS malaria. Clin Exp Immunol, 117, 343-349.
Schandené L, Alonso-Vega C, Willems F, Gérard C, Delvaux A, Velu T, Devos R,
de Boer M, Goldman M. (1994). B7/CD28-dependent IL-5 production by human
resting T cells is inhibited by IL-10. J Immunol, 152 (9), 4368-74.
Schmieg, J., Gonzalez-Aseguinolaza, G. and Tsuji, M. (2003). The role of natural
killer T cells and other T cell subsets against infection by the pre-erythrocytic
stages of malaria parasites. Microbes Infect, 5, 499-506.
Schmitz, J., Assenmacher, M. and Radbruch, A. (1993). Regulation of T helper
cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur J
Immunol, 23 (1), 191-9.
Schofield,  L.  and  Grau,  G.  E.  (2005).  Immunological  processes  in  malaria
pathogenesis. Nat Rev Immunol, 5 (9), 722-35.208
Sedegah, M., Charoenvit, Y., Minh, L., Belmonte, M., Majam, V. F., Abot, S,
Ganeshan, H., Kumar, S., Bacon, D. J., Stowers, A., Narum, D. L., Carucci, D. J.
and Rogers, W. O. (2004). Reduced immunogenicity of DNA vaccine plasmids in
mixtures. Gene Ther, 11 (5), 448-56.
Seixas, E., Fonseca, L. and Langhorne, J. (2002). The influence of gamma delta T
cells on the CD4+ T cell and antibody response during a primary Plasmodium
chabaudi chabaudi infection in mice. Parasite Immunol, 24 (3), 131-40.
Shankar,  A.  H.  (2000).  Nutritional  modulation  of  malaria  morbidity  and
mortality. J Infect Dis, 182 Suppl 1, S37-53.
Shear, H. L., Marino, M. W., Wanidworanun, C., Berman, J. W. and Nagel, R. L.
(1998). Correlation of increased expression of intercellular adhesion molecule-1,
but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium
yoelii 17XL, a rodent model of cerebral malaria. Am J Trop Med Hyg, 59, 852-
858.
Sher,  A.,  Pearce,  E. and  Kaye,  P.  (2003).  Shaping  the  immune  response  to
parasites: role of dendritic cells. Curr Opin Immunol, 15, 421-429.
Silvie, O., Franetich, J. F., Charrin, S., Mueller, M. S., Siau, A., Bodescot, M.,
Rubinstein, E., Hannoun, L., Charoenvit, Y., Kocken, C. H., Thomas, A. W., Van
Gemert, G. J., Sauerwein, R. W., Blackman, M. J., Anders, R. F., Pluschke, G.
and Mazier, D. (2004). A role for apical membrane antigen 1 during invasion of
hepatocytes  by Plasmodium  falciparum  sporozoites. J  Biol  Chem, 279,  9490-
9496.
Sim, B. K., Chitnis, C. E., Wasniowska, K., Hadley, T. J. and Miller, L. H. (1994).
Receptor  and  ligand  domains  for  invasion  of  erythrocytes  by Plasmodium
falciparum. Science, 264, 1941-1944.
Skamene,  E.,  Stevenson,  M.  M.  and  Lemieux,  S.  (1983).  Murine  malaria:
dissociation  of  natural  killer  (NK)  cell  activity  and  resistance  to  Plasmodium
chabaudi. Parasite Immunol, 5 (6), 557-65.209
Skeen, M. J., Miller, M. A., Shinnick, T. M. and Ziegler, H. K. (1996). Regulation
of  murine  macrophage  IL-12  production.  Activation  of  macrophages  in  vivo,
restimulation in vitro, and modulation by other cytokines. J Immunol, 156 (3),
1196-206.
Slifka, M. K., Matloubian, M. and Ahmed, R. (1995). Bone marrow is a major site
of long-term antibody production after acute viral infection. J Virol, 69, 1895–
1902.
Slifka, M. K., Antia, R., Whitmire, J.K. and Ahmed, R. (1998). Humoral immunity
due to long-lived plasma cells. Immunity 8: 363–372.
Smith, E. C and Taylor-Robinson, A. W. (2003). Parasite-specific immunoglobulin
isotypes during lethal and non-lethal murine malaria infections. Parasitol Res,
89 (1), 26-33.
Smith,  C. M.,  Belz,  G. T., Wilson,  N. S.,  Villadangos,  J. A.,  Shortman,  K.,
Carbone,  F.  R.  and  Heath,  W. R.  (2003).  Cutting  edge:  conventional CD8α
+
dendritic cells are preferentially involved in CTL priming after footpad infection
with herpes simplex virus-1. J Immunol, 170, 4437–4440.
Snow, R. W., Shenton, F. C., Lindsay, S. W., Greenwood, B. M., Bennet, S.,
Wheeler,  J.,  Del  Giudice,  G.,  Verdini,  A.  S.  and  Pessi,  A. (1989).  Sporozoite
antibodies  and  malaria  in  children  in  a  rural  area  of  The  Gambia. Annals  of
tropical medicine and parasitology, 83, 559-568.
Soloway, P.,  Fish,  S.,  Passmore,  H.,  Gefter,  M.,  Coffee,  R.  and  Manser,  T.
(1991). Regulation  of  the  immune  response  to  peptide  antigens:  differential
induction  of  immediate-type  hypersensitivity  and  T  cell  proliferation  due  to
changes  in  either  peptide structure  or  major  histocompatibility  complex
haplotype. J Exp Med, 174 (4), 847-58.
Soulard, V., Roland, J., Sellier, C., Gruner, A. C, Leite-de-Moraes, M., Franetich,
J.  F.,  Rénia,  L.,  Cazenave,  P.  A.  and  Pied,  S.  (2007). Primary  infection  of
C57BL/6 mice with Plasmodium yoelii induces a heterogeneous response of NKT
cells. Infect Immun, 75 (5), 2511-22.210
Sponaas, A. M., Cadman, E. T., Voisine, C., Harrison, V., Boonstra, A., O'Garra,
A.  and  Langhorne,  J.  (2006).  Malaria  infection  changes  the  ability  of  splenic
dendritic cell populations to stimulate antigen-specific T cells. JEM, 203 (6),
1427-1433.
Stager, S., Alexander, J., Carter, K. C., Brombacher, F. and Kaye, P. M. (2003).
Both interleukin-4  (IL-4)  and  IL-4  receptor  alpha  signaling  contribute  to  the
development of hepatic granulomas with optimal antileishmanial activity. Infect
Immun, 71, 4804-4807.
S.  Stager,  J.  Alexander,  A.C.  Kirby,  M.  Botto,  N.V.  Rooijen,  D.F.  Smith,  F.
Brombacher,  P.M.  Kaye.  (2003).  Natural  antibodies  and  complement  are
endogenous adjuvants for vaccine-induced CD8þ T-cell responses. Nat Med, 9
1287-1292.
Stavnezer. J. (1996). Immunoglobulin class switching. Curr Opin Immunol, 8 (2),
199-205.
Stempin, C. C., Dulgerian L. R., Garrido, V. V. and Cerban F. M. (2010). Arginase
in  parasitic  infecitons:  Macrophage  activation,  immunosuppression,  and
intracellular signals. J Biomed Biotechnol, 2010, 683485.
Stephens, R., Albano, F. R., Quin, S., Pascal, B. J., Harrison, V., Stockinger, B.,
Kioussis, D., Weltzien, H. and Langhorne, J. (2005). Malaria-specific transgenic
CD4
+ T  cells  protect  immunodeficient  mice  from lethal  infection  and
demonstrate requirement for a protective threshold of antibody production for
parasite clearance. Blood, 106 (5), 1676-1684.
Stephens, R. and Langhorne, J. (2006). Priming of CD4+ T cells and development
of CD4+ T cell memory; lessons for malaria. Parasite Immunol, 28 (1-2), 25-30.
Stephens, R. and Langhorne, J. (2010). Effector memory Th1 CD4 T cells are
maintained in a mouse model of chronic malaria. PLoS Pathog, 6 (11), e1001208.
Stevenson, M. M. and Riley, E. M. (2004). Innate immunity to malaria. Nat Rev
Immunol, 4, 169-180.211
Stevenson, M. M. and Tam, M. F. (1993). Differential induction of helper T cell
subsets during blood-stage Plasmodium chabaudi AS infection in resistant and
susceptible mice. Clin Exp Immunol, 92, 77-83.
Stevenson,  M.  M.  and  Zavala,  F.  (2006).  Immunology  of  malaria  infections.
Parasite Immunol, 28, 1-4.
Stevenson, M. M., Tam, M. F., Belosevic, M., van der Meide, P. H. and Podoba,
J. E. (1990). Role of endogenous gamma interferon in host response to infection
with blood-stage Plasmodium chabaudi AS. Infect Immun, 58, 3225-3232.
Stevenson, M. M., Huang, D. Y., Podoba, J. E. and Nowotarski, M. E. (1992).
Macrophage  activation  during Plasmodium  chabaudi  AS  infection  in  resistant
C57BL/6 and susceptible A/J mice. Infect Immun, 60, 1193-1201.
Stevenson,  M.  M.,  Su,  Z.,  Sam,  H. and  Mohan,  K.  (2001).  Modulation  of  host
responses  to  blood-stage  malaria  by interleukin-12:  from  therapy  to adjuvant
activity. Microbes Infect, 3, 49-59.
Struik, S. S. and Riley, E. M. (2004). Does malaria suffer from lack of memory?.
Immunol Rev, 201, 268-90.
Su,  Z.  and  Stevenson,  M.  M.  (2002).  IL-12  is  required  for  antibody-mediated
protective  immunity  against  blood-stage Plasmodium  chabaudi AS  malaria
infection in mice. J Immunol, 168, 1348-1355.
Su, Z., Segura, M., Morgan, K., Loredo-Osti, J. C. and Stevenson, M. M. (2005).
Impairment  of  protective  immunity  to  blood-stage  malaria  by  concurrent
nematode infection. Infect Immun, 73, 3531-3539.
Su,  Z.  and  Stevenson,  M.  M.  (2000).  Central  role  of  endogenous  gamma
interferon in protective immunity against blood-stage Plasmodium chabaudi AS
infection. Infect Immun, 68, 4399-4406.
Süss, G., Eichmann, K., Kury, E., Linke, A. and Langhorne, J. (1988) Roles of
CD4- and CD8-bearing T lymphocytes in the immune response to the erythrocytic
stages of Plasmodium chabaudi. Infect Immun, 56, 3081–3088.212
Suzuki, Y., Yang, Q., Yang, S., Nguyen, N., Lim, S., Liensenfeld, O., Kojima, T.
and  Remington,  J.  S. (1996). IL-4  is  protective  against  development  of
toxoplasmic encephalitis. J Immunol, 157, 2564-2569.
Swain, S. L, Bradley, L. M, Croft, M., Tonkonogy, S., Atkins, G., Weinberg, A. D.,
Duncan, D. D, Hedrick, S. M., Dutton, R. W. and Huston, G. (1991). Helper T-cell
subsets:  phenotype,  function  and  the  role  of  lymphokines  in  regulating  their
development. Immunol Rev, 123, 115-44.
Taniguchi, T., Tachikawa, S., Kanda, Y., Kawamura, T., Tomiyama-Miyaji, C., Li,
C., Watanabe, H., Sekikawa, H. and Abo, T. (2007). Malaria protection in beta 2-
microglobulin-deficient  mice  lacking  major  histocompatibility  complex  class  I
antigens:  essential  role  of  innate  immunity,  including  gammadelta  T  cell.
Immunol, 122 (4), 514-21.
Taylor, R. R., Egan, A., McGuinness, D., Jepson, A., Adair, R., Drakely, C. and
Riley,  E.  (1996)  Selective recognition  of  malaria  antigens  by  human  serum
antibodies  is  not  genetically determined  but  demonstrates  some  features  of
clonal imprinting. Int Immunol, 8, 905–915.
Taylor-Robinson, A. W. and Phillips, R. S. (1992). Functional characterization of
protective  CD4+  T-cell  clones  reactive  to  the  murine  malaria  parasite
Plasmodium chabaudi. Immunology, 77, 99-105.
Taylor-Robinson, A. W. and Phillips, R. S. (1993). Protective CD4+ T-cell lines
raised against Plasmodium chabaudi show characteristics of either Th1 or Th2
cells. Parasite Immunol, 15, 301–310.
Taylor-Robinson, A. W. and Phillips, R. S. (1994a). B cells are required for the
switch from Th1- to Th2-regulated immune responses to Plasmodium chabaudi
chabaudi infection. Infect Immun, 62, 2490-2498.
Taylor-Robinson,  A.  W.  and  Phillips,  R.  S.  (1994b).  Th1  and  Th2  CD4+  T  cell
clones  specific  for Plasmodium  chabaudi but  not  for  an  unrelated  antigen
protect against blood stage P. chabaudi infection. Eur J Immunol, 24, 158-164.213
Taylor-Robinson, A. W., Phillips, R. S., Severn, A., Moncada, S. and Liew, F. Y.
(1993). The role of TH1 and TH2 cells in a rodent malaria infection. Science,
260, 1931-1934.
Taylor-Robinson,  A.  W.  (1995). Regulation  of  immunity  to  malaria:  valuable
lessons learned from murine models. Parasitol Today, 11 (9), 334-42.
Terrazas,  C.  A.,  Terrazas,  L.  I.  and  Gómez-Garcia,  L.  (2010). Modulation  of
dendritic cell responses by parasites: A Common Strategy to Survive. Journal of
Biomed and Biotechnol, 2010, 357106.
Thawani, N., Tam, M. and Stevenson, M. M. (2009).STAT6-mediated suppression
of erythropoiesis in an experimental model of malarial anemia. Haematologica,
94, 195-204.
Trape, J. F., Pison, G., Spiegel, A., Enel, C. and Rogier, C. (2002). Combating
malaria in Africa. Trends Parasitol, 18, 224-230.
Trenn, G., Takayama, H., Hu-Li, J., Paul, W. E. and Sitkovsky, M. V. (1988). B
cell stimulatory factor 1 (IL-4) enhances the development of cytotoxic T cells
from Lyt-2_ resting murine T lymphocytes. J. Immunol, 140, 1101–1106.
Troye-Blomberg, M., Worku, S., Tangteerawatana, P., Jamshaid, R., Söderström,
K.,  Elghazali,  G.,  Moretta,  L.,  Hammarström,  M.  and  Mincheva-Nilsson,  L.
(1999).  Human  gamma  delta  T  cells  that  inhibit  the  in  vitro  growth  of  the
asexual  blood  stages  of  the  Plasmodium  falciparum  parasite express  cytolytic
and proinflammatory molecules. Scand J Immunol, 50 (6), 642-50.
Tsutsui, N. and Kamiyama, T. (1999). Transforming growth factor beta-induced
failure of resistance to infection with blood-stage Plasmodium chabaudi in mice.
Infect Immun, 67, 2306-2311.
Urban, B. C., Ing, R. and Stevenson, M. M. (2005). Early interactions between
blood-stage plasmodium parasites and the immune system. Curr Top Microbiol
Immunol, 297, 25-70.214
Uzonna,  J.  E.,  Wei,  G.,  Yurkowski,  D.  and  Bretscher,  P.  (2001).  Immune
elmination  of Leishmania  major  in  mice:  implications  for  immune  memory,
vaccination, and reactivation disease. J Immunol, 167 (12), 6967-74.
van der Heyde, H. C., Pepper, B., Batchelder, J., Cigel, F. and Weidanz, W. P.
(1997).  The  time  course  of selected  malarial  infections  in  cytokine-deficient
mice. Exp Parasitol, 85, 206-213.
van der Heyde, H. C., Batchelder, J. M., Sandor, M. and Weidanz, W. P. (2006).
Splenic γδ T  Cells regulated  by  CD4
+ T cells are required to  control chronic
Plasmodium chabaudi malaria in the B-Cell-deficient mouse. Infect Immun, 74
(5), 2717-2725.
van der Heyde, H. C., Pepper, B., Batchelder, J., Cigel, F. and Weidanz, W. P.
(1997).  The  time  course  of  selected  malarial  infections  in  cytokine-deficient
mice. Exp Parasitol, 85 (2), 206-13.
von der Weid, T., Kitamura, D., Rajewsky, K. and Langhorne, J. (1994a). A dual
role for B cells in Plasmodium chabaudi chabaudi (AS) infection? Res Immunol,
145, 412-419.
von der Weid, T., Kopf, M., Kohler, G. and Langhorne, J. (1994b). The immune
response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J
Immunol, 24, 2285-2293.
von der Weid, T., Honarvar, N. and Langhorne, J. (1996). Gene-targeted mice
lacking  B  cells  are  unable  to  eliminate  a  blood-stage  malaria  infection. J
Immunol, 156, 2510–2516.
Waki, S., Uehara, S., Kanbe, K., Nariuch, H. and Suzuki, M. (1995). Interferon-
gamma  and  the  induction  of  protective  IgG2a  antibodies  in  non-lethal
Plasmodium berghei infections of mice. Parasite Immunol, 17, 503-508.
Walther,  M.,  Woodruff,  J.,  Edele,  F.,  Jeffries,  D.,  Tongren,  J.  E.,  King,  E.,
Andrews, L., Bejon, P., Gilbert, S. C., De Souza, J. B., Sinden, R., Hill, A. V. and
Riley, E. M. (2006). Innate immune responses to human malaria: heterogeneous
cytokine  responses  to  blood-stage  Plasmodium  falciparum  correlate  with
parasitological and clinical outcomes. J Immunol, 177 (8), 5736-45.215
Weinbaum,  F.  I.,  Evans,  C.  B.  and  Tigelaar,  R.  E.  (1976).  Immunity  to
Plasmodium Berghei yoelii in mice. I. The course of infection in T cell and B cell
deficient mice. J Immunol, 117, 1999-2005.
Weindanz, W. P., LaFleur, G., Brown, A., Burns, J. M., Gramaglia, I. and van der
Heyde, H. C. (2010). γδ T cells but not NK cells are essential for cell-mediated
immunity against Plasmodium chabaudi malaria. Infect Immun, 78 (10), 4331-
4340.
Weiss, W. R., Kumar, A., Jiang, G., Williams, J., Bostick, A., Conteh, S., Fryauff,
D., Aguiar,  J.,  Singh, M.,  O’Hagan,  D.,  Ulmer,  J.  and  Richie,  T.  (2007).
Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine
depends  on optimal  DNA  priming  and  inclusion  of  blood  stage antigens. PLoS
One, 2, e1063.
White, W. I., Evans, C. B. and Taylor, D. W. (1991). Antimalarial antibodies of
the immunoglobulin G2a isotype modulate parasitemias in mice infected with
Plasmodium yoelii. Infect Immun, 59, 3547-3554.
World  Health  Organization.  World  Malaria  Report. (2008). Available  online  at
http://whqlibdoc.who.int/publications/2008/9789241563697_eng.pdf
World Health Organization. Malaria. Fact sheet No 94. (2010). Available online at
http://www.who.int/mediacentre/factsheets/fs094/en/index.html
Wilson,  E. H.,  Wille-Reece,  U.,  Dzierszinski,  F.  and  Hunter,  C. A.  (2007). A
critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J
Neuroimmunol, 165 (1-2), 63-74.
Wilson, S., Jones, F. M., Mwatha, J. K., Kimani, G., Booth, M., Kariuki, H. C.,
Vennervald,  B.  J.,  Ouma,  J.  H.,  Muchiri,  E.  and  Dunne,  D.  W. (2009).
Hepatosplenomegaly associated with chronic malaria exposure: evidence for a
pro-inflammatory mechanism exacerbated by shistosomiasis. Parasite Immunol,
31 (2), 64-71.216
Wunderlich,  F.,  Marinovski,  P.,  Benten,  W. P.,  Schmitt-Wrede,  H.  P.  and
Mossmann,  H.  (1991). Testosterone  and  other  gonadal  factor(s)  restrict  the
efficacy  of  genes  controlling  resistance  to  Plasmodium  chabaudi  malaria.
Parasite Immunol, 13 (4), 357-67
Wykes, M. N., Zhou, Y. H., Liu, X. Q. and Good, M. F. (2005). Plasmodium yoelii
can ablate vaccine-induced long-term protection in mice. J Immunol, 175 (4),
2510-6.
Xu,  H.,  Wipasa,  J.,  Yan,  H.,  Zeng,  M.,  Makobongo,  M.  O.,  Finkelman,  F.  D.,
Kelso, A. and Good, M. F. (2002). The mechanism and significance of deletion of
parasite-specific CD4+ T cells in malaria infection. J Exp Med, 195 (7), 881-92.
Yanez, D. M., Manning, D. D., Cooley, A. J., Weidanz, W. P. and van der Heyde,
H. C. (1996). Participation of lymphocyte subpopulations in the pathogenesis of
experimental murine cerebral malaria. J Immunol, 157 (4), 1620-4.
Yoneto, T., Yoshimoto, T., Wang, C. R., Takahama, Y., Tsuji, M., Waki, S. and
Nariuchi,  H.  (1999).  Gamma  interferon  production  is  critical  for  protective
immunity to infection with blood-stage Plasmodium berghei XAT but neither NO
production nor NK cell activation is critical. Infect Immun, 67 (5), 2349-56.
Yoneto,  T.,  Waki,  S.,  Takai,  T.,  Tagawa,  Yi.,  Iwakura,  Ylk  Mizuguchi,  J.,
Nariuchi, H. and Yoshimoto, T. (2001). A critical role of Fc receptor-mediated
antibody-dependent  phagocytosis  in  the  host  resistance  to  blood-stage
Plasmodium berghei XAT infection. J Immunol, 166 (10), 6236-41.
Yu,  K., Mitchell,  C., Xing,  Y., Magliozzo,  R.  S., Bloom, B.  R.  and Chan, J.
(1999).Toxicity  of  nitrogen  oxides  and  related  oxidants  on  mycobacteria: M.
tuberculosis is resistant to peroxynitrite anion. Tubercle Lung Dis, 79, 191–198.
Zhang,  S.,  Kim,  C.  C.,  Batra,  S.,  McKerrow,  J.  H.  and  Loke,  P.  (2010).
Delineation  of  diverse  macrophage  activation  programs  in  response  to
intracellular parasites and cytokines. PLoS Negl Trop Dis, 4 (3), e648.217
Zhang, J. G., Hilton, D. J., Willson, T. A., McFarlane, C., Roberts, B.A., Moritz,
R.L.,  Simpson,  R.J.,  Alexander,  W. S.,  Metcalf,  D.  and Nicola,  N. A. (1997).
Identification, purification, and characterization of a soluble interleukin (IL)-13-
binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-
4 receptor alpha-chains. J Biol Chem, 272, 9474-9480.
Zhang,  Z., Chen,  L.,  Saito, S.,  Kanagawa,  O.  and  Sendo,  F.  (2000). Possible
modulation  by  male  sex  hormone  of  Th1/Th2  function  in  protection  against
Plasmodium chabaudi chabaudi AS infection in mice. Exp Parasitol, 96 (3), 121-
9.
Zinkernagel,  R.  M.  and  Hengartner,  H.  (2006). Protective  ‘immunity’  by  pre-
existent neutralizing antibody titers and preactivated T cells but not by so-called
‘immunological memory’. Immunol Rev, 211, 310–319.
Zuk, M and McKean, K. A. (1996). Sex differences in parasite infections: patterns
and processes. Int J Parasitol, 26 (10), 1009-23.
Zurawski, G. and de Vries, J. E. (1994). Interleukin 13 elicits a subset of the
activities of its close relative interleukin 4. Stem Cells, 12, 169-174.
Zurawski, G. and de Vries, J. E. (1994). Interleukin 13, an interleukin 4-like
cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today,
15,19-26.